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The use of ozone for the transformation of alkenes to carbonyls has been well
established. The reaction of ozone with alkenes in this fashion generates either a 1,2,4trioxolane (ozonide) or a hydroperoxyacetal, either of which must undergo a separate
reduction step to provide the desired carbonyl compound. There is considerable interest
in being able to perform a reductive ozonolysis to directly provide the carbonyl. Previous
reports from the Dussault lab have shown that amine N-oxides are able to perform a
reductive ozonolysis. In the course of efforts to expand this reaction to other oxyanions it
was realized that water was also able to efficiently perform a net reductive ozonolysis via
nucleophilic capture of the carbonyl oxide. This transformation was investigated for a
variety of substrates and was shown to offer a useful alternative to conventional
ozonolysis conditions.
Malaria is a global health epidemic that affects between 300-500 million people
annually, with the most deadly strain being P. falciparum. The current treatment for
malaria is artemisinin combination therapy, but the development of artemisinin-resistant
strains of malaria has spurred the need for the development of new treatments. 1,2,4Trioxolanes exhibit high efficacy against malaria, but concerns remain about their

thermal and serum stability. Our analysis of the likely mechanism of action of ozonides
guided our development of structurally related 3-alkoxy-1,2-dioxolanes as a potential
treatment for malaria. This class of compounds has shown to possess high levels of
activity against P. falciparum in vitro. The synthesis of these dioxolanes required the
development of new synthetic routes, which will be discussed in detail, as will efforts to
optimize the activity of 3-alkoxy-1,2-dioxolanes.

In addition, the synthesis and

evaluation of 1,2,4-trioxepanes as potential antimalarials was explored.
In the course of our investigation into the synthesis of 3-alkoxy-1,2-dioxolanes,
we found Re (VII) oxide to be an effective catalyst for the transetherification of 3-alkoxy1,2-dioxolanes.

Re (VII) oxide was briefly explored as a catalyst for allylation or

etherification reactions that involve stabilized carbocations as intermediates.

iii
Acknowledgements

First, I would like to thank my advisor, Professor Patrick Dussault for his help and
guidance. I am grateful for all the time he spent helping me and his patience. I believe
that he has helped me become a better scientist.
I would like to thank the members of my committee: Prof. Takacs, Prof. Du, Prof.
Nickerson, Prof. Redepenning, and Prof. Choe. I am indebted to the help that Joe
Dumais and Sara Basiaga provided on the NMR and the other small instruments.
Without the help of Sergio Wittlin and Matthias Rottman, who performed the
antimalarial screening, and Tony Lloyd, from EHS who helped with the shipments, I
would have no biological data and I thank them. I also thank Prof. Jonathan Vennerstrom
and Yuxiang Dong at the University of Nebraska-Medical Center for there guidance on
medicinal chemistry.
I would like to thank Chris Schwartz, Chunping Xu, Roman Schepin, and
Prasanta Ghorai for helping me during my first year. I thank Brad Johnson for
challenging me and for the lively white board discussions that we would have. I am also
grateful for all of the current group members who have helped me.
I am fortunate for having parents who have been supportive of me through this
journey. They never doubted me and provided encouragement at all the right times.
Finally, I would like to thank my fiancée Van Nguyen Mai for her help, support, and
guidance. She has been a true pillar of stability for me during this journey.

iv
Chapter 1: Improved procedure for alkene ozonolysis .................................................. 1
Section 1............................................................................................................................. 2
Section 1.1 Mechanism of ozonolysis ............................................................................. 2
Section 1.2 Issues with O3 in synthesis............................................................................ 3
Section 1.3 Reductive ozonolysis using N-Oxides .......................................................... 4
Section 1.4 Reductive ozonolysis using water................................................................. 5
Section 2............................................................................................................................. 6
Section 2.1 Rationale ...................................................................................................... 6
Section 2.2 Initial phase transfer studies.......................................................................... 7
Section 2.3 Anhydrous tetrabutyl ammonium salts .........................................................8
Section 2.4 Water as a trap .............................................................................................. 9
Section 2.5 Substrate scope............................................................................................ 13
Section 2.6 Conclusions................................................................................................. 15
Section 2.7 Experimentals ............................................................................................. 15
Section 3 References........................................................................................................ 25
Chapter 2: 3-Alkoxy-1,2-dioxolanes as potential antimalarials ................................ 28
Section 1........................................................................................................................... 29
Section 1.1 Malaria ........................................................................................................ 29
Section 1.2 Antimalarial treatments............................................................................... 30
Section 1.3 Artemisinin as a treatment for malaria........................................................31
Section 1.4 Mechanism of Fe-mediated artemisinin degradation..................................31
Section 1.5 Artemisinin mechanism of action against malaria...................................... 33
Section 1.6 Vennerstrom’s ozonides.............................................................................. 34

v
Section 1.7 Rationale for 3-alkoxy-1,2-dioxolanes ....................................................... 36
Section 2............................................................................................................................. 38
Section 2.1 Previous synthesis of 1,2-dioxolanes..........................................................38
Singlet oxygen ......................................................................................................... 38
DePuy ring expansion .............................................................................................. 40
Thermolysis.............................................................................................................. 41
Conjugate addition to α-β-unsaturated carbonyls .................................................... 42
Ozonolysis of enol ethers......................................................................................... 42
Radical cyclization................................................................................................... 43
Electrophilic cyclization .......................................................................................... 45
Section 2.2 Reactions of 1,2-dioxolan-3-ols and 3-alkoxy-1,2-dioxolanes................... 47
Acid-mediated etherification ................................................................................... 47
Base-mediated etherification ................................................................................... 48
Allylation of 3-alkoxy-1,2-dioxolanes..................................................................... 49
Section 3............................................................................................................................. 50
Section 3.1 Early work on 3-alkoxy-1,2-dioxolanes ..................................................... 50
Section 3.2 Synthesis of 3-alkoxy-1,2-dioxolanes......................................................... 51
Section 3.3 Antimalarial results..................................................................................... 56
Section 4............................................................................................................................. 58
Section 4.1 Rationale for new series.............................................................................. 58
Section 4.2 Incorporation of spirocycle at C5/5’ ........................................................... 59
Section 4.3 Effect of ring size at C5/5’.......................................................................... 63
Section 4.4 Improved leaving group.............................................................................. 64

vi
Section 4.5 Spirocyclic 3-alkoxy-1,2-dioxolanes ..........................................................69
Section 4.6 Future directions ......................................................................................... 72
Section 5............................................................................................................................. 74
Section 5.1 Esters........................................................................................................... 74
Rationale .................................................................................................................. 74
Synthesis .................................................................................................................. 75
Antimalarial results and analysis ............................................................................. 77
Section 5.2 Alcohols ...................................................................................................... 78
Rationale .................................................................................................................. 78
Synthesis .................................................................................................................. 78
Antimalarial results and analysis ............................................................................. 79
Section 5.3 Derivatized alcohol ..................................................................................... 80
Rationale .................................................................................................................. 80
Synthesis and antimalarial results............................................................................ 81
Section 5.4 Other functional groups .............................................................................. 81
Rationale .................................................................................................................. 81
Synthesis and antimalarial results............................................................................ 82
Section 5.5 Animal studies ............................................................................................ 82
Section 5.6 Stability of 3-alkoxy-1,2-dioxolanes .......................................................... 83
Section 5.7 Future work................................................................................................. 83
Section 6 Experimentals .................................................................................................... 86
Section 7 References........................................................................................................ 163
Chapter 3: 1,2,4-Trioxepanes as potential antimalarials ......................................... 173

vii
Section 1 Previous synthesises....................................................................................... 174
Acid displacement.................................................................................................. 174
Cobalt-mediated peroxidation................................................................................ 175
Oxetane opening .................................................................................................... 179
Thiol-Olefin-Co-Oxygenation ............................................................................... 180
Singlet oxygen ....................................................................................................... 181
Electrophilic cyclization ........................................................................................ 182
Ozonolysis.............................................................................................................. 183
Section 2 Rationale ........................................................................................................ 184
Section 3 Results and discussion ................................................................................... 185
Section 4 Antimalarial results........................................................................................ 189
Section 5 Experimentals ................................................................................................ 190
Section 6 References...................................................................................................... 200
Chapter 4: Re (VII) oxide as a catalyst for the generation of stabilized
carbocations.................................................................................................................... 202
Section 1 Previous work ................................................................................................ 203
Isomerization of allylic alcohols by rhenium......................................................... 203
Utilization in Prins cyclization............................................................................... 205
Section 2 Hypothesis...................................................................................................... 206
Section 3 Etherification/acetalization of 3-alkoxy-1,2-dioxolanes................................ 206
Section 4 Etherification of lactols.................................................................................. 208
Section 5 Allylation ....................................................................................................... 209
Section 6 Stabilized carbocations .................................................................................. 210

viii
Section 7 Conclusions.................................................................................................... 212
Section 8 Experimentals ................................................................................................ 213
Section 9 References...................................................................................................... 220

1
Chapter 1
Improved procedure for alkene ozonolysis

This chapter discusses the mechanism of ozonolysis and the trapping of the
carbonyl oxide by various nucleophiles. In addition, the use of water in a reductive
ozonolysis fashion will be discussed.

Section 1: Mechanism of ozonolysis and previous work involving trapping of
the carbonyl oxide
Section 2: Trapping of the carbonyl oxide with water
Section 3: References

2
Section 1
Section 1.1: Mechanism of ozonolysis
Section 1.2: Issues with O3 in synthesis
Section 1.3: Reductive ozonolysis using N-oxides
Section 1.4: Reductive ozonolysis using water

Ozonolysis is a powerful synthetic tool for the cleavage of alkenes to their
corresponding carbonyl compounds.

The use of ozonolysis in synthesis and as a

synthetic tool has been extensively reviewed.1-5

In this chapter, I will review the

mechanism of ozonolysis with a focus on trapping of the carbonyl oxide.
Section 1.1
Mechanism of ozonolysis
The postulated mechanism of ozonolysis has been extensively reviewed.6-10
The Criegee mechanism for ozonolysis is now widely accepted. The first step of,
the Criegee mechanism of ozonolysis is the cycloaddition of ozone to an alkene
generating a 1,2,3-trioxolane (primary ozonide), 2. The primary ozonide is a short lived
species that undergoes fragmentation to the carbonyl oxide (3) and carbonyl.

The

carbonyl oxide can undergo cyclization with a carbonyl group, either the co-generated
species or an exogenously added reagent, to form a 1,2,4-trioxolane (secondary ozonide),
4. The rate of this cycloaddition is related to the dipolarophilicity of the carbonyl, with
aldehyde and electron-poor ketones reacting most rapidly.9 Alternatively, in the presence
of a nucleophile the carbonyl oxide will be trapped forming a hydroperoxy acetal (5).
The best nucleophile for the trapping of the carbonyl oxide is a primary alcohol.6 The

3
ozonides and hydroperoxyacetals are often reduced in a separate step to furnish carbonyl
products.
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Recent isotopic labeling studies directly support the Criegee mechanism. In 1998,
Berger reported NMR studies of the trapping of 17O-labeled benzaldehyde in ozonolysis.
Isotopically labeled ozonide 8 with the 17O in the ether was the sole ozonide isolated and
gives support for the intermediacy of the carbonyl oxide during ozonolysis.11 The lack of
17

O in the peroxide argues against some more complicated mechanisms, which have been

proposed as an alternative to the Criegee mechanism.10,12,13

Section 1.2
Issues with O3 in synthesis
The use of ozonolysis as a synthetic tool is to some degree limited by the need to
employ a separate reduction step to convert the ozonide or peroxide intermediates to the
desired carbonyl compound.

The use of powerful reducing agents such as BH3,14

Zn/HOAc,15 and LiAlH416 can lead to compatibility issues with other functional groups.
The use of a milder reducing agent such as Me2S17 can lead to incomplete reduction of

4
the ozonide. The use of PPh3 usually leads to complete reduction of the ozonide, but the
resulting O=PPh3 needs to be removed from the final product.18
Section 1.3
Reductive ozonolysis using N-oxides
The development of a reductive ozonolysis approach is desired as it would
eliminate the need for a separate reduction step. A second advantage to this approach is
that the reduction takes time, while with reductive ozonolysis the reduction is complete
when the ozonolysis is complete. The Dussault lab has an interest in affecting the
outcome of ozonolysis through intercepting the carbonyl oxide. It was postulated that
since alcohols9 are capable of trapping the carbonyl oxide it possible that another oxygen
nucleophile would also be successful. The use of dimethyl sulfoxide had been previously
reported and prompted the exploration of other oxyanions.19,20
In the course of these explorations, our lab has shown that a variety of N-oxides
are able to trap the carbonyl oxide and produce the desired carbonyl in a one-pot
manner.21,22 The postulated mechanism for this reaction involves addition of N-oxide to
carbonyl oxide 3 to form tetrahedral intermediate 9. Intermediate 9 then undergoes
fragmentation to provide aldehyde 6. The only byproducts of this reaction are oxygen
and the corresponding amine.
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Section 1.4
Reductive ozonolysis using water
These results, in conjunction with the known reactivity of alcohols and carbonyl
oxides, made us wonder if water was able to trap the carbonyl oxide. A literature search
revealed that trapping of the carbonyl oxide with water has been mainly reported in the
literature related to atmospheric (gas phase) ozonolysis reactions.23-26

There are a

handful of relevant examples in solution. Pryor and Church reported that the ozonolysis
of fatty acids in emulsions produced aldehydes and a stoichiometric amount of hydrogen
peroxide.27,28 In 1998, Von Sonntag explored the ozonolysis of ethene and its derivatives
and found a similar result.29 In 1982, Niki explored the relative reactivity of various
protic solvents towards the carbonyl oxide.30 The ozonolysis of tetramethylethylene with
methanol and water revealed that methanol was a superior trap of the carbonyl oxide. In
all of the literature the proposed mechanism involves intermediate 11, which fragments to
generate the aldehyde and one equivalent of hydrogen peroxide.

In 2007, Molander reported the cleavage of alkene 13 to ketone 14.31 What is
notable about this approach is the high yield obtained even at -70oC. This substrate
formed stable ozonides, that were difficult to reduce, and this procedure was one of
several explored. The use of this procedure on another alkene (styrene analog of 13) led
to a mixture of products and this reaction was not explored.
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Section 2
This section describes my attempts to trap the short lived carbonyl oxide
intermediate generated in ozonolysis to directly provide a carbonyl in a “reductive”
ozonolysis.

Section 2.1: Rationale
Section 2.2: Initial phase transfer studies
Section 2.3: Anhydrous tetrabutyl ammonium salts
Section 2.4: Water as a trap
Section 2.5: Substrate scope
Section 2.6: Conclusions
Section 2.7: Experimentals
Section 2.8: References
Section 2.1
Rationale
Previous research in the Dussault lab had demonstrated that trapping of carbonyl
oxides by nucleophilic amine oxides led to the direct formation of carbonyl groups by the
formation and decomposition of an unstable tetrahedral intermediate containing a
peroxyanion as well as an oxyammonium salt (Section 1.3). I became interested in
whether this process was limited to oxyammonium species or was general for species
containing a nucleophilic oxygen connected weakly to another heteroatom (periodate for
example).

As will be discussed below, my results suggest that the reductive

fragmentation may be possible for other fragments combining a nucleophilic oxygen with
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an easily cleaved oxygen-heteroatom bond. However, in the course of this work I
discovered conditions for the highly efficient trapping of water to afford the desired
carbonyl compound.

Initially, sodium periodate was chosen to test this hypothesis as it possess a
nucleophilic oxyanion, is commercially available, and is cheap.

NaIO4 would be

solubilized in water and the interaction with the carbonyl oxide of decene would be
facilitated by a phase transfer agent.
Section 2.2
Initial phase transfer studies
As expected under aprotic ozonolysis conditions, the ozonide was formed as the
major product (Table 1.1 entry 1). To my delight, ozonolysis in the presence of water,
CH2Cl2, a phase-transfer agent, and periodate switched the selectivity and aldehyde was
isolated as the major product (Entry 2). CCl4, a non-polar aprotic solvent, was not
suitable and led to the ozonide being formed as the major product. Commercial bleach
(Entry 4) and oxone (Entry 5) could be used as additives to afford aldehyde 16. To rule
out periodate performing a Hon fragmentation32 (E1CB), pure ozonide was resubjected to
the reaction conditions and no further reaction was observed.
A control reaction which included water and a phase-transfer catalyst but which
omitted the oxyanion nucleophile also produced aldehyde in good yield (Entry 6). This
suggests that water is able to trap the carbonyl oxide. This result led me to question the
relative contributions of water and the oxyanion nucleophile in promoting the apparent
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fragmentation. Water appears capable of trapping the carbonyl oxide and the resulting
intermediate undergoes decomposition to the desired product. When water and NaIO4
are used together it is unclear which species is trapping the carbonyl oxide. To answer
this question two different approaches were taken.

Entry

Additive
(eq)
None
NaIO4 (1)
NaIO4 (1)
NaOCl (1)
Oxone (1)
None

H2O
(eq)
0
92
92
0
92
92

TBABr
(eq)
0
0.1
0.1
0.1
0.1
(0.3)

Solvent

1
CH2Cl2
2
CH2Cl2
3
CCl4
4
CH2Cl2
5
CH2Cl2
6
CH2Cl2
Table 1.1
Initial screen of various additives and decene

Yield (%)
16
13
32
3
42
30
42

Yield (%)
17
72
8
34
11
9
9

Section 2.3
Anhydrous tetrabutyl ammonium salts
A variety of anhydrous oxyanions solubilized with a bulky quaternary ammonium
salt were screened to determine if a oxyanion is capable of trapping the carbonyl oxide
(Table 1.2). It was found that various anhydrous oxyanions are able to trap the carbonyl
oxide to form nonanal, 16, in a one pot manner (Entries 4-7). For reasons of economy
TBAIO4 was chosen to find optimal conditions. Increasing the equivalents of O3 (Entry 2
vs. 3) improved the yield of aldehyde. The reason for this improvement is unclear as
previous reactions all appeared to go to completion.

In the presence of super

stoichiometric amounts of TBAIO4 the yield of aldehyde is tripled (Entry 4). This
method is capable of providing a synthetically useful yield of nonanal, but the need for a
large excess of reagent complicates purification.

9

Yield (%) 16
Yield (%) 17
Entry Additive (eq) Ozone (eq)A
1
None
1.2
13
72
2
TBAIO4 (1)
1.2
35
ND
3
TBAIO4 (1)
1.7
55
ND
4
TBAIO4 (3)
1.7
72
17
5
TBANO2 (1)
1.2
38
13
6
TBANO3 (1)
1.2
38
13
7
TBAOCN (1)
1.2
32
25
8
TEMPO (1)
1.2
None by TLC
Present by TLC
Table 1.2 Screen of various anhydrous salts and their ability to influence the
formation of aldehyde
A
Based upon calibration of delivery against a known substrate
Section 2.4
Water as a trap
With the knowledge that water is able to trap the carbonyl oxide, it became
necessary to determine the optimum trapping conditions (Table 1.3). A screen was
performed based upon monitoring (NMR) the relative yields of nonanal (16) vs. decene
ozonide (17) derived upon ozonolysis of decene under a given set of conditions. It was
found the addition of water in the absence of a phase transfer agent led to a lower yield of
both aldehyde and ozonide (Entry 2). Widely varying results for the reaction in CH2Cl2
vs. CCl4 suggests a key factor could be solvent polarity and/or the amount of solubilized
water (Entries 3-5).

We therefore hypothesized that higher yields of aldehyde should be

obtained in a water-miscible solvent such as acetone or acetonitrile. This hypothesis was
found to be true (Entries 7-9). When water immiscible ethyl acetate was employed the
yield of aldehyde decreased (Entry 10).

10

Entry

Phase Transfer
(eq)
1
None
2
None
3
TBABr (1)
4
TBAHSO4 (.1)
5
TBABr (0.1)
7
None
8
None
9
None
10
None
Table 1.3 a Isolated yields
Yields determined by NMR

Water
(eq)
None
18
92
92
92
92
18
18
18

Solvent

Yield (%)
16
13a
8
54
33
12
46
67
42
35

DCM
DCM
DCM
DCM
CCl4
Acetone
Acetone
MeCN
EtOAc

Yield (%)
17
72a
21
ND
9
59
2.9
6
8
6

The relative volatility of nonanal led to relatively low isolated yields, and we
developed a screen based upon the oxidation of 9-decenyl acetate, which would generate
a less volatile product. This approach led to similar trends as those present in Table 1.4,
namely, that the use of a non-polar solvent led to poor yields (Entry 4), while the use of
more polar CH2Cl2 led to good yields (Entries 2-4) in the presence of a phase transfer
agent. As was expected the use of acetone led to good yield of aldehyde (Entry 6).
CH2
H

AcO(H2C)8

+
H

AcO(H2C)8

18

Entry Phase Transfer
(eq)
1
None
2
TBABr (0.1)
3
TBABr (1)
4
TBABr (0.1)
5
TBABr (0.1)a
6
None

O O

O
O3

Water (eq)

Solvent

None
92
92
92
92
18

DCM
DCM
DCM
CCl4
DCM
Acetone

O

AcO(H2C)8

19

20

Yield (%)
19
13
42
72
12
63
72

Table 1.4 Use of 9-decenylacetate as an ozonolysis substrate
a
NaHCO3 added

Yield (%)
20
72
9
17
59
9
14
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It was unknown what effect varying amounts of solubilized water would have on
the reaction. To determine this, I investigated the ozonolysis of alkene 18 in acetonitrile
and acetone containing varying amounts of solubilized water. New bottles of solvent
were utilized for this screen, but the solvent underwent no additional drying. As little as
0.6% added water led to a remarkable increase in the yield of aldehyde and this high
yield was maintained up to 20% added water. It is expected that at a certain point the
solvent mixture is able to no longer solubilize both the alkene and water, resulting in a
decline in yield of the aldehyde. Based upon these results 5% added water (v/v) was used
for all further experiments.

Isolated yield of the
aldehyde

100
80
60

acetone
acetonitrile

40
20
0
0

5

10

15

20

Percent added water

I wanted to verify that the consumption of the alkene was linearly related to the
formation of aldehyde. Thus 18 was subjected to ozonolysis and aliquots were taken
every 33 seconds and filtered through a silica plug. 1H NMR was taken and showed 18
and 19, but no ozonide. A graph of the calculated relative amounts of the consumed
alkene vs. the generated products shows a linear trend.

12

120

Relative percent

100

80
aldehyde

60
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40

20
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50

100
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200
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The hypothesis, which is supported by previous literature, is that solubilized water
is able to trap the carbonyl forming hydroperoxyacetal intermediate, 23. This type of
trapping has been reported in the literature for atmospheric chemistry (gas phase) and has
not been previously applied as a general synthetic method to solution chemistry.23,24 For
more complete coverage of this field see Section 1.4.

Tetrahedral intermediate 23

undergoes in situ fragmentation giving the desired carbonyl, 24, and hydrogen peroxide
as a byproduct.

To test this hypothesis, I performed the ozonolysis of 18 in 95:5

acetone/water (v/v) and collected the aqueous layer remaining after extraction with
CH2Cl2. Testing this layer with calibrated peroxide test strips indicated that hydrogen
peroxide was present in stoichiometric amounts.
O+
R

R
21

O-

O
R

22

OH

OH
23

O
H2O2 R
24
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Section 2.5
Substrate scope
A variety of alkenes were subjected to ozonolysis under these conditions to
determine substrate scope. Some of the initial yields were in our opinion lower than
would be expected. It was thought that excess ozone might be problematic and as a
solution to this indicator Sudan Red III was employed.33 As was expected from the
screening studies the ozonolysis of 18 and 25 proceeded in good yield.

Likewise,

ozonolysis of styrenes 26 and 27 proceeded in moderate to excellent yield. Styrene 27
was chosen as an alkene which undergoes ozonolysis to give the aldehyde and
formaldehyde O-oxide. Therefore, the quantitative yield indicates that the water is able
to trap the formaldehyde carbonyl oxide before recombination with 27 can occur. The
ozonolysis of structurally more complicated terpene 29 proceeded in quantitative yield.
Ozonolysis of β-pinene (30) produced the ozonide as the major product.

14

No Sudan
Red III
(%)

Sudan Red
III (%)

18

72

NA

25

NA

72

26

NA

73

27

NA

quant.

28

NA

52

29

76

quant.

30

NA

19

31

54

75

Substrate

Structure

Methyl oleate, 32, was used to determine if the two chemically different
aldehydes could be isolated. Both aldehydes 33 and 16 were isolated, however, the yield
for 33 was depressed.
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Section 2.6
Conclusions
This work has shown two new methodologies for the formation of aldehydes or
ketones directly from alkenes. The first is utilizing oxyanions as a new method for the
“reductive” ozonolysis of alkenes. This route requires a large excess of reagents that
must be removed making this approach less than ideal. The second is the use of water to
directly trap the carbonyl oxide giving the desired carbonyl compound. The advantage of
this route is the need for no elaborate purification. The disadvantage is the generation of
a stoichiometric amount of hydrogen peroxide
Section 2.7
Experimentals
All reagents were used as received from commercial vendors, with the exception of
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from
sodium/benzophenone. All reactions were conducted under an atmosphere of N2 except
where noted; “RBF” indicates round-bottom flask. Thin layer chromatography (TLC)
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized
by staining: 1% ceric sulfate and 10% ammonium molybdate in 10% H2SO4 (general
stain, after charring); 1% N,N’-dimethyl-p-phenylenediamine solution in 1:20:100 acetic
acid/water/methanol (specific for peroxides);34 1% aq. KMnO4 (for unsaturated
compounds);. “Standard drying and purification” refers to drying of organic extracts
over Na2SO4, removal of solvent under vacuum, and purification by flash
chromatography using the indicated eluting solvent. 1H /13C NMR spectra were recorded

16
at 300 (75), 400(100), or 500(125) MHz in CDCl3 unless otherwise indicated; peaks are
reported as: chemical shift (multiplicity, J couplings in Hz, number of protons).

We experienced no safety issues in the course of performing this research. Ozonides
and peroxides can be explosive and dangerous and all prudent safety precautions
should be taken.35,36

Nonanal (16):
Representative procedure for ozonolysis in CH2Cl2 in the presence of H2O, a phase
transfer agent, and NaIO4
To a flame-dried RBF containing a solution of decene (3 mmol) in CH2Cl2 (20 mL) was
added sequentially NaIO4 (3 mmol) in H2O (5 mL) and phase transfer agent (0.1-1mmol)
and cooled to 0oC. A stream of O3/O2 was passed through the reaction for the allotted
amount of time and the reaction flask was purged with a stream of O2 for 2 min. H2O (25
mL) was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL).
The combined organic layers were washed with brine (25 mL) and dried with NaSO4.
The residue obtained upon concentration in vacuo was subjected to column
chromatography with 10 % EA/hex to afford 16 as a colorless oil. Rf (10 % EA/hex):
0.56. 1H NMR (300 MHz): 9.71 (t, J = 1.8, 1H), 2.82 (dt, J = 1.7, 7.3, 2H), 1.6 (m, 2H),
1.45-1.13 (10H), 0.83 (t, J = 6.9, 3H).
Also formed is 3-octyl-1,2,4-trioxolane as a colorless oil. 1H NMR (300): 5.20 (s, 1H),
5.13 (t, J = 3.2, 1H), 5.04 (s, 1H), 1.72 (m, 2H), 1.51-1.20 (12H), 0.89 (t, J = 6.8, 3H).
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Representative procedure for the ozonolysis in CH2Cl2 /H2O in the presence of a
phase transfer agent
To a flame-dried RBF containing a solution of decene (3 mmol) in CH2Cl2 (20 mL) was
added sequentially H2O (5 mL) and phase transfer agent (0.1-1 mmol). The solution was
cooled to 0oC and a stream of O3/O2 was passed through the reaction for the allotted
amount, after which the reaction was purged with a stream of O2 for 2 min. H2O (25 mL)
was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL). The
combined organic layers were washed with brine (25 mL) and subjected to standard
drying and purification with 10 % EA/hex to afford 16 as a colorless oil. For yields see
Table 1.2.

9-decenenyl acetate (18):
To a flame-dried RBF containing a solution of 9-decen-1-ol (4.0135g, 26 mmol) in
pyridine (40 mL) was added sequentially Ac2O (2.86 mL, 39 mmol) and DMAP (319.8
mg, 2.6 mmol) and reaction was stirred overnight. 2 N HCl (80 mL) was added and the
resulting suspension was extracted with Et2O (3 x 80 mL). The combined organic layers
were washed with sat. aq. NaHCO3 (2 x 80 mL), brine (80 mL), and were subjected to
standard drying and purification with 5% EA/hex to afford 18 (4.6201 g, 90%) as a
colorless oil. Rf (5 % EA/hex): 0.44. 1H NMR (300 MHz): 5.79 (ddt, J = 17.0, 10.2, 6.7,
1H), 4.95 (m, 2H), 4.03 (t, J = 6.7, 2H), 2.08 – 1.97 (5H), 1.66 – 1.53 (2H), 1.43 – 1.22
(10H).

13

C (75 MHz): 171.3, 139.2, 114.3, 64.7, 33.9, 29.5, 29.3, 29.1, 29.0, 28.7, 26.0,

21.1. The NMR spectra matched those previously reported.37

18

8-(1,2,4-trioxolan-3-yl)octyl acetate (20):
In a flame-dried RBF containing 18 (0.5281g, 2.6 mmol) was added in CH2Cl2 (20 mL).
The solution was cooled to -78 oC and a stream of O3/O2 was passed through the solution
until blue and the flask was purged with O2 for 2 min. The solution was concentrated in
vacuo and purified via flash chromatography with 10% EA/hex to afford 20 (416.6mg,
63%) as a colorless oil. Rf (10% EA/hex) = 0.4.

1

H NMR (400 MHz): 5.043 (s, 1H),

4.977 (t, J = 4.95, 1H), 4.871 (s, 1H), 3.908 (t, J = 6.74, 2H), 1.884 (s, 3H), 1.57 (m, 2H),
1.49 (m, 2H), 1.31-1.19 (10H).

13

C NMR (100 MHz): 170.6, 103.5, 93.8, 64.2, 31.4,

30.9, 29.1, 28.9, 28.4, 25.7, 23.6, 20.6. HRMS: calc for C12H23O5: 247.1546; found:
247.1545.

9-oxononyl acetate (19):
Representative procedure for the ozonolysis in CH2Cl2 /H2O in the presence of a
phase transfer agent
To a flame-dried RBF containing a solution of 18 (3 mmol) in CH2Cl2 (20 mL) was
added sequentially H2O (5 mL) and phase transfer agent (0.1-1 mmol).

The flask was

cooled to 0oC and a stream of O3/O2 was passed through the reaction for the allotted
amount of time. The reaction flask was purged with a stream of O2 for 2 min. H2O (25
mL) was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL).
The combined organic layers were washed with brine (25 mL) and subjected to standard
drying and purification with 10 % EA/hex to afford 19 as a colorless oil. Rf (10%
EA/hex): 0.33. 1H NMR (300 MHz): 9.72 (t, J = 1.7, 1H), 4.0 (t, J = 4, 2H), 2.38 (dt, J =
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1.7, 7.2, 2H), 2.0 (2, 3H), 1.65 – 1.49 (4H), 1.37 – 1.23 (8H).

13

C (75 MHz): 202.9,

171.3, 64.6, 43.9, 29.3, 29.1, 29.0, 28.6, 25.9, 22.1, 21.1. The NMR spectra matched
those previously reported.38

((dec-9-en-1-yloxy)methyl)benzene:
A suspension of NaH (630 mg, 15.8 mmol, 60% in mineral oil) in a flame-dried
RBF was washed with THF (10 mL) and suspended in THF (20 mL). 9-decen-1-ol
(2.074 g, 13.3 mmol) and benzyl bromide (2.44 g, 14.3 mmol) were added sequentially
and the reaction was stirred overnight. H2O (20 mL) was added and extracted with EA (2
x 30 mL) and washed with brine (30 mL). The combined organic layers were subjected
to standard drying and purification with 5% EA/hex to afford ((dec-9-en-1yloxy)methyl)benzene (1.3305 g, 41%) as a yellow oil. Rf (10 % EA/hex): 0.86. 1H
NMR (400 MHz): 7.41 – 7.26 (5H), 5.84 (ddt, J = 17.0, 10.2, 6.7, 1H), 2.50 (m, 2H), 5.0
(m, 2H), 4.53 (s, 2H), 3.49 (t, J = 6.8, 2H), 2.11- 2.02 (2H), 1.69 – 1.59 (2H), 1.45 – 1.26
(10H).

13

C (100 MHz): 139.3, 138.9, 128.5, 127.8, 127.6, 114.3, 73.0, 70.7, 33.9, 29.6,

29.3, 29.1, 26.4. The NMR spectra matched those previously reported.39

9-(Benzyloxy)nonanal (25):
To a flame-dried RBF containing a solution of 9-dencenyl benzylether (748.5 mg,
3.04 mmol) in acetone (20 mL) was added sequentially added H2O (1 mL, 56 mmol) and
Sudan Red III (trace). The solution was cooled to 0oC and mixture of O3/O2 was passed
through the flask until the red color dissipated. The reaction was purged with O2 for 2
min. H2O (25 mL) was added and the resulting suspension was extracted with CH2Cl2 (2
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x 25 mL).

The combined organic layers were subjected to standard drying and

purification with 10% EA/hex to EA to afford 25 (545.3 mg, 72%) as a yellow oil. Rf
(10% EA/hex): 0.34. 1H NMR (400 MHz): 9.77 (t, J = 1.8, 1H), 7.40-7.26 (5H), 4.52 (s,
2H), 3.48 (t, J = 6.6, 2H), 2.43 (dt, J = 1.9, 7.4, 2H), 1.66 – 1.58 (4H), 1.44 – 1.27 (9H).
13

C (100 MHz): 203.0, 138.8, 128.4, 127.7, 127.6, 72.9, 70.5, 44.0, 29.9, 29.4, 29.3, 29.2,

26.2, 22.1. The NMR spectra matched those previously reported.40

4-Methyl-benzaldehyde (26):
To a flame-dried RBF containing a solution of 4-methylstyrene (369.8 mg, 3.1
mmol) in acetone (20 mL) was added H2O (1.0 mL, 56 mmol) and Sudan Red III (trace).
The solution was cooled to 0oC and O3/O2 was passed through the flask until the red color
dissipated. H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x
25 mL). The combined organic layers were subjected to standard drying and purification
with 10% EA/hex to afford 26 (275.9 mg, 73%) as a yellow oil. Rf (10% EA/hex): 0.52.
1

H NMR (400 MHz): 9.95 (s, 1H), 7.76 (d, J = 8.1, 2H), 7.32 (d, J = 8.1, 2H), 2.42 (s,

3H). NMR spectra matched commercially available samples.
O
O2N

4-nitrobenzaldehdye (27):
To a flame-dried RBF containing a solution of 4-nitrostyrene (307.5 mg, 2.1 mmol) in
acetone (13 mL) was added H2O (0.66 mL, 37 mmol) and Sudan Red III (trace).

The

solution was cooled to 0oC and O3/O2 was passed through the flask until the red color
dissipated. H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x
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25 mL). The combined organic layers were subjected to standard drying and purification
with 30% Et2O/pent to afford 27 (312.3 mg, quantitative) as a white solid. Rf (30%
Et2O/pent): 0.57. 1H NMR (400 MHz): 10.17 (s, 1H), 8.41 (d, J = 8.4, 2H), 8.09 (d, J =
8.4, 2H).

13

C (100 MHz): 190.5, 151.3, 140.2, 130.7, 124.5. The NMR spectra matched

those previously reported. 41

Benzophenone (28):
To a flame-dried RBF containing a solution of 1,1-Diphenylethylene (578.7 mg, 3.2
mmol) in acetone (20 mL) was added H2O (1.0 mL, 56 mmol) and Sudan Red III (trace).
The solution was cooled to 0oC and O3/O2 was passed through the flask until the red color
dissipated. H2O (25 mL) was added and the resulting suspension was extracted with
CH2Cl2 (2 x 25 mL). The combined organic layers were subjected to standard drying and
purification with 10% EA/hex to afford 28 (303.5 mg, 52%) as a white solid. Rf (10%
EA/hex): 0.43.
(4H).
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1

H NMR (300 MHz): 7.87 – 7.79 (4H), 7.64 – 7.56 (2H), 7.53 – 7.45

C (75 MHz): 196.9, 137.7, 132.5, 130.2, 128.4. The NMR spectra matched those

previously reported.42
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5-acetyl-2-methyl-cyclohexanone (29):
Small Scale (3 mmol):
To an oven dried RBF containing a solution of dihydrocarvone (396.3 mg, 3
mmol) in acetone (17 mL) was added sequentially H2O (0.9 mL, 49.5 mmol) and Sudan
Red III (trace). The solution was cooled to 0oC and a stream of O3/O2 was passed
through the flask until the red color dissipated. The flask was purged with O2 for 2 min.
H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 25 mL). The
combined organic layers were subjected to standard drying and purification with 40 %
Et2O/hex to afford 29 (401.9 mg, quant.) as a yellow oil. 1H NMR (300 MHz): 2.78 (m,
1H), 2.43 (d, J = 9, 2H), 2.34 (apparent sextet, J = 6.3, 1H), 2.15 (s, 3H), 2.2-2.05 (2H),
1.68 (apparent qd/ddd, J = 13.3, 3.4, 1H), 1.39 (apparent qd/ddd, J = 13.1, 3.4, 1H), 0.98
(d, J = 9.5, 3H).

13

C NMR (75 MHz): 211.5, 208.3, 52.0, 44.5, 42.7, 34.5, 28.3, 27.8,

14.3. HRMS: calc for C9H15O2: 155.1072; found: 155.1066.
Large Scale Procedure (Chromatographic purification):
To an oven dried RBF containing a solution of dihydrocarvone (3g, 20 mmol) in
acetone (133 mL) was added H2O (6.8 mL, 378 mmol) and Sudan Red III (trace). The
solution was cooled to 0oC and O3/O2 was passed through the flask until the red color
dissipated. The flask was purged with O2 for 2 min. H2O (150 mL) was added and the
resulting suspension was extracted with CH2Cl2 (2 x 130 mL). The combined organic
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layers were subjected to standard drying and purification with 40 % Et2O/hex to afford 29
(2.6249g, 86%) as a yellow oil.
Large Scale procedure (purification by distillation):
To a flame-dried RBF containing a solution of dihydrocarvone (4.9395g, 32
mmol) in acetone (213 mL) was added H2O (10 mL, 556 mmol) and Sudan Red III
(trace). The solution was cooled to 0oC and O3/O2 was passed through the flask until the
red color dissipated. The flask was purged with O2 for 2 min. H2O (100 mL) was added
and extracted with CH2Cl2 (1 x 130 mL and 1 x 30 mL). The combined organic layers
were washed with H2O (30 mL) and dried with Na2SO4. The residue obtained upon
concentration in vacuo was purified by Kugelrohr (bulb-to-bulb) distillation (245 oC @
90 torr) to afford 29 as a yellow oil (3.9331g, 78%).

Citronellyl benzoate:
In a flame-dried RBF containing a solution of B-citronellol (2.1399g, 13.7 mmol) in
pyridine (20 mL) was added benzoyl chloride (2.0705g, 14.1 mmol). The reaction was
stirred for 4 hours.

Et2O (40 mL) was added and the organic layer was washed

sequentially with 1 N HCl (20 mL), sat. aq. NaHCO3 (40 mL), and brine (40 mL). The
combined organic layers were subjected to standard drying and purification with 5 %
EA/hex to afford citronellyl benzoate (3.1784 g, 89%) as a yellow oil. Rf (10% EA/hex) =
0.74.

1

H NMR (300 MHz): 8.05 (d, J = 7.5, 2H), 7.62-7.39 (3H), 5.16-5.05 (1H), 4.37

(m, 2H), 2.14-0.91 (16H).

13

C (75 MHz): 166.8, 133.0, 131.6, 130.7, 129.7, 128.5,

124.7, 63.6, 37.1, 35.7, 29.7, 25.9, 25.6, 19.7, 17.8.
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3-Methyl-6-oxohexyl benzoate (33):
To an oven-dried RBF containing citronellyl benzoate (762.6 mg, 2.93 mmol) in acetone
(20 mL) was added H2O (1 mL, 56 mmol) and Sudan Red III (trace). The solution was
cooled to 0oC and O3/O2 was passed through the flask until the red color dissipated. H2O
(25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 25 mL). The
combined organic layers were subjected to standard drying and purification with 30%
Et2O/hex to afford 33 (515.5 mg, 75%) as a yellow oil. Rf (30% Et2O/pentane): 0.72. 1H
(300 MHz): 9.74 (t, J = 1.7, 1H), 8.05-7.92 (2H), 7.58-7.33 (2H), 4.41-4.26 (2H), 2.542.34 (2H), 1.88-0.76 (8H). The NMR spectra matched those previously reported.43
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Chapter 2
3-Alkoxy-1,2-dioxolanes as potential antimalarials

This chapter will discuss the disease malaria and current treatments using both
synthetic and natural peroxides. There is also an in depth discussion of 3-alkoxy-1,2dioxlanes as a new class of peroxides for the treatment of malaria.

Section 1: Malaria and current antimalarial treatments
Section 2: Previous synthesizes and reactivity of 3-alkoxy-1,2,-dioxolane
Section 3: “First Generation” 3-alkoxy-1,2-dioxolanes
Section 4: “Second Generation” 3-alkoxy-1,2-dioxolanes
Section 5: “Third Generation” 3-alkoxy-1,2,-dioxolanes
Section 6: Experimentals
Section 7: References
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Section 1

Section 1.1: Malaria
Section 1.2: Antimalarial Treatments
Section 1.3: Artemisinin as a treatment for malaria
Section 1.4: Mechanism of Fe-mediated artemisinin degradation
Section 1.5: Artemisinin mechanism of action against malaria
Section 1.6: Vennerstrom’s ozonides
Section 1.7: Rationale for 3-alkoxy-1,2-dioxolanes

Section 1.1
Malaria
Malaria is a global health epidemic affecting 300-500 million people and causing
1-2 million deaths annually, predominately in children.1

Malaria infection occurs

primarily in Africa and Southeast Asia. There are five strains of malaria that infect
humans; the most deadly strain of malaria is P. falciparum.1
The following is a very brief overview to provide a perspective on the challenges
in treating this disease. An excellent review on malaria infection was published by Miller
in 2002.2 The life cycle of malaria is complex and occurs in both the transmitting
mosquito and the infected host. The multiplication of malaria in the infected mosquito
occurs in the midgut and takes approximately 10 days for the salivary glands to become
infected.3 Humans are infected by a bite from an infected mosquito. Within one hour the
transferred sporozites infect the cells of the liver.3 Over the next 5-15 days the infection
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develops into exoerythrocytic shizonts that contain tens of thousands of merozoites.3
Release of these merozoites into the blood stream leads to rapid infection of red blood
cells. The eventual rupture of the infected red blood cells leads to further infection.3 The
presence of multiple stages makes treating malaria difficult.
Section 1.2
Antimalarial treatments
The ultimate goal for the treatment of malaria is the development of a vaccine;
however, this goal has proved elusive.4

As such, a continued need exists for the

development of novel chemotherapeutics.

Several reviews have been published on

chemotherapeutic treatments of malaria.3,5-11
Malaria can be treated by non-peroxide means (quinine,6 chloroquine,6
mefloqquine,6 ferrocene conjugates,12-14 peptides15-17).

Several classes of peroxide-

containing compounds have demonstrated activity against malaria: 1,2-dioxanes,18 1,2,4trioxepanes,18-20 1,2,4-trioxanes,21-24 tetraoxanes,25-27 artemisinin dimers,28-30 and
artemisinin derivatives.31,32 However, only a few of these have demonstrated efficacy in
humans. Artemisinin combination therapy (ACT) is currently the prescribed treatment
for malaria, but the development of artemisinin resistant malaria in Cambodia has
spurned the interest in chemotherapeutics.33

This introduction will discuss artemisinin,

along with 1,2,4-trixolanes (ozonides); several molecules of the later class are in clinical
trials against malaria.
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Section 1.3
Artemisinin as treatment for malaria
Artemisinin (1) is a naturally occurring endoperoxide isolated from the Chinese
wormwood.34 Isolation continues to be the primary source of artemisinin but synthetic
approaches have been reported.5 The total synthesis of artemisinin was first reported by
Schimd and Hofheinz in 1983.35 Semi-synthesis of artemisinin based upon biosynthesis
of artemisinic acid has been reported by Keasling.36,37 Currently, artemisinin (1) is not
used directly for treatment due to rapid metabolism.
artemether (2)38

Instead, the closely related

and artesunate (3)38 are given as part of a combination therapy.39

Artemisinin and analogs 2 and 3 demonstrate long shelf life40 as well as stability to many
chemical transformations.41

However, artemisinin is degraded by Pd-catalyzed

hydrogenation and treatment with strong acid or base.34
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Section 1.4
Mechanism of Fe-mediated artemisinin degradation
In 1992, Posner undertook a study of an

18

O-labeled artemisinin analog to

elucidate a mechanism for the Fe (II)-mediated degradation of the endoperoxide. The
degradation can proceed by two pathways. The first is by radical scission to provide
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intermediate 5 with the alkoxy radical on O1.

This intermediate can undergo C-C

cleavage via β-scission to generate the mixed acetal 6, which undergoes hydrolysis to
provide aldehyde 7. Alternatively, if the initial cleavage occurs to create an alkoxy
radical on O2, intermediate 8 is obtained. A subsequent 1,5-H shift provides intermediate
9, which can undergo cyclization with loss of Fe(II) to furnish epoxide 10. A later paper
supports the transformation of 9 to 10 through the generation of a hydroxyl-epoxide and
Fe(IV)=O.42 The combined yields of 7 and 10 (~2:1) were 60 – 70%, demonstrating that
these are major pathways.

With a preliminary mechanism proposed, Posner explored the 1,5-H shift
involved in the conversion of alkoxy radical 8 to carbon radical 9. The hypothesis was
that if the hydrogen was not in the correct spatial alignment to undergo a shift there
would be no activity.43 Peroxides 11 and 12 were synthesized and activity against P.
falciparum was measured test this hypothesis. When no H is available to perform a shift
(12), no activity is observed. Likewise, when the H is in the wrong spatial alignment (11)
to allow hydrogen abstraction, the peroxide is devoid of activity. In contrast, control
peroxide 4, which is similar to artemisinin in stereochemistry at the methyl-bearing
center, possessed high activity.
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Section 1.5
Artemisinin mechanism of action against malaria
Several reviews have been published on the mechanism of action (MOA) of
artemisinin.44-46
In 1991, Meshnick reported the alkylation of heme by artemisinin.47 However,
Meshnick and subsequent researchers have struggled to understand the role that the
alkylated heme plays in antimalarial activity.

More recently proposed MOAs have

included artemisinin blocking PfATP6 (Plasmodium falciparum Ca2+ ATPase)48,49 and
artemisinin causing parasite membrane damage.50 Although a MOA based upon Fe(II)mediated generation of reactive radicals is the most widely accepted. A minority of
research papers support the idea that activity is not derived from the formation of carbon
centered radicals, but rather a result of reactive intermediates derived from an ionic
opening of the peroxide.51-53 None of these MOAs are without debate and thus far no
consensus is present in the literature.

Arguably, until the MOA of endoperoxide

containing drugs is confirmed no truly rationale design of a potential treatment can be
undertaken.
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Section 1.6
Vennerstrom’s ozonides
In 2004, Vennerstrom and coworkers reported the first example of a 1,2,4trioxolane (ozonide) as a potential treatment for malaria.54 Ozonide 13 was synthesized
utilizing a Griesbaum co-ozonolysis of oxime 14 and ketone 15 to afford ozonide 16.55
Saponification of ester 16 to the corresponding acid 17 followed by amine coupling
produced arterolane (OZ-277), 13.

Arterolane exhibits high activity against both

chloroquine sensitive (NF54) and chloroquine resistant (K1) strains of P. falciparum in
vitro (2.5 nM). Excellent activity is also observed in vivo with P. berghei infected mice
(100% cure); this system is typically used as the standard mammalian model for malaria.
Arterolane is now in phase III trials.56

Further structural optimizations led to the

discovery of OZ-439, which is currently in a Phase I clinical trial.57,58 In an attempt to
determine the MOA of arterolane, Vennerstrom investigated the reactivity of 1,2,4trioxolanes towards heme. Vennerstrom reported that synthetic 1,2,4-trioxolanes can
alkylate free heme,59 but not the protein bound heme that is abundant in healthy cells.60
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The postulated antimalarial activity of arterolane is derived from the formation of
carbon centered free radicals. (A discussion of this mechanism in the context of 1,2,4trioxolanes, 1,2,4-trioxanes, and 1,2,4-trioxpenaes will be discussed in section 5.) To test
this hypothesis, model ozonide 18 was treated with FeBr2 where iron can attack either O1
or O2 of the peroxide bond. 23 Experimentally, it was found that attack on O1 is preferred
and was rationalized by O1 being more accessible then O2. The resulting alkoxy radical
19 undergoes β-scission to afford carbon radical 20. Intramolecular attack of the radical
on the ester carbonyl and loss of Fe(II) forms products 23-25, with lactone 23 being the
predominant product. If iron attacks O2, the resulting alkoxy radical (21) would be
expected to undergo β-scission to provide carbon radical 22. The only isolated product
related to 22 is bromo acid 26 which is formed in very low yield.
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OFeIII
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It was unclear if the 1,2,4-trioxolane (ozonide) functionality was necessary or if
the same level of antimalarial activity could be accomplished with a 1,2-dioxolane, a
class of peroxide expected to have much greater stability.61 However, only limited
investigations of 1,2-dioxolanes as antimalarials have been reported.62

To test the

relative activity of 1,2-dioxolanes and 1,2,4-trioxolanes, Vennerstrom prepared and
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screened 1,2-dioxolane 27 for in vitro activity against P. falciparum.63 The results reveal
that 1,2-dioxolane 27 possesses virtually no activity when compared to ozonide 14.
Reaction of 1,2-dioxolane 27 with FeBr2 did not lead to formation of carbon centered
radicals through β-scission, as determined by trapping with 4-oxo TEMPO.63

This

suggests that the fate of the intermediate alkoxy radicals may be a crucial factor in the
antimalarial activities of ozonides.

Section 1.7
Rationale for 3-alkoxy-1,2-dioxolanes
We became interested in 3-alkoxy-1,2-dioxolanes as potential antimalarials
because they are isosteric to ozonides and should possess similar activity. The oxygen
alpha to the peroxide bond should facilitate β-scission of one of the derived 3-alkoxy-1,2dioxolane radicals, enhancing generation of a carbon centered radical. This hypothesis is
supported by theoretical and experimental work reported by Erhardt on a related
system.22 Our hypothesis is illustrated for 3-alkoxy-1,2-dioxolane 28. We postulated
that 3-alkoxy-1,2-dioxolane 28 would undergo β-scission to provide radical intermediate
29. This intermediate could either undergo quenching to afford 30 or β-scission to
provide the desired free radical 32. As can be seen, the alkoxydioxolanes undergoes
reaction with FeBr2 to predominantly furnish the expected products from formation and
scission of an α-alkoxy radical.
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The potential advantage of 3-alkoxy-1,2-dioxolanes relative to ozonides is their
increased stability and the safety of their synthesis.

By design ozonides, such as

arterolane, require the use of ozone which can lead to the buildup of unstable
intermediates. Although no stability issues have been reported by Vennerstrom, ozonides
such as arterolane are high energy species that can undergo exothermic decomposistion.64
In contrast, the synthesis of 3-alkoxy-1,2-dioxolanes can be done in the absence of ozone.
Though the synthesises that follow do utilize some potentially hazardous reagents, the
peroxide bond is always installed with molecular oxygen and not ozone. As a class, 1,2dioxolanes exhibit increased stability over 1,2,4-trioxolanes, potentially making them a
platform for development of drugs which are more field stable.61
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Section 2
Section 2.1
Synthesis of 3-alkoxydioxolanes and 1,2-dioxolan-3-ols
This section describes investigations of the synthesis and reactivity of 3-alkoxy-1,2dioxolanes and related species. A review of the synthesis of cyclic peroxides has been
written by Bachi.65
Singlet oxygen
In 1980, Ensley studied the addition of 1O2 to α-β-unsaturated ketones and
lactones.66 In the course of this work, he reported the reaction of 1O2 and (R)-(+)pulegone, 33, to form the 1,2-dioxolan-3-ol 34 in 75% yield. The oxygenation of more
sterically hindered cyclohexylidine analog 35 produced 1,2-dioxolan-3-ol 36 as the major
product in comparable yield.
O

R

HO
R

33 R = Me
35 R = (CH2)5

O

O

1

R
R

O2
34 75%
36 78%

Several groups have investigated the reaction of cholest-5-en-3-one, 37, with 1O2
and reported the isolation of alcohols, after a reductive workup.67-70 Note that in the
example as well as an additional example below, 1O2 is generated via dye-sensitized
excitation of 3O2 in the presence of substrate. From the location of the alcohols the
authors extrapolated that they had been hydroperoxides before reduction. Based upon the
work below, we can suggest the precursors of the alcohols were in fact 1,2-dioxolan-3ols.

In 1990, Schiesser studied the reaction of 1O2 on cholest-5-en-3-one, 37, and

reported the first isolation of a 1,2-dioxolan-3-ol.71 Schiesser reported that reaction of 37

39
with 1O2 in the absence of a reductive workup resulted in isolation of 1,2-dioxolan-3-ol
38 after chromatography.

In the same report Schiesser disclosed that this reaction is not specific to cholest5-en-3-one, but is also successful on a much simpler system.

The treatment of

octahydronaphthalenone 39 with 1O2 afforded 1,2-dioxolan-3-ol 40 as the major product
and hydroperoxide 41 as a minor product.

In 1999, Adam explored the reaction of 1O2 and adamantylidene alcohol 42.72
The treatment of 42 with 1O2 led to formation of 43 and 44 in approximately equal
amounts as judged by 1H NMR. However, 44 was the major isolated product. Dioxetane
43 was isolated almost exclusively as the threo isomer (shown), a result rationalized on
the basis of hydroxyl-directed addition of 1O2 to a single major conformer, which is
favored by allylic 1,2-strain present in other conformations. 1,2-Dioxolan-3-ol 44 is
presumably formed in situ cyclization of the initially generated hydroperoxide in the ene
product.

When the oxygenation was performed in a polar protic solvent such as

methanol, dioxetane 43 was formed almost exclusively.
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In the course of efforts directed towards the synthesis of (+)-Premnalane A
Vassilikogiamakis and coworkers investigated the oxygenation of 45.

The desired

spiroendoperoxide 47 was formed but as a minor product with the spiroalkoxydioxolane
48 formed as the major product.73 The synthesis of 45 was accomplished in six steps
from commercially available (+)-sclareolide. The authors found that 46 needs to be
preformed via a oxygenation/fragmentation of the silylcyclopentadiene 45. Subsequent
addition of 1O2 to 46 leads to a mixture of 47 and 48. The authors screened several
conditions for this reaction and determined that 3-alkoxy-1,2-dioxolane 48 was the
preferred product under all conditions. Though desired product 47 was not formed
exclusively, this route shows the power of 1O2 to quickly form very complex peroxide
containing systems.
O

O
SiMe3
OH
1

O2
30 sec
H
45

O

O

O
1. 1O2, hv
conditions
2. PTSA or SiO2

H 46

O

O

O

O

+

H 47
47:48
Conditions
CDCl3, MB, 8oC
1:2
MeOH, MB, 8oC
1:4
Toluene, TPP, 8oC
1:1.3
Toluene, TPP, 65oC 1:1.2

H 48
Yield
73%
NR
NR
NR

DePuy ring expansion
In 1969, DePuy reported the oxidative expansion of cyclopropanols under O2 as a
synthetic route to 1,2-dioxolan-3-ols.74 Cyclopropanol 49 underwent ring expansion to
hydroperoxyalkenoate 51 presumably through intermediate 50. The cyclization of 51
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was accomplished under basic conditions to afford perlactone 52, but no yield was
reported.

With this methodology established, DePuy showed that 1,2-dioxolan-3-ols can be
synthesized via a similar approach. The expansion of 53 was reported to give the desired
1,2-dioxolan-3-ol 54; however, no yield was reported.

Thermolysis
In 1992, Baumstark reported the thermolysis of azahydroperoxide 55 to generate
1,2,-dioxolane-3-ol 58.75

He postulated that the reaction proceeded through radical

intermediate 56, which rapidly trapped O2 forming hydroperoxide 57. In situ cyclization
of hydroperoxide 57 affords the desired 1,2-dioxolan-3-ol 58. The reaction worked well
with a variety of substitution patterns in 55, but the limiting factor in this methodology is
the synthesis of the precursors, 55. The reported synthesis of the azohydroperoxides is
not general enough to make this a widely applicable reaction.76
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Conjugate addition to α-β-unsaturated carbonyls
In 1958, Payne reported the first example of the addition of basic hydrogen
peroxide to an enone, mesityl oxide.77 The reaction was further explored by Rieche in
1960.78 Early work used alkaline bases but more recent work has used hydrotalcite79,80 or
natural phosphate81. In all of these systems the reaction proceeds through conjugate
addition of hydroperoxy anion to the enone generate an enolate, which protonates to
generate hydroperoxy ketone 61. Subsequent cyclization affords 1,2-dioxolan-3-ol 62.
However, the intermediate hydroperoxyenolate 60 can easily undergo a 3-exo cyclization
to form an epoxide, which can often become the major product.

Attempts to use this methodology on more hydrophobic substrates have proved
problematic. Dussault reported that the conversion of 63 to 64 can be accomplished, but
required highly optimized conditions to obtain even modest yields.82

Ozonolysis of enol ethers
In 1984, Kuczkowski reported the first synthesis of 3-alkoxy-1,2-dioxolanes
through ozonolysis.83 In this initial report, the ozonolysis of methyl vinyl ether, 65, in
pentane afforded the desired 3-alkoxy-1,2-dioxolane 66. The use of methyl formate or
ethyl acetate as solvent led to lower yields, while the use of methanol resulted in the
isolation of hydroperoxyacetal as the only product.
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In subsequent work, Kuczkowski expanded this reaction to methoxy and
ethoxyethene,84 1- ethoxypropene,85 and 1,2-dimethoxyethene.86 This synthetic approach
is limited to unsubstituted 3-alkoxy-1,2-dioxolanes as decreased yield occurs with
aliphatic substitution at C5 in 65. In addition, the substituents cannot contain ozone
reactive groups (for example, alkenes) other than the enol ether.
Radical cyclization
The 6-exo cyclization of a peroxyl radical onto an alkene for the synthesis of 1,2dioxanes has been established and will not be discussed in detail.87-90 To the best of my
knowledge a radical cyclization has not been used for the synthesis of 3-alkoxy-1,2dioxolanes or 1,2-dioxolan-3-ols, but I will discuss radical cyclization in the synthesis of
1,2-dioxolanes.
In 1976, Porter reported the synthesis of 1,2-dioxolanes through radical
cyclization as part of a program towards the synthesis of prostaglandins.88

Porter

reported that reaction of hydroperoxy alkenes 67 in the presence of a radical initiator, ditert-butyl-peroxyoxalate (DBPO), and O2 resulted in cyclization to afford 1,2-dioxolanes
68. No yields were reported other than to say that analytically pure samples were
obtained.
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In 1989, Bloodworth undertook a study to determine the relative rate of 1,2dioxolane vs. 1,2-dioxane formation via free radical cyclization.91 Bloodworth found that
radical cyclization of hydroperoxydiene 70 led to 1,2-dioxolane exclusively.

The

reaction was completed successfully under two different sets of conditions to afford
either 69 or 71 as the final 1,2-dioxolane products, though no yields were reported.

In 2002, Mayrargue undertook a study of peroxyl radical cyclizations in an effort
to develop 7-exo-trig cyclization.87 A 7-exo cyclization (not shown) was unsuccessful,
but the 5-exo-trig cyclization of hydroperoxyalkene 72 proceeded in low yield.

The ring opening of vinylcyclopropanes via a free radical process has been
explored heavily in the literature92-95 and has formed the core of an approach towards
plakortide E.96 The general mechanism is outlined below. Addition of phenylselenide
radical to alkene 74 forms an unstable cyclopropylcarbinal radical, 75. The homoallyl
radical derived from opening of 76 is rapidly trapped by O2, providing peroxide radical
77, which after cyclization and loss of phenylselenyl radical affords the desired 1,2dioxolane 79.
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Electrophilic cyclization
To the best of my knowledge, the use of electrophilic cyclization with iodine or
mercury to afford 3-alkoxy-1,2-dioxolanes has not been previously reported.

The

following section will discuss the synthesis of 1,2-dioxolanes via electrophilic
cyclization.
In 1978, Bloodworth reported the synthesis of 1,2-dioxolanes through
peroxymercuration.97

Diene

80

was

first

subjected

to

intermolecular

hydroperoxymercuration to afford hydroperoxide 81 as a transient intermediate that
undergoes an intramolecular electrophilic peroxymercuration to the 1,2-dioxolane.
Demercuration was accomplished with NaBH4 affording the desired 1,2-dioxolane 83. A
further study of this type of cyclization was reported by Bloodworth in 1980.98

Bloodworth later reported the relative rates of electrophilic cyclizations to form
1,2-dioxolanes and 1,2-dioxanes.91 The major products of peroxymercuration were 1,2dioxanes, but 1,2-dioxolanes were isolated as the minor product. The cyclization of
hydroperoxide 84 was accomplished using Hg(NO3)2 to form 1,2-dioxolane 85.
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BrHg
1. Hg(NO3)2
2. KBr
O O
85

OOH
84

The problem that has plagued the formation of 1,2-dioxolanes using electrophilic
cyclization has been the final demercuration or dehalogenation.

As early as 1970

Bloodworth reported that decomposition of the peroxide occurred when transforming a βperoxyorganomercurial to a halide.99 In 1972, Bloodworth reported an investigation of
the demercuration of β-peroxyorganomercurial with NaBH4.100 Radical scission of the
peroxide bond leads to epoxide 88 while trapping of the radical leads to peroxide 89.
Bloodworth reported that this side reaction can be decreased through reduction at lower
temperature, but cannot be eliminated. In subsequent work, Bloodworth reported that
increased substitution of the peroxide R = Me increases the rate of the scission.101
OR1
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CH2HgX
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In 1978, Porter undertook a study of the SH scission reaction and concluded that
the dihedral angle of the peroxide bond and the radical must be 180o for maximum
reactivity.102 When bromides 90-93 were treated with Bu3SnH it was found that each of
the bromides gave a different ratio of reduction (peroxide) vs. scission (epoxide).
Bromide 91 is easily able to adopt the proper dihedral angle in a low-energy chair
conformation and as a result undergoes predominantly scission. For the bromoalkyl
dioxolanes 90 and 92, the conformation allowing overlap of the radical with the backside
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of the peroxide is disfavored, and reduction of the radical becomes the dominant reaction.
In the case of a 4-bromo-1,2-dioxepane (93), the intermediate radical is unable to interact
with the backside of the O-O and only reduction is observed.

Section 2.2
Reactions of 1,2-dioxolan-3-ols and 3-alkoxy-1,2-dioxolanes
Acid-Mediated etherification
In 1994, Baumstark undertook an investigation of the etherification of 1,2dioxolan-3-ols under acidic conditions.103 Subjecting 1,2-dioxolan-3-ols 94-96 to acidic
conditions led to decomposition at varying rates to the corresponding diketone.
Qualitatively the order of decomposition was found to be 94>95>96.

Baumstark

postulated the 1,2-dioxolan-3-ols underwent a Criegee-like decomposition with C-O
migration to afford the diketone and a molecule of alcohol or phenol.
R1
R2

R
OH

O O
94 R=R1=R2=Ph
95 R=R1=Me; R2=Ph
96 R=Ph; R1=R2=Me

H+

R

R1

+
O

R2OH

O

As 96 underwent decomposition the slowest, it was resubjected to the same
conditions in the presence of methanol as a nucleophile. The result was the synthesis of
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the 3-methoxy-1,2-dioxolane in good yield. This represented a new synthetic strategy
that was later exploited by Dussault in his synthesis of 3-alkoxy-1,2-dioxolanes.82
Base-Mediated etherification
In 1994, Baumstark reported a base mediated etherification of 1,2-dioxolan-3ols.103 Pentasubstituted 1,2-dioxolan-3-ol, 97, successfully underwent base mediated
silylation (TMSCl), alkylation (MeOTf), and esterification (Ac2O) in good yield.
Attempts to use less active electrophiles such as MeI and MeOTs were unsuccessful.
This reaction was only reported for pentasubstituted 1,2-dioxolan-3-ols.
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Allylation of 3-alkoxy-1,2-dioxolanes
The allylation of either hydroperoxyacetals104-106 or silyl peroxyketals107 that
result in the formation of 1,2-dioxolanes has been reported and will not be discussed in
depth.
In 1999, Dussault reported the allylation of 3-alkoxy-1,2-dioxolanes to form 1,2dioxolanes. The reaction of 98 with allyltrimethylsilane and SnCl4 proceeded in good
yield to afford 1,2-dioxolanes 99. The authors suggested that the reaction involved
ionization to a peroxide-stabilized carbenium anion. The best yield was obtained when
SnCl4 was used as opposed to TiCl4 as the Lewis acid. A variety of silyl enol ethers were
also successfully applied as nucleophiles under similar the reaction conditions (Not
shown).
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Section 3

This section describes the synthesis of first generation 3-alkoxy-1,2-dioxolanes and
evaluation of their antimalarial activity.
A portion of this work has been previously published.108
Section 3.1: Early work
Section 3.2: Synthesis of 3-alkoxy-1,2p-dioxolanes
Section 3.3 Antimalarial results
Section 3.1
Early work on 3-alkoxy-1,2-dioxolanes
Previous work in the Dussault lab by Dr. Liu led to a new method for the
synthesis of 3-alkoxy-1,2-dioxolanes.82 Six of these 3-alkoxy-1,2-dioxolanes, 100-105,
were later tested against P. falciparum and showed promising in vitro activity (Table
2.1).109-111 Inhibition was determined by measuring the uptake and incorporation of
[3H]hypoxanthine by the parasite compared to the control. Initial analysis of quantitative
structure activity relationship (QSAR) data suggested the following: R should not be an
aliphatic hydrocarbon (compare 100 and 105); and, that the molecule as a whole not be
too polar (compare 103 vs. 104). Two of the initial compounds with the best activity,
101 and 102, share the common structural feature of an aromatic ring in the alkoxy side
chain.
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R
Compound
R1
Me
Heptyl
100
Me
Bn
101
Me
2-phenylethyl
102
Me
2-methoxyethyl
103
Bu
2-methoxyethyl
104
Bu
propyl
105
Table 2.1 Initial Screen of 3-alkoxy-1,2-dioxolanes

IC50 (nM)
>1000
472
415
>1000
392
>1000

Section 3.2
Synthesis of additional “first generation” 3-alkoxy-1,2-dioxolanes
These early results encouraged further exploration of the QSAR of 3-alkoxy-1,2dioxolanes to gain more insight into which features affect activity. At this stage, I mainly
focused on varying only the substitution on the alkoxy sidechain. The synthesis of 107
utilized addition of basic H2O2 to mesityl oxide, 106.77 The low yield was tolerated as
mesityl oxide is both cheap and commercially available. The synthesis of 110 began with
commercially available enone 108 which underwent a nucleophilic addition and oxidative
rearrangement to afford enone 109 in moderate yield. However, conjugate addition of
basic H2O2 to this more hydrophobic enone led primarily to the epoxide and gave the
desired 1,2-dioxolan-3-ol, 110, in low yield.
O

OH

30% H2O2
24%
O

108

O O
107

106
1. n-BuLi (56%)
2. PDC (69%)

O

109

Bu

30% H2O2
7%

OH

Bu
O O
110

Since a route to ketone 109 was established, I decided to investigate Mukaiyama
cobalt-mediated peroxidation for the insertion of the peroxide bond.112 It was envisioned
that the crude product of oxygenation, 111, would cyclize in the presence of acid to form
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the desired 1,2-dioxolan-3-ol, 110.

However, upon performing the oxygenation under

standard conditions, analysis of the reaction by TLC found that only starting ketone 109
and 1,2-dioxolan-3-ol 110 were present in appreciable amounts. A faint spot that might
have been 111 was present, but all attempts to isolate this spot were unsuccessful. The
attractiveness of this route is the formation of 110 in a one-pot fashion. In addition,
unreacted 109 can be recovered and resubmitted to the reaction conditions.

The Co-mediated oxygenation, while an improvement over the conjugate addition
of H2O2, does have a couple of drawbacks. When the recovered ketone is resubmitted to
the reaction conditions, the reaction does not always initiate.

This issue can be

circumvented by utilizing Isayama’s protocol of adding a catalytic amount of tBuOOH.113 In addition, purification of 1,2-dioxolan-3-ol (110) is hampered by the coelution of a species whose exact identity was never determined but was assumed to be a
CoIII species based upon the green color. One solution to this problem is the use of a
larger ratio of silica gel to compound. Another solution is to transform 110 into the
trimethylsilyl ether 112, which is easily purified.
With the synthetic route to the precursors established, it became necessary to
decide which alkoxy sidechains would be employed. The best results in the initial screen
were observed for substituents which contained an aromatic ring (Table 2.1).

To

determine if the beneficial effect of the aromatic ring was related to steric bulk, we
became interested in the potential of an adamantane ring. In addition to allowing the
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investigation of steric bulk, the adamantane ring allows investigation of isomeric modes
of connectivity (1 vs. 2-adamantyl) to the alkoxide sidechain.
2-Adamantanemethanol (115) and 2-adamantaneethanol (116) were not
commercially available and needed to be synthesized. Two different approaches were
employed. The synthesis of 115 began with Wittig olefination of 2-adamantanone to
afford alkene 114 which, without purification, was subjected to hydroboration/oxidation
to provide 2-adamantanemethanol, 115. A Horner-Wadsworth-Emmons olefination of 2adamantanone afforded ester 116 which upon reduction with Dibal-H provided allylic
alcohol 117. Hydrogenation of 117 was accomplished over a Pd/C catalyst, but under
these conditions the deoxygenated product was also isolated. This problem can be
circumvented by hydrogenation over Pt/C. Regardless of which catalyst is used, 2adamantaneethanol, 118 is isolated in moderate yield.

Acid catalyzed etherification of the 1,2-dioxolan-3-ols with a variety of alcohols
proceeded in low yield and required long reaction times.

It was thought that the

corresponding OTMS ether 112 might be a more effective electrophile that would react to
generate the same carbocation as the 1,2-dioxolan-3-ol but would not liberate water. This
approach worked better than expected, providing improved yields of 3-alkoxy-1,2dioxolane, 119, after much shorter reaction times as compared with the free alcohol. The
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superiority of the trimethylsiloxydioxolanes as electrophiles for transetherification was
also observed for other backbones as can be seen in Table 2.2.

Compound
X
H
119
TMS
119
TMS
120
H
121
TMS
121
TMS
122
TMS
123
H
124
TMS
124
H
125
TMS
125
H
126
TMS
126
H
127
TMS
127
H
128
Table 2.2 C5-Bu/C5’-Me series

R
Bn
“
Cyclohexanemethyl
CH2CH2Ph
“
Cyclohexaneethyl
CH2CH2CH2Ph
1-adamantanemethyl
“
2-adamantanemethyl
“
1-adamantaneethanol
“
2-adamantaneethanol
“
Butyl

t (h)
>12
0.3
2
>12
1
2
3
48
1
72
1
72
1
12
1
48

Yield (%)
60
60
86
30
80
82
92
26
62
34
57
43
72
23
60
56
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With the 5,5’-butyl/methyl series complete, I undertook the synthesis of the 5methyl/methyl series. The same strategy as described above was employed for this series
as well. As expected, utilization of the trimethylsiloxydioxolane led to improved yields
and shorter reaction times compared with the use of 1,2-dioxolan-3-ol.

Compound
X
H
129
TMS
129
TMS
130
H
131
TMS
132
H
133
H
134
TMS
134
H
135
TMS
135
H
136
TMS
136
H
137
H
138
TMS
138
Table 2.3 C5 /C5’ Me series

R
Bn
“
Cyclohexanemethyl
CH2CH2Ph
Cyclohexaneethyl
CH2CH2CH2Ph
1-adamantanemethyl
“
2-adamantanemethyl
“
1-adamantaneethyl
“
2-adamantanethyl
Butyl
Butyl

t (h)
3
<0.1
2
5
2
2
12
3
48
2
12
1
12
3
1

Yield (%)
66
74
84
73
71
71
33
65
75
62
16
76
59
56
51
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Section 3.3
Antimalarial results and discussion
The results of in vitro antimalarial screening for 3-alkoxy-1,2-dioxolanes 119-138 are
shown in Table 2.4.109-111

Compound
R
Bu
119
Bu
120
Bu
121
Bu
122
Bu
123
Bu
124
Bu
125
Bu
126
Bu
127
Bu
128
Me
129
Me
130
Me
131
Me
132
Me
133
Me
134
Me
135
Me
136
Me
137
Me
138
Table 2.4 Antimalarial results

R1
Bn
Cyclohexanemethyl
CH2CH2Ph
Cyclohexaneethyl
CH2CH2CH2Ph
1-adamantanemethyl
2-adamantanemethyl
1-adamantaneethyl
2-adamantaneethyl
Butyl
Bn
Cyclohexanemethyl
CH2CH2Ph
Cyclohexaneethyl
CH2CH2CH2Ph
1-adamantanemethyl
2-adamantanemethyl
1-adamantaneethyl
2-adamantaneethyl
Butyl

IC50 nM
140
69
76
91
27
136
118
155
169
1400
472
83
415
132
46
289
257
252
218
>10000

I was excited to see several of the molecules with IC50 values <100 nM. When
analyzing the QSAR data the most obvious trend is the importance of the substitution at
C5: dioxolanes with R = Bu are significantly more active than those with R = Me. Only
the trends within the R = Bu series will be discussed in detail; the same trends also hold
in R = Me series. The most active compounds 123 and 133 were synthesized at a later
date. They are included in this table as they are structurally most closely related to the
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“first generation” shown here. Of the originally synthesized compounds, 131 was the
most active and demonstrates that the length of the alkoxy sidechain is important, for
example 119 vs. 121. The use of a cyclohexane ring in the sidechain instead of the
aromatic ring leads to a slight decrease in activity, as can be seen for 120 and 122. When
a bulkier adamantyl group is present in the alkoxy side chain (124-127) there is a
decrease in activity, regardless of connectivity. Taken together, these results suggest that
the most active compound will have a bulky group at C5 and an alkoxy sidechain that is
phenylethyl.
These results show that the 3-alkoxy-1,2-dioxolanes are a promising scaffold for
potential antimalarials and support further exploration of this framework is needed.
Given that there was limited rational design to the molecules that were initially
synthesized, it is reasonable to believe that even higher activities are attainable. These
early results give the impression that higher activities can be obtained by placing a
bulkier group or aromatic ring here or there, but subsequent work will reveal that
identification of optimal attributes within this system is more complicated.
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Section 4
Second generation alkoxydioxolanes: design and synthesis

Portions of the work described in this section have been previously published.108

This chapter has been organized in the following sections:
Section 4.1: Rationale
Section 4.2: Incorporation of spirocycle at C5/C5’
Section 4.3: Effect of ring size at C5/C5’
Section 4.4: Investigation of the nature of the radical leaving group at C3
Section 4.5: Spirocyclic alkoxydioxolanes
Section 4.6: Future directions
Section 4.7: Experimentals
Section 4.1
Rationale for new series
With the knowledge that even simple 3-alkoxy-1,2-dioxolanes possessed
significant antimalarial activity, I set about optimizing the structures to maximize
activity. I approached this optimization from three different angles. The first was
incorporating cyclic restraint in the form of a spirocyclohexane at the C5 position
forming a family of spirocycles exemplified by 139. The second approach is related to
our hypothesis, which was that the postulated activity of 3-alkoxy-1,2-dioxolanes is
related to a carbon centered radical generated at the C3 position. We therefore predicted
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that changing the proposed radical leaving group to a better leaving group should lead to
increased activity (140).
R
OR
O O
139

O O
140

O

Ph

The third approach was to synthesize a molecule that more closely resembled
Vennerstrom’s ozonides enabling a direct comparison.63

As described in the

introduction, Vennerstrom reported that 1,2-dioxolanes such as 142 had essentially zero
antimalarial activity even though analogous ozonides (141) were very potent.

We

hypothesized that this difference reflected a lower rate of β-fragmentation of the
intermediate alkoxy radical compared with the α-alkoxy alkoxy radical derived from the
ozonides. We hypothesized that the faster rate of fragmentation would be restored in 3alkoxy-1,2-dioxolanes such as 143. Like the ozonides, the alkoxydioxolanes place an
oxygen on the peroxide-bearing carbon. Support for this approach comes from
McCullough’s work demonstrating that 1,2,4-trioxanes undergo rapid β -scission forming
a carbon centered radical.22

Section 4.2
Incorporation of a spirocycle at C5/5’
I began with the synthesis of the spirocyclic series represented by 139.

I

envisioned a Mukaiyama cobalt peroxidation of an unsaturated ketone as the key step to
insert the peroxide.

A Prins114 reaction of 144 with acetaldehyde furnished the

homoallylic alcohol which underwent Swern oxidation to afford ketone 145. However,
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peroxidation of ketone 145 under Mukaiyama conditions proceeded in moderate yield
with starting material being recovered (~30%).112

Isayama reported that the use of catalytic t-BuOOH led to decreased reaction
times and increased yields in the Mukaiyama cobalt-mediated peroxidation.113
Serendipitously, I discovered that the use of 100 mol % of t-BuOOH as an additive leads
to both rapid initiation and increased yield of 146. This protocol, while more efficient in
terms of reactivity, still requires optimization as 1,2-dioxolan-3-ol 146 is not produced as
the sole product. A TLC of the reaction appears to show some uncyclized intermediate
(hydroperoxy ketone), but all attempts to force the cyclization with the use of TsOH led
to decomposition. The more significant problem with this approach is the formation of an
alkene impurity that is not present in reactions conducted in the absence of t-BuOOH or
in the presence of catalytic amounts of t-BuOOH. The impurity can be removed by
ozonolysis, creating a tradeoff of increased yield versus an additional purification step.

The transetherification of 147 was undertaken with a variety of primary alcohols.
Both aromatic and non-aromatic containing alkoxy sidechains were introduced in this
manner. In all cases the transetherification proceeded in good yield to afford compounds
148-155. It was subsequently discovered that 3-alkoxy-1,2-dioxolanes derived from 2phenylethanol (148) was contaminated with less than 5% of the acetal formed from 2phenylethanol and bis-2-phenylethylacetal of 2-phenylacetaldehyde.

Although I could
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detect very little of the aldehyde as an impurity in the 2-phenylethanol used as a reagent,
the problem was solved by using a fresh supply of reagent.

Compound

R

2-phenylethyl
148
Bn
149
3-phenylpropyl
150
4-phenylbutyl
151
2-cyclohexylethyl
152
Cyclohexylmethyl
153
1-adamantylethyl
154
1-adamantylmethyl
155
Table 2.5 spirocycle at C5/5’

t
(h)
2
1
2
3
2
2
24
2

Yield
(%)
86
57
88
72
81
84
70
89

IC50 (nM)
NF54
9
19
19
17
41
30
29
35

The screening of this set of molecules provided some important QSAR data that
helped guide subsequent synthesis. All of the different ethers 148-155 demonstrate good
or better activity then the “first generation” ether (Section 3), suggesting the most
important design element is the C5/C5’ spirocycle group. The most active molecule in
this series, 148, contains a phenylethyl side chain. The two carbon spacer between the
oxygen and the arene was optimal, but the chain could either be shortened or lengthened,
149-151, with only slight decrease in activity. As was found in the earlier series, there
was a loss of activity when the non-aromatic analogs were employed (148 vs. 152, 149
vs. 153), though again this decrease was minor. Finally, incorporation of adamantane as
a bulky non-aromatic group in the alkoxy sidechain is effective, but led to a lower IC50
than the aromatic analog.
Since the best activity in 3-alkoxy-1,2-dioxolanes was observed in substrates
containing an aromatic ring in the ether sidechain, Dr. Vennerstrom suggested that I
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complete a Topliss scheme. The Topliss scheme, developed by John Topliss provides a
pathway for modifying the substitution around an aromatic ring to most rapidly identify
the derivatives with the best activity.115,116 Due to the time delay between synthesis and
biological testing, I did not follow the Topliss scheme literally. Instead, I synthesized
several “Topliss” generations of 3-alkoxy-1,2-dioxolanes which were submitted for
biological testing. The alkene impurity formed as a byproduct in the t-BuOOH mediated
synthesis of 147 complicated the purification of this series. Initially, I hoped it would be
possible to adequately purify the compounds by HPLC, but this was not the case. It
became necessary to ozonize 3-alkoxy-1,2-dioxolanes 156-163 in a separate step prior to
chromatography. The majority of the compounds were not affected, but electron rich
substrates such as 157 and 165 underwent significant decomposition.

Compound
148
156
157
158
159
160
161
162
163
164
165
Table 2.6 Topliss results

X
H
4-Cl
4-OMe
4-Me
3,4-Cl
3-Cl
4-F
4-tBu
4-OH
2-Cl
4-Br

t
(h)
3
24
2
3
3
3
3
4
3
3

Yield
(%)
61
39
65
22
37
71
65
62
57
47

IC50 (nM)
NF54
9
18
15
18
18
19
15
23
11
18
29

IC50 (nM)
K1
ND
13
14
15
20
17
14
19
11
16
30

Compounds 156-165 were tested in vitro against both chloroquine-sensitive
(NF54) and chloroquine-resistant (K1) strains of P. falciparum and all exhibited excellent
activity.109-111 Moreover, in almost all cases 156-165 exhibit as good if not better activity
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against chloroquine-resistant malaria as against chloroquine-sensitive malaria. Analyses
of the results from a Topliss perspective show they do not follow the expected activity
trends. Since p-chlorophenol derivative 156 was less active than unsubstituted arene 148,
it was expected that p-methoxyphenol derivative 157 would be more active, however, this
is not the case. These results suggest that the sterics or electronics of the substituents of
the aromatic ring are not a major factor in activity. The fact that the substitution of the
aromatic ring does not significantly affect activity suggests the ring may provide a
synthetic handle to synthesize a more diverse set of compounds.
Section 4.3
Effect of ring size at C5/C5’
O’Neill reported that the antimalarial activity of 1,2,4,5-tetraoxanes could be
modified by altering the attached ring in the following sequence: cyclohexane <
cyclodecane < adamantyl.25 This report prompted me to briefly explore the effect ring
size at the C5 position in 3-alkoxy-1,2-dioxolanes to see if it follows the trend reported
by O’Neill.

I prepared the C5,5’ spirocyclopentane (5-membered) and the

spirocyclodecyl (12-membered) rings following a similar strategy to that used for the
synthesis of 148. The synthesis began with alkenes 166/167, which readily underwent
Prins114 addition and Swern oxidation to afford ketones 168/169. As expected, the
cobalt-mediated peroxidation followed by silylation afforded the trimethylsiloxy
alkoxydioxolanes 170/171. Finally, transetherification with 2-phenylethanol under acidic
conditions afforded the desired 3-alkoxy-1,2-dioxolanes 172/173.

Both of the final

compounds were accompanied by an alkene impurity, which could be removed by
ozonation followed by HPLC purification.
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(CH2)n
166 n = 1
167 n = 8

1. Acetaldehyde
Me2AlCl
2. Swern

O

Co(acac)2
Et3SiH, O2
ClCH2CH2Cl

(CH2)n
168 64% two steps
169 70% two steps

(CH2)n

(CH2)n
HOCH2CH2Ph
OTMS
PTSA
O O
170 55% two steps
171 71% two steps

OCH2CH2Ph
O O
172 n = 1 62%
173 n = 8 24%

In vitro testing against P. falciparum revealed a decrease in activity as the ring
size either increased or decreased.109-111 This does not follow the trend extrapolated from
O’Neill’s work. Though 172/173 are less active then 148, they possess good activity and
show how robust the system is to changes away from the 3-alkoxy-1,2-dioxolane core.
If, for example, activity of 148 was related to binding the spirocyclohexyl into a cleft or
pocket, it would be expected that 173 would have virtually no activity as the larger
molecule would not be able to fit in the same pocket as 148. These results appear to
indicate that the size of the ring at C5 is important but not critical to activity.

Section 4.4
Improved leaving group
Based upon the hypothesis that the antimalarial activity is related to ejection of a
carbon radical from the intermediate α-alkoxyl radical, I wanted to investigate alterations
of the putative leaving group. To test this hypothesis I prepared compounds 174-176. I
postulated that activity would increase with the ability of the leaving group to stabilize a
developing radical, and should follow the trend 174>175>176.

The synthesis of 176

(phenylethyl leaving group) as a negative control was undertaken for two reasons. The
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first is that it should behave in a similar manner to methyl in terms of radical stabilization
while possessing steric bulk more similar to benzyl, enabling a more direct measure of
the effect the leaving group has on activity. Synthesis of both the C5 Me/Me and
spirocyclohexyl series was undertaken as it was not known if substitution at that position
would have an effect on activity.

The synthesis of 181 and 182 began with the Prins114 reaction of the appropriate
aldehyde to afford homoallylic alcohols 177 and 178. The alcohols underwent Swern
oxidation to afford ketones 179 and 180.

Subsequent Mukaiyama cobalt-mediated

peroxidation with the t-BuOOH modification was followed by silylation to afford
siloxydioxolanes 181 and 182.

The synthesis of 187 began with the addition of Grignard 184 to aldehyde 183 to
provide alcohol 185. Oxidation of the alcohol with PDC afforded ketone 186. Cobaltmediated peroxidation under Isayama conditions113 provided 1,2-dioxolan-3-ol 187. The
yield for this reaction is low, in line with my previous experiences for enones. This low
yield, in conjunction with the low yields of the previous steps, made this route not viable.
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I had observed that cobalt-mediated peroxidation of deconjugated systems often
proceed in higher yields. I therefore was interested in preparing β-γ-unsaturated ketone
258.

I decided to utilize a Prins reaction of 183 with isobutylene to afford 188.

However, the Swern oxidation of 188 was accompanied by isomerization of the alkene
leading to isomers 189 and 186.

Use of a Weinreb amide would allow the formation of the ketone without having
to perform any oxidation. Formation of the Weinreb amides, 190 and 191, from the
corresponding

acids

was

accomplished

in

excellent

yield.

Addition

of

methylallylmagnesium chloride proceeded in good yield to afford 189 and 192.
However, if excess 2N HCl was used during workup, isomerization of the alkene does
become a problem. The synthesis of dioxolanes 187 and 193 was completed by cobaltmediated peroxidation and silylation.

The final molecules in this class that I wished to synthesize would incorporate a
cyclohexane at C3. The addition of Grignard 184 to aldehyde 194 afforded alcohol 195
in moderate yield. The oxidation of 195 proceeded to complete conversion only with
PDC; the use of MnO2 or Swern oxidation either led to incomplete oxidation or a mixture
of products. Unfortunately, the cobalt-mediated peroxidation proceeded in very low
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yield to give 1,2-dioxolan-3-ol 197. This route was deemed impractical due to the series
of low yielding steps and the difficulty in obtaining the cyclohexylidene analog of 184.

This setback encouraged me to employ a DePuy ring expansion to install the
peroxide moiety.74 The attractiveness of the DePuy expansion in this system was the
ease of setup and the mildness of the conditions. The synthesis began with commercially
available dicyclohexyl ketone 198 which was converted to the silyl enol ether. SimmonsSmith reaction formed cyclopropane 199. The workup of the Simmons-Smith reaction
led to formation of 10% of the deprotected product 200. If I was to perform this
synthesis again, I would perform an acidic workup and isolate only cyclopropanol 200.
Deprotection of 199 was accomplished with TBAF to afford cyclopropanol 200 in
excellent yield. Finally, DePuy oxidative ring expansion proceeded in good yield to
afford desired 1,2-dioxolan-3-ol 201. In the course of scaling the reaction up, I found this
process to be less efficient at larger scale. In addition, the use of distilled benzene was
found to be vital as the use of benzene from the bottle did not work even with the
addition of triethylborane.

I attempted to extend this methodology to the 3-adamantyl analog of 206, but this
endeavor turned out to be more challenging than anticipated. Initially, a route that
utilized the Mukaiyama cobalt-mediated peroxidation was planned on the ketone derived
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from 204. However, the synthesis of the precursor allylic alcohol (204) proved more
difficult then anticipated. The synthesis of 202 was uneventful. However, preparation of
203 by oxidation of the corresponding alcohol was plagued by formation of the formate
as a major byproduct. At this point it was decided that it was more important to know if
the planned cobalt peroxidation would work, so the synthesis continued with impure 203.
Reaction of the alkenyl lithium of 202, generated in situ, and aldehyde 203 afforded 204.
The oxidation of 204 could not be accomplished with a variety of oxidants including
Swern, PCC, MnO2, or Dess-Martin. Undeterred by this set back, I converted alcohol
204 to acetate 205. Unfortunately, the acetate also failed to undergo Mukaiyama cobaltmediated peroxidation.

With most of the desired 1,2-dioxolan-3-ol precursors in hand, I performed a
series of acid catalyzed transetherifications yielding 3-alkoxy-1,2-dioxolanes 207-213.
The resulting 3-alkoxy-1,2-dioxolanes were tested in vitro against P. falciparum
(NF54).109-111 As predicted from the previous generations, the molecules containing a
spirocyclohexyl at C5 led to increased activity over those with C5/5’ dimethyl.
According to the leaving group hypothesis, benzyl 210 should be the most active
molecule of the series 210-213; instead it was the least active. In contrast, 213 which was
predicted to be middle of the road, was very active. The negative controls 211 and 212
were also very active. Closer examination of the screening data reveals that none of the
modifications were able to increase activity above the level of 148, which features a C3
Me as the putative leaving group. Sterically, 148 and 211 are almost identical and have
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virtually the same activity. The inhibition data on 212 suggests that having too much
steric bulk leads to decreased activity. The only constant in these results is that the
activity is not greatly improved by having a better radical leaving group at C5, as
evidenced by the lower activity of 207 and 210.

Compound

R

X

R1

207A
Me
Bn
Me
Bn
Me
Me
CH
208
2
Me
CH2Bn
CH2Bn
209
(CH2)5
Bn
Me
210
(CH2)5
CH2Bn
Me
211
(CH2)5
CH2Bn
CH2Bn
212
(CH2)5
C6H10
Me
213 A
(CH2)5
Me
CH2Bn
148
Table 2.7 AFree 1,2-dioxolan-3-ol was employed

t
(h)
72
>12
5
>12
5
6
>12
2

Yield
(%)
73
99
61
93
66
66
90
86

IC50 (nM)
NF54
968
23
30
335
8.6
21
9.2
9

Section 4.5
Spirocyclic 3-alkoxy-1,2-dioxolanes
The final target in this series was 143, which would be a close structural mimic
for one of Vennerstrom’s ozonides and would therefore allow comparison of the 3alkoxy-1,2-dioxolanes and the ozonides.

Retrosynthetically, I envisioned 143 being

formed via an acid catalyzed ring closure of 214, with the key step in this synthesis being
a Mukaiyama cobalt-mediated peroxidation of alkenyl hemiacetal 215. It was hoped that
214 could be quickly assembled via addition of alkenyl lithium 217 to lactone 216. A
test reaction showed that n-BuLi could be added successfully to 216. However, when
this reaction was repeated with alkenyl lithium 217 the desired lactol 216 was either not
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formed

or

formed

in

very

low

yield

as

part

of

a

mixture.

Ultimately, I decided upon a route that would establish the 1,2-dioxolane via
electrophilic cyclization. Hydroxyalkenone 220 would be treated with acidic hydrogen
peroxide to form hydroperoxyacetal 219.

Cyclization with Hg (II) would provide

organomercurial 218, which upon demercuration would afford the target 3-alkoxy-1,2dioxolane 143.

The synthesis of the cyclization precursor 219 began from commercially available
5-hexen-1-ol, 221. The alcohol was protected as the OTBS ether and the alkene was
subjected to ozonolysis, affording aldehyde 222.

Prins reaction of 222 with

methylenecyclohexane, followed by a Swern oxidation of the resulting alcohol afforded
ketone 224. Treatment of 224 with TBAF resulted in deprotection to the free alcohol.
Some isomerization of the alkene occurred during the desilylation. This was of no
concern as a treatment of the mixture under acidic conditions with urea hydrogen
peroxide afforded solely 219. 117
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Unsaturated hydroperoxide 219 underwent electrophilic cyclization with
Hg(OAc)2 to afford organomercurial 218, as a mixture of isomers. Demercuration with
NaBH4 led to a mixture of epoxide 225 and 3-alkoxy-1,2-dioxolane 143. The epoxide
arises through a SHi reaction of the intermediate radical. Demercuration with HsnBu3, a
method

reported

by

Bloodworth,

was

unsuccessful

on

this

system.118

I therefore pursued the corresponding peroxyiodination assuming that
dehalogenation of an iodide would be more easily accomplished. Peroxyiodination of
219 furnished dioxolane 231 in moderate yield. Initially, reduction of the iodide was
performed with a dilute solution of HsnBu3 in benzene, but the SHi product dominated.
Increasing the concentration of Bu3SnH resulted in the desired peroxide 143 becoming
the major product. The use of neat Bu3SnH leads to almost complete suppression of 225
formation. Separation of 225 and 143 could only be accomplished by HPLC, so the
crude mixture was treated with a hydride reagent to selectively reduce 225 to the more
polar alcohol. Dibal-H did not lead to complete consumption of ester 225, but LiAlH4
was employed successfully. Since an alkyl tin was used in the final stages of this
synthesis, there was concern that residual tin might be present in 143. ICPMS revealed
that tin was present, but only in ppb concentration.
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When 143 was tested against P. falciparum in vitro the reported activity was 16
nM.109-111 This result is in line with the other 3-alkoxy-1,2-dioxolanes that have tested,
but is a significant improvement compared with the corresponding Vennerstrom ozonide
141.119 An explanation for this difference in activity is not known, but suggests the need
for further exploration of these dispiro systems.

Section 4.6
Future directions
The following discussions suggest potentially profitable future research directions
related to the results described within this section.
For the cyclohexyl 3-alkoxy-1,2-dioxolanes (sec. 2.1), future work needs to focus
on the incorporation of amine containing sidechains. Throughout this work the presence
of an aromatic ring has led to increased activity and the Topliss work has shown the
robustness of this system. By robust I mean that the 3-alkoxy-1,2-dioxolanes do not
appear to lose significant efficacy despite changes made around the 1,2-dioxolane core.
It would have been expected that as changes were made to the aromatic ring there would
have been an increase or decrease in activity, but, instead it remained fairly constant. The
next step in the development of this class of compounds would be the incorporation of an
amine into the alkoxy sidechain to facilitate solubility and drug delivery.
I do not believe that further investigations into a better radical leaving group are
warranted (Sec 4.4). The nature of the leaving group appears to have no effect on activity
and thus the one that is simplest to incorporate synthetically should be employed. This
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anomaly can be further explored if the mechanism of action is ever studied. It would be
interesting to determine if the better radical leaving groups are less active because the
radicals are insufficiently reactive with the yet unknown target. Or does the radical
binding require a sterically small radical like a methyl or phenylethyl? Based upon the
most widely accepted MOA the major radical formed from artemisinin is in essence an
ethyl radical (see section 1) 226 needs to be synthesized. Out of all the compounds
synthesized, I believe that this molecule has the highest potential for further success as it
is a direct analog of the ozonide series, some of the most active synthetic peroxide
antimalarials. The higher activity of 143 to 141 suggests that 226 should have even
higher activity. Likewise 227 would provide the other Vennerstrom mimic and should
be synthesized as well.
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Section 5
“Third generation” 3-alkoxy-1,2-dioxolanes”
This section describes investigations of 3-alkoxy-1,2-dioxolanes bearing
additional functionalization beyond that contained in the frameworks explored in Section
2. All but one of the compounds in this section features the C5/5’ dimethyl substitution.
While the spirocyclohexyl analogs are always more active than the dimethyl analogs, the
same trends hold in the two lines. Therefore, since the dimethyl is both quicker and
cheaper to synthesize it was used as the initial screen to find potential hits.
This section contains:
Section 5.1: Esters
Section 5.2: Alcohols
Section 5.3: Derivatized alcohols
Section 5.4: Other Functional groups
Section 5.5: Animal studies
Section 5.6: Comments on stability
Section 5.7: Future directions
Section 5.1
Esters
Rationale
The synthesis of 3-alkoxy-1,2-dioxolanes containing esters in the alkoxy
sidechain was driven by the desire to create more polar 3-alkoxy-1,2-dioxolanes and to
add a synthetic handle for further functionalization. For example, saponification of the
ester would provide an acid that could be used to install a more biologically relevant
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amide. Up to this point, all of the 3-alkoxy-1,2-dioxolanes have been hydrophobic with
Log P values 1.5 to 6.73, as computed by ChemDraw. Though the majority of previously
synthesized 3-alkoxy-1,2-dioxolanes fall within Lipinski’s guidelines for Log P,120 most
are at the higher end of the Log P limit. Therefore, I wanted to synthesize a small library
of compounds with Log P values ranging from 1.47 to 4.26.
Synthesis
The key step in the synthesis of the esters would utilize the Ca(OCl)2-mediated
decomposition of hydroperoxyacetals, a reaction that was recently reported in our lab.121
Peroxide 107-OTMS underwent acid-catalyzed transetherification with 3-buten-1-ol to
afford 3-alkoxy-1,2-dioxolane 228. Ozonolysis of the alkene in the presence of methanol
afforded the hydroperoxyacetal, which was subsequently treated with Ca(OCl)2 in the
same reaction flask to provide ester 229 in moderate yield.

Saponification of ester 229 was attempted with K2CO3, but no reaction was
observed. The addition of KOH pellets and heating of the reaction led to consumption of
the starting ester. By TLC the reaction appeared to be complete and the crude acid 230
was subjected to column chromatography. However, by NMR the resulting acid was
impure. An acid/base extraction provided a product that appeared by TLC to be pure, but
remained impure by NMR, suggesting that the impurity was also an acidic species.
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Failure of the saponification led to the exploration of other routes to acid 303.
The oxidative cleavage of alkenes to the corresponding acid is well established and I
decided to explore this route. The use of NaIO4 and KmnO4 or OsO4 and oxone122 led to
complete conversion of the starting material, but the acid could not be purified. The use
of Jones reagent to oxidize the alcohol was not employed as there were concerns that the
acidic conditions might lead to the hydrolysis of the 3-alkoxy-1,2-dioxolane to produce
the 1,2-dioxolan-3-ol.

In hindsight, the formation of the benzyl ester followed by

hydrogenation should lead to the desired acid and should have been explored.
With a route established for the synthesis of the esters, I set about preparing two
additional targets. The synthesis began with transetherification of 107-OTMS using 5hexen-1-ol or 10-undecen-1-ol to afford 3-alkoxy-1,2-dioxolane 231 and 232
respectively.

Formation of the hydroperoxyacetal and subsequent treatment with

Ca(OCl)2 provided the desired esters 233 and 234.

The synthesis of a 3-alkoxy-1,2-dioxolane that contained both an ester and
aromatic ring was also undertaken. Transetherification of 107-OTMS with alcohol 235
to afford 3-alkoxy-1,2-dioxolane 236 was accomplished using Re2O7. The use of Re2O7
as a catalyst for this reaction will be discussed in chapter 4.
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Antimalarial results and analysis
The ester-substituted 3-alkoxy-1,2-dioxolanes were tested for antimalarial
activity, as described previously (section 1.3).109-111 What is most striking about this
class of substrates is that all of the activities are higher for the K1 (chloroquine resistant)
strain of P. falciparum compared with the chloroquine sensitive NF54 strain. Out of this
series, ester 236 is the most active possibly due to the presence of an aromatic ring in the
alkoxy sidechain. The other esters all exhibited similar in their activity against NF54
(chloroquine sensitive). I would have expected a greater change in activity as either the
Log P or the length of the alkoxy sidechain changed. In future generations of this class, it
would be interesting to alter the ester group to determine what effect this has on activity.
For example, would the benzyl or phenylethyl ester lead to higher activity or would it
lead to a drop off in activity?
O
O

O

O

O

O

229

OMe

O

O

MeO

233

O
O
O

O

(CH2)6

OMe

O
O

234

O

O

236

OMe

Compound
229
233
234
236
Table 2.8 Esters in alkoxy side chain

Log P
1.47
2.17
4.26
3.2

IC50 (nM)
NF54
159
130
174
56

IC50 (nM)
K1
93
60
141
34
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Section 5.2
Alcohols
Rationale
The synthesis of 3-alkoxy-1,2-dioxolanes featuring a free alcohol in the C3alkoxide was undertaken. The alcohols would provide polarity, a functional handle for
subsequent modification, and an opportunity to test the stability of 3-alkoxy-1,2dioxolanes under a variety of reaction conditions. The synthesis of sidechain diols was
also undertaken because of a 2007 report from Agre demonstrating the importance of the
glycerol channel to malaria infection in the mouse model.123 If the glycerol channel was
knocked out, then malaria resistance was imparted onto the mice. De Kimpe124 and
Flitsch125 reported small molecules that they claim were able to block the glycerol
channel. With this knowledge, it was thought that 3-alkoxy-1,2-dioxolanes possessing a
diol sidechain could either block the glycerol channel or else hijack this channel for
transport of the 3-alkoxy-1,2-dioxolanes.

Synthesis
The synthesis of diols 239 and 240 was straightforward and began with the
synthesis of 3-alkoxy-1,2-dioxolanes 237 and 238.

These were then subjected to

dihydroxylation with OsO4 to afford diols 239 and 240 in good yield. After diol 240 had
already been submitted for in vitro screening it was found to be contaminated with a
small amount of alkene impurity that appeared to have formed during the synthesis of
146.
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The synthesis of alcohol 243 began with the transetherification of 107-OTMS
with alcohol 241 to afford 3-alkoxy-1,2-dioxolane 242. Diol monoether 241 was used
instead of 1,3-propanediol because of a desire to avoid dimer formation. The dimer side
reaction could also have been suppressed by the use of a gross excess of 1,3-propanediol,
but this would have complicated purification. TBAF deprotection of 242 afforded the
desired 3-alkoxy-1,2-dioxolane 243 in good yield. The pentanediol derivative 244 was
obtained as a byproduct of the attempted synthesis of the dimer, was also isolated and
tested.

Antimalarial results and analysis
The analysis of the in vitro screening data shows diols 239 and 240 to exhibit low
to moderate activity against P. falciparum.109-111 Though 240 does possess moderate
activity it is not clear if the activity results from blocking the glycerol channel or through
the hypothesized formation of a carbon radical upon Fe (II)-mediated scission of the 3alkoxy-1,2-dioxolane. One way to determine which of the pathways is operative would
be to prepare an analog lacking the peroxide group.
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The activity of the alcohols suggests there is not a direct correlation between Log
P and activity. Compound 243 has low activity, but the slightly less polar 244 possesses
remarkable activity. Up to this point the hypothesis has been that there was a correlation
between high activity and a bulky group in the alkoxy sidechain. However, 3-alkoxy-1,2dioxolane 244 does not possess a bulky sidechain, yet has an activity rivaling that of the
most active compounds described in section 4. If a Log P argument is applied there is
also no direct correlation as 148, phenylethyl sidechain, has a Log P of 4.55.

Compound
239
240
243
244
148
Table 2.9 Alcohols and Diols

Log P
0.6
1.49
1.24
3
4.55

IC50 (nM)
NF54
1318
63
278
20
9

IC50 (nM)
K1
ND
ND
180
13
ND

Section 5.3
Derivatized alcohol
Rationale
When analyzing the data from the first generation 3-alkoxy-1,2-dioxolanes
(Section 1.3) I became interested in the activity, of substrates featuring a methoxyethyl
sidechain. As the Log P of the compound increased the activity also increased, for
example 103 vs. 104. Previous results have demonstrated that having an aromatic ring in
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the alkoxy sidechain increases activity. Therefore, I thought that combining these two
factors in compound 245 would provide a compound that was destined to have good
activity.

Synthesis and antimalarial results
The

synthesis

of 245 was accomplished through an acid mediated

transetherification of 107-OTMS with alcohol 246.

As predicted, 3-alkoxy-1,2-

dioxolane 245 exhibited very good activity against P. falciparum (NF54) in vitro, 41
nM.109-111

This represents a promising lead that should be followed up with a

cyclohexane analog to investigate the role of the aromatic ring.

Section 5.4
Other functional groups
Rationale
The synthesis of several compounds with polar alkoxy sidechains was undertaken
to test the limits of what functionality could be tolerated in this position. The choice of
substrates did not reflect any systematic search, but rather was intended to rapidly test the
boundaries of the influences of polar functional groups on the activity of 3-alkoxy-1,2dioxolanes.
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Synthesis and antimalarial results
The synthesis of 246 began with previously synthesized 3-alkoxy-1,2-dioxolane
231. Reaction with mCPBA afforded epoxide 246. Nitrile 247 was prepared by acidcatalyzed transetherification of peroxide 107-OTMS. Neither epoxide 246 nor nitrile
247 possessed notable antimalarial activity.

IC50 values are in vitro against P. falciparum (NF54)
Section 5.5
Animal studies
Having indentified several 3-alkoxy-1,2-dioxolanes that possessed very good in
vitro activity, I was interested in pursuing in vivo studies against P. berghei.

The

molecules chosen as candidates possess good in vitro activity and have a polar functional
group. However, no therapeutic effect was observed; all of the mice needed to be
euthanized on day three. It is unclear as to why the 3-alkoxy-1,2-dioxolanes had no
therapeutic effect in vivo and further investigation needs to be undertaken.110
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Parasitized
RBC over
100

% control

244

15.94

92.59

163

17.23

100.06

233

19.71

114.46

103

16.06

93.28

245

18.50

107.41

17.22

NA

3-alkoxy-1,2-dioxolane

NA

Control

Table 2.10 In vivo testing against P. berghei. Method of administration was
subcutaneous injection and values are an average over three days.
Section 5.6
Stability of 3-alkoxy-1,2-dioxolanes
Throughout this work a variety of 3-alkoxy-1,2-dioxolanes have been subjected to
conditions that would lead to decomposition of many peroxides. The tetrasubstituted 3alkoxy-3,5,5-trialkyl-1,2-dioxolanes proved stable to reducing agents (LiAlH4, Dibal-H,
and PPh3), base (TBAF, KOH), oxidants (mCPBA, O3), and heat (60oC for 3 days).
Decomposition of 3-alkoxy-1,2-dioxolanes was only accomplished with FeBr2. This
stability provides an excellent platform on which to explore SAR.
Section 5.7
Future work
My research has shown that 3-alkoxy-1,2-dioxolanes possess a remarkable
robustness in terms of maintaining antimalarial activity across a range of structures, as
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long as the 3-alkoxy-1,2-dioxolane core is kept intact. Changes to the substitution at
either C3 or C5 do lead to changes in activity but as a whole, do not lead a dramatic
change in activity. However, in vivo studies found little activity for these relatively
hydrophobic 3-alkoxy-1,2-dioxolanes. This makes the most obvious future direction to
synthesize molecules that are more drug-like and determine if that increases their in vivo
efficacy. One of the ways, I envision this can be done is by changing the substitution at
C5. The optimal alkoxy sidechain for C3 is the phenylethyl and the best substitution thus
far at C3 has been a spirocyclohexyl. I propose changing the cyclohexane by making a
compound similar to 248. In this system the 4-position of the cyclohexane can undergo
further derivatization to give the molecule more drug-like properties.

A more ambitious goal is to determine the mechanism of action (MOA) of 3alkoxy-1,2-dioxolanes. Currently, the MOA of peroxide antimalarials is of debate and
most synthetic peroxide antimalarials have been developed based upon the hypothesis of
the generation of a carbon centered free radical upon reductive cleavage of the peroxide
bond. The exact MOA of 3-alkoxy-1,2-dioxolanes has not been determined as they are a
new class of peroxide antimalarials. Determination of the MOA might allow more
rationale design of a small molecule.
I do not have a comprehensive plan to determine the MOA of 3-alkoxy-1,2dioxolanes, but do have several experiments that would be beneficial in that pursuit. A
degradation study was done with FeBr2, but was never done in the presence of heme to
determine if the radical formed from the Fe (II)-mediated peroxide decomposition is able
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to alkylate the heme. If alkylation of heme was noted, the alkylated product can be tested
in a manner similar to that reported by Meshnick47 to determine if the alkylated
compound is the source of activity. This experiment is beneficial because if a lack of
alkylation would indicate that 3-alkoxy-1,2-dioxolanes utilize a novel MOA from the
other reported synthetic peroxides.
The synthesis of the non-peroxide analog of a 3-alkoxy-1,2-dioxolane should be
undertaken to determine if antimalarial activity is from the decomposition of the peroxide
bond.

The possibility that 3-alkoxy-1,2-dioxolanes block a channel has not been

excluded and the synthesis of a non-peroxide analog would quickly show if this was a
component of activity.
Though outside of my field of expertise, utilization of either radio labeled or
flourophore tagged 3-alkoxy-1,2-dioxolanes can be used to determine if there is uptake of
the 3-alkoxy-1,2-dioxolane into the infected cell. I believe that the peroxide is being
uptaken by the cell, but without experimental evidence it is impossible to rule out some
surface binding effect.
Since all of these experiments have been conducted with either artemisinin or a
synthetic peroxide, they will in their own right not prove the answer, but will instead
provide a roadmap.

Determination of the MOA of 3-alkoxy-1,2-dioxolanes would

require significant collaboration across several disciplines. In the end, the MOA of this
class of compounds may never be discovered, but even attempts would provide much
needed information to guide future synthesis.
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Section 6
Experimentals
Abbreviations: THF (tetrahydrofuran); DMF (N,N-dimethylformamide); TsOH (ptoluenesulfonic

acid,

monohydrate);

EA/hex

(ethyl

acetate/hexane);

DMSO

(dimethylsulfoxide); RBF (round-bottom flask); rt (room temperature); TLC (thin-layer
chromatography),
General Experimental Conditions: All reagents were used as received from commercial
vendors, with the exception of CH2Cl2, which was distilled from calcium hydride, and
THF, which was distilled from sodium/benzophenone. All reactions were conducted
under an atmosphere of N2 except where noted. Thin layer chromatography (TLC) was
performed on 0.25 mm hard-layer silica G plates; developed plates were visualized with a
hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium molybdate in
10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-p-phenylenediamine
solution in 1:20:100 acetic acid/water/methanol (specific for peroxides);126 1% aq.
KMnO4 (for unsaturated compounds); 3% vanillin in 3% H2SO4 in ethanol (general stain
after charring). “Standard drying and purification” refers to drying of organic extracts
over MgSO4, removal of solvent under vacuum, and purification by flash
chromatography using the indicated eluting solvent. 1H /13C NMR spectra were recorded
in CDCl3 unless otherwise indicated; peaks are reported as: chemical shift (multiplicity, J
couplings in Hz, number of protons). Infrared spectra were recorded as neat films (ZnSe,
ATR mode) with selected absorbances reported in wavenumbers (cm-1). Melting points

87
were collected using a melting point apparatus and all values are uncorrected unless
otherwise noted.

3,5,5-Trimethyl-1,2-dioxolan-3-ol (107):
Mesityl oxide (5.2924 g, 53.9 mmol) was stirred with aq. KOH (1.0 mL, 7.1 mmol, 7.1
M) in a RBF for 5 min at -5 ºC, after which aq. H2O2 (11 mL, ~97 mmol, 30%) was
added. The resulting solution was stirred at 0 ºC for 3 h and then allowed to warm to rt
and held at that temperature for 1 h. The reaction mixture was then extracted with Et2O
(30 mL) and the organic layer washed with brine (2 x 30 mL). The combined organic
layers were dried with MgSO4 and chromatographed twice with 30% ether/hexanes to
afford 107 as a colorless oil (1.5647 g, 24%). Rf (30% ether/hexanes): 0.22.

1

H NMR

(300 MHz): 3.15 (s, 1H), 2.51 (d, J = 12.8, 1H), 2.42 (d, J = 12.8, 1H), 1.55 (s, 3H), 1.40
(s, 3H), 1.37 (s, 3H). 13C (75 MHz): 106.3, 84.2, 58.7, 27.4, 25.0, 23.5. IR: 3292, 2899,
2847. HRMS (ESI): calc for C6H12O3Na: 155.0684; found: 155.0686 (1.3 ppm).

3-Trimethylsilyloxy-3,5,5-trimethyl-1,2-dioxolane (107-OTMS):
A solution of 107 (142.1 mg, 1.07 mmol) in CH2Cl2 (7.5 mL) in a flame-dried RBF was
treated sequentially with imidazole (257.7 mg, 2.8 mmol) and chlorotrimethylsilane (0.3
mL, 2 mmol). After 10 min, the reaction was filtered and the filtrate concentrated in
vacuo. The residue was purified by flash chromatography with 5% EA/hex to afford
107-OTMS, as a colorless oil (129 mg, 57%). Rf (5% EA/hex): 0.68.

1

H NMR (400

MHz): 2.56 (d, J = 12.4, 1H), 2.40 (d, J = 12.4, 1H), 1.52 (s, 3H), 1.36 (s, 3H), 1.34 (s,
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3H), 0.18 (s, 9H).

13

C (100 MHz): 107.4, 83.7, 61.3, 27.4, 25.3, 24.8, 1.5. HRMS (ESI):

calc for C9H20NaO3Si: 227.1079; found: 227.1052 (11.0 ppm).

(3E,3Z)-4-methyl-3-octen-2-one (109):
To a -78 °C solution of 4-penten-2-one (9.7962 g, 117 mmol) in ether (238 mL) in
a flame-dried RBF was added n-BuLi (119 mL, 298 mmol, 2.5 M in hexanes). The
reaction was stirred for 30 min at -78ºC and at rt for 14 hr. The reaction was quenched
with H2O (60 mL) and filtered through a pad of Celite. The combined Et2O extracts (3 x
100 mL) were subjected to standard drying and purification with 15% EA/hex and a
subsequent column with 10% EA/hex to afford E-4-methyl-3-octen-2-ol as a yellow oil
(6.5554 g, 56%). Rf (15% EA/hex): 0.57. 1H NMR (400 MHz): 5.68-5.48 (2H), 1.7 (dd,
J = 6, 1.1, 3H), 1.5 (m, 2H), 1.38 (s, 1H), 1.36-1.21 (7H), 0.91 (overlapping triplets, J =
7, 3H). 13C (100 MHz): 138.4, 122.7, 73.0, 42.8, 28.0, 26.4, 23.3, 17.9, 14.3. IR: 3381,
2958, 2932, 2861. HRMS (CI ): calc for C9H19O: 143.1436; found: 143.1435 (0.6 ppm).
To a 0 °C solution of pyridinium dichromate (3.047 g, 8 mmol) in DMF (12.6
mL) was added E-4-methyl-2-octen-4-ol (871.0 mg, 6.1 mmol) as a solution in DMF (1
mL). The reaction was stirred for 4 h at 0 ºC and rt for 3 hr, and then diluted with H2O
(100 mL). The combined Et2O extracts (3 x 30 mL) were washed with brine (30 mL) and
subjected to standard drying and purification with 15% EA/hex to afford 109 as a
colorless oil and as an E/Z mixture (68:22) (352.9 mg, 41%). Rf (10% EA/hex): 0.42. 1H
NMR: 6.05 (m, 1H), 2.55 (m, 0.5H), 2.25-2.06 (5.5H), 1.87 (d, J = 1.3, 1H), 1.50-1.21
(4H), 0.91 (t, J = 7.4, 3H). 13C NMR (75 MHz): 199.0, 159.7, 159.1, 124.0, 123.4, 41.0,
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33.4, 31.8, 30.3, 29.7, 25.4, 22.9, 22.4, 19.3, 14.0, 13.9. IR: 2957, 2931, 2862, 1687,
1614. HRMS (CI): calc for C9H16ONa: 163.1099; found: 163.1094 (3.1 ppm).

(3,5-cis)(3,5-trans)-5-Butyl-3,5-dimethyl-1,2-dioxolan-3-ol (110):
H2O2 method: To a RBF containing 109 (1.2125, 8.5 mmol) in THF (8.5 mL) was added
aq. KOH (0.15 mL, 1.1 mmol, 7.1 M). The solution was cooled to 0 ºC, after which aq.
H2O2 (1 mL, ~5 mmol, 30%) was added. The resulting solution was allowed to warm to
rt and was stirred for 2 days. The reaction mixture was then diluted with H2O (10 mL)
and extracted with Et2O (2 x 20 mL) and the combined organic layers washed with brine
(2 x 30 mL) and subjected to standard drying and purification with 20% EA/hex to afford
a 1:1 cis/trans mixture of 110 as a colorless oil (105.5 mg, 7%). Rf (10% EA/hex): 0.25.
1

H NMR (100 MHz): 3.45 (s, 1H), 2.53 (d, J = 12.9, 0.5H), 2.45 (d, J = 12.8, 0.5H), 2.41

(d, J = 12.8, 0.5H), 2.31 (d, J = 12.9, 0.5H), 1.73-1.44 (5H), 1.42-1.16 (7H), 0.90
(apparent triplet, J = 6.5, 3H). 13C (100 MHz): 106.1, 105.9, 86.7, 86.3, 57.6, 57.3, 39.7,
37.9, 27.2, 26.6, 25.1, 23.5, 23.3, 23.2, 23.1, 22.4, 14.1, 14.0. IR: 3448, 2957, 2935,
2870. HRMS (ESI): calc for 197.1154; found: 197.1149 (2.5 ppm).
Cobalt method: To a RBF containing cobalt (II) acetylacetone (490 mg, 1.9 mmol) in
1,2-dichloroethane (170 mL) was added sequentially 4-methyl-3-octen-2-one (2.7228g,
19 mmol) in 1,2-dichloroethane (20 mL) and triethylsilane (6.1 mL, 38 mmol). The
mixture was placed under an O2 balloon and stirred overnight. The reaction was diluted
with sat. aq. NH4Cl (50 mL) and extracted with CH2Cl2 (2 x 50 mL). The combined
organic layers were subjected to standard drying and purification with 10% EA/hex to
afford a 1:1 cis/trans mixture of 110 as a colorless oil (395.7 mg, 36% BRSM)

90

(3,5-cis)(3,5-trans)-3-Trimethylsilyloxy-5-butyl-3,5-dimethyl-1,2-dioxolane (112):
A solution of 110 (129.9 mg, 0.92 mmol) in CH2Cl2 (9.2 mL) in a flame-dried RBF was
treated sequentially with imidazole (195mg, 2.7 mmol) and chlorotrimethylsilane (302
mg, 2.8 mmol). After 2 h, the reaction was quenched with sat. NH4Cl (10 mL) and
extracted with CH2Cl2 (10 mL). The organic layer was was subjected to standard drying
and purification with 5% EA/hex to afford a 1:1 cis/trans mixture of 112 as a colorless oil
(129 mg, 57%). Rf (5% EA/hex): 0.69. 1H NMR (300 MHz): 2.58 (d, J = 12.5, 0.5H),
2.50 (d, J = 12.4, 0.5H), 2.40 (d, J = 12.4, 0.5H), 2.30 (d, J = 12.5, 0.5H), 1.76-1.6 (2.5H),
1.6-1.48 (3.5H), 1.44-1.2 (7H), 0.91 (overlapping triplets, J = 6.8, 3H), 0.20 (overlapping
singlets, 9H).

13

C (75 MHz): 107.4, 107.3, 86.4, 86.0, 60.4, 60.0, 40.2, 37.9, 27.3, 26.8,

25.6, 25.5, 25.2, 23.4, 23.3, 22.6, 14.2, 14.2, 1.7. HRMS (ESI): cal for C12H26O3SiNa:
269.1549; found: 269.1547 (0.7 ppm).

2-adamantanemethanol (115):
In a flame-dried three neck RBF a solution of methyltriphenylphosphine bromide
(16.84 g, 47 mmol) in THF (32 mL) was cooled to 0ºC. A solution of n- BuLi (26.4 mL,
66 mmol, 2.5M in hexanes) was added and the solution was brought to rt and stirred for 1
hr. A solution of 2-adamantanone (5.2883g, 35.5 mmol) in THF (35 mL) was added
dropwise from an addition funnel. The reaction was heated at reflux for 7 hrs, and then
cooled to 0ºC. The reaction was quenched with H2O (100 mL), and extracted with Et2O
(2 x 100 mL). The combined organic layers were dried with MgSO4, and filtered through
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a silica plug.

The 2-methyleneadamantane obtained was used without further

purification.
The 2-methyleneadamantane (nominally 4.3g, 29 mmol) was dissolved in THF
(58mL) in a flame-dried RBF and the solution cooled to 0ºC. A solution of BH3-THF
(20.6 mL, 20.6 mmol, 1M in THF) was added drop wise. The reaction was stirred for 30
min, after which H2O (3 mL, 167 mmol) was added. The reaction was heated to 45ºC
and treated sequentially with aq. NaOH (3 M, 15 mL, 46 mmol), and H2O2 (8.2 mL, 65
mmol, 30% in H2O). After 1 hr, the reaction was diluted with H2O (50 mL) and extracted
with Et2O (2 x 50 mL). The combined organic layers were subjected to standard drying
and purification with 10% EA acetate/hex): 0.29. Melting point: 90-91ºC. 1H NMR (400
MHz): 3.74 (d, J = 7.06, 2H), 1.04-1.72 (13H), 1.56 (d, J = 11.92, 2H), 1.26 (s, 1H).

13

C

NMR (100 MHz): 65.1, 47.1, 38.9, 38.2, 31.9, 29.2, 28.4, 28.0. IR: 3247, 2900, 2848.
HRMS (CI): calc for C11H18O: 166.1358; found: 166.1361.

Adamantan-2-ylidene-acetic acid ethyl ester (116):
In a flame-dried RBF sodium hydride (1.3g, 32 mmol) in THF (45 mL) was
slurried. Triethyl phosphonoacetate (8.1g, 36 mmol) was added drop wise, and the
resulting solution was stirred for 1 hr. A solution of 2-adamantanone (4.1g, 27 mmol) in
THF (20 mL) was added and the reaction stirred overnight. The reaction was quenched
with sat. NH4Cl (80 mL) and extracted with Et2O (3 x 80 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 116
as a colorless oil (4.7267 g, 79%). Rf (10% EA/hex): 0.6. 1H NMR (400 MHz): 5.6 (s,
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1H), 4.15 (q, J = 7, 2H), 4.08 (s, 1H), 2.45 (s, 1H), 2.06-1.93 (6H), 1.92-1.80 (6H), 1.29
(t, J = 7, 3H). 13C (100 MHz): 172.3, 167.1, 108.6, 59.4, 41.4, 40.1, 39.1, 36.8, 32.9, 27.9,
14.3. IR: 2902, 2850, 1709, 1644. HRMS (FAB): calc for C14H20O2Li: 227.1623; found:
227.1627.

2-Adamantylideneethanol (117):
A solution of enoate 116 (1.0083 g, 4.5 mmol) in THF (15 mL) was added to a
flame-dried RBF and cooled to -40ºC. DIBAL-H (1.5 M in toluene, 6.7mL, 10 mmol)
was added and the reaction stirred at -40ºC for 2 hrs. The reaction was warmed to rt and
quenched with a solution of sat. aq. Rochelles salt (20 mL). The resulting mixture was
treated sequentially with glycol (1 mL) and ethyl acetate (10 mL). After 2 hrs, the
mixture was extracted with Et2O (25 mL). The combined organic layers were subjected
to standard drying and purification with 30% EA/hex to afford 117 as a colorless oil
(748.6 mg, 92%). Rf (30% EA/hex): 0.57. 1H NMR (400 MHz): 5.35 (t, J = 7.1, 1H), 4.15
(d, J = 7.1, 2H), 2.90 (s, 1H), 2.40 (s, 1H), 2.08-1.68 (12H), 1.18 (s, 1H).

13

C (100 MHz):

152.8, 115.4, 58.2, 40.4, 39.7, 39.1, 37.1, 32.4, 28.4. IR: 3207, 2897, 2846. HRMS
(FAB): calc for C12H18OLi: 185.1518; found: 185.1514.
OH

2-Adamantaneethanol (118):
A RBF was charged with 10% Pd/C (2.46 g, 0.23 mmol) and evacuated under
vacuum. The flask was placed under an atmosphere of H2 (balloon) and a solution of 117
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(2.0311 g, 11.4 mmol) in EA (110 mL) was added and the reaction was allowed to stir
overnight. The flask was purged with N2 and the supernatant filtered through celite. The
filtrate was concentrated in vacuo and the residue was purified by flash chromatography
with 30% EA/hex to afford 118 as a white solid (1.18 g, 57%). Rf (10% EA/hex): 0.21.
Melting point: 60-62ºC. 1H NMR (400 MHz): 3.69 (t, J = 6.9, 2H), 1.92-1.66 (14H), 1.55
(m, 3H), 1.22 (s, 1H).

13

C NMR (100 MHz): 61.7, 40.7, 39.1, 38.4, 35.9, 32.0, 31.7,

28.2, 28.0. IR: 3292, 2899, 2847. HRMS (FAB): calc for C12H20OLi: 187.1674; found:
187.1668.
Method A: From the corresponding 1,2-dioxolan-3-ol
Method B: From the corresponding 3-trimethylsiloxy-1,2-dioxolane

(3,5-cis)(3,5-trans)-3-(1-Phenyl)methoxy-5-butyl-3,5-dimethyl-1,2-dioxolane (119):
Method A:
To a vial containing 110 (197.6 mg, 1.1 mmol) was added sequentially benzyl alcohol
(15.5, 143 mmol) and TsOH (37.2 mg, 0.2 mmol) and the reaction was stirred overnight.
The reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 119 as a yellow oil (180.7 mg, 60%).
Method B:
To a vial containing 112 (126.7 mg, 0.52 mmol) in CH2Cl2 (5 mL) was added
sequentially benzyl alcohol (175 mg, 1.62 mmol) and TsOH (9.2 mg, 0.05mmol). After
20 min, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (10 mL) and
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extracted with CH2Cl2 (20 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 119 as a yellow oil (83.4 mg, 60%).
Rf (10% EA/hex):0.45. 1H NMR (400 MHz): 7.48-7.24 (5H), 4.78 (d, J = 11.2, 1H), 4.52
(d, J = 11.2, 1H), 2.71 (d, J = 12.5, 0.5H), 2.62 (d, J = 12.5, 0.5H), 2.45 (d, J = 12.5,
0.5H), 2.35 (d, J = 12.5, 0.5H), 1.83-1.55 (5H), 1.52-1.28 (7H), 0.95 (overlapping triplets,
J = 6.9, 3H). 13C (100 MHz): 138.8, 128.3, 128.2, 127.8, 127.7, 127.3, 108.4, 108.3, 86.4,
86.0, 64.0, 63.9, 57.8, 57.4, 40.1, 37.6, 27.2, 26.6, 25.5, 23.2, 22.3, 20.2, 19.6, 14.1, 14.0.
HRMS (CI): calc for C16H24O3: 264.1725; found: 264.1727.

(3,5-cis)(3,5-trans)-3-Butyl-5-(cyclohexylmethoxy)-3,5-dimethyl-1,2-dioxolane (120)
Method B:
To a vial containing 112 (196.5 mg, 0.80 mmol) in CH2Cl2 (8 mL) was added
sequentially cyclohexanemethanol (0.5 mL, 4.05 mmol) and TsOH (15 mg, 0.08 mmol).
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard
drying and purification with 10% ethyl acetate/hexanes to afford 120 as a yellow oil
(185.8 mg, 86%). Rf (10% /hex): 0.61. 1H NMR (600 MHz): 3.40 (m, 1H), 3.21 (m, 1H),
2.56 (d, J = 12.5, 0.5H), 2.46 (d, J = 12.5, 0.5H), 2.33 (d, J = 12.5, 0.5H), 2.22 (d, J =
12.5, 0.5H), 1.83-1.49 (8H), 1.45 (d, J = 12.5, 3H), 1.40-1.11 (10H), 1.0-0.86 (5H).

13

C

(150 MHz):108.1, 108.0, 86.3, 85.9, 67.43, 67.41, 58.0, 57.5, 40.3, 38.33, 38.31, 37.8,
30.3, 30.28, 30.25, 27.3, 26.9, 26.8, 26.1, 26.0, 25.7, 23.4, 23.3, 22.5, 20.1, 19.6, 14.2,
14.1. HRMS (ESI): calc for C16H30O3Na: 293.2093; found: 293.2088 (2 ppm).
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(3,5-cis)(3,5-trans)-3-Butyl-3,5-dimethyl-5-(2-phenyl)ethoxy-1,2-dioxolane (121):
Method A:
To a vial containing 110 (62 mg, 0.35 mmol) was added sequentially 2-phenylethanol
(5.4186g, 44 mmol) and TsOH (7.2 mg, 0.04 mmol) and the solution stirred overnight.
The reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard drying
and purification with 5% EA/hex to afford 121 as a yellow oil (32.6 mg, 30%).
Method B:
To a vial containing 112 (74.0 mg, 0.3 mmol) in CH2Cl2 (5 mL) was added sequentially
2-phenylethanol (102 mg, 0.84 mmol) and TsOH (6.7 mg, 0.04mmol). After 1 hr, the
reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted
with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying
and purification with 5% EA/hex to afford 121 as a yellow oil (66.6 mg, 80%). Rf (10%
EA/hex):0.5.

1

H NMR (400 MHz): 7.4-7.2 (5H), 3.88 (m, 1H), 3.66 (m, 1H), 2.9 (m,

2H), 2.58 (d, J = 12.5, 0.5H), 2.50 (d, J = 12.5, 0.5H), 2.37 (d, J = 12.5, 0.5H), 2.25 (d, J
= 12.5, 0.5H), 1.78-1.5 (2H), 1.47 (d, J = 9, 3H), 1.44-1.24 (7H), 0.93 (overlapping
triplets, J = 6.9, 3H). 13C (100 MHz): 139.2, 129.0, 128.2, 126.1, 108.1, 108.0, 85.9, 62.6,
62.5, 57.8, 57.3, 40.1, 37.6, 36.7, 27.2, 26.6, 25.4, 23.2, 22.2, 20.0, 19.5, 14.1, 14.0.
HRMS (FAB): calc for C17H26O3Li: 285.2042; found: 285.2053.
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(3,5-cis)(3,5-trans)-3-Butyl-5-(2-cyclohexylethoxy)-3,5-dimethyl-1,2-dioxolane (122)
Method B:
To a vial containing 112 (133.5 mg, 0.54 mmol) in CH2Cl2 (6 mL) was added
sequentially 2-cyclohexylethanol (0.38 mL, 2.7 mmol) and TsOH (10 mg, 0.05 mmol).
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 122 as a yellow oil (126.1 mg, 82%).
Rf (10% EA/hex): 0.55. 1H NMR (600 MHz): 3.64 (m, 1H), 3.44 (m, 1H), 2.55 (d, J =
12.6, 0.5H), 2.47 (d, J = 12.6, 0.5H), 2.33 (d, J = 12.6, 0.5H), 2.22 (d, J = 12.6, 0.5H),
1.80-1.10 (23H), 0.96-0.84 (5H).

13

C (150 MHz):108.1, 108.0, 86.3, 86.0, 59.62, 59.60,

57.9, 57.5, 40.3, 37.8, 37.6, 34.8, 34.7, 33.74, 33.71, 33.24, 33.21, 27.3, 26.9, 26.8, 26.6,
26.5, 25.7, 23.4, 23.3, 22.5, 20.1, 19.6, 14.2, 14.1. HRMS (ESI): calc for C17H32O3Na:
307.2249; found: 307.2243 (2 ppm).

(3,5-cis)(3,5-trans)-3-butyl-3,5-dimethyl-5-(3-phenylpropoxy)-1,2-dioxolane (123)
Method B:
To a vial containing 112 (211.3 mg, 0.86 mmol) in CH2Cl2 (8 mL) was added
sequentially 3-phenyl-1-propanol (0.55 mL, 4.1 mmol) and TsOH (15 mg, 0.08 mmol).
After 3 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard
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drying and purification with 10% EA/hex to afford 123 as a yellow oil (211.3 mg, 92%).
Rf (10% EA/hex): 0.41.

1

H NMR (600 MHz): 7.29 (5H), 3.63 (m, 1H), 3.44 (m, 1H),

2.71 (m, 2H), 2.58 (d, J = 12.5, 0.5H), 2.48 (d, J = 12.5, 0.5H), 2.35 (d, J = 12.5, 0.5H),
2.23 (d, J = 12.5, 0.5H), 1.88 m, 2H, 1.72-1.48 (2H), 1.44 (d, J = 13.2, 3H), 1.40-1.23
(7H), 0.88 (m, 3H).

13

C (150 MHz): 142.5, 128.73, 128.71, 128.4, 125.8, 108.2, 108.1,

86.4, 86.0, 61.0, 60.9, 58.0, 57.5, 40.3, 37.8, 32.6, 32.6, 32.0, 31.9, 27.3, 26.8, 25.6, 23.4,
23.3, 22.5, 20.2, 19.6, 14.2, 14.1. HRMS (ESI): calc for C18H28O3Na: 315.1936; found:
315.1936 (<1 ppm).

(3,5-cis)(3,5-trans)-3-(1-(1-Adamantyl)methoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane
(124):
Method A:
To a vial containing 110 (161.9 mg, 0.93 mmol) in CH2Cl2 (10 mL) was added
sequentially 1-adamantanemethanol (754.1 mg, 4.54 mmol) and TsOH (42.2 mg, 0.22
mmol). After 48 hrs, the reaction was treated with sat. aq NaHCO3 (5 mL) and H2O (5
mL) and extracted with CH2Cl2 (2 x 10mL). The combined organic layers were subjected
to standard drying and purification with 2.5% EA/hex to afford 124 as a yellow oil (78.4
mg, 26%).
Method B:
To a vial containing 112 (74.5 mg, 0.3 mmol) in CH2Cl2 (5 mL) was added sequentially
1-adamantanemethanol (176.9 mg, 1.1 mmol) and TsOH (5 mg, 0.03mmol). After 1 hr,
the reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted
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with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying
and purification with 5% EA/hex to afford 124 as a yellow oil (60.4 mg, 62%). Rf (5%
EA/hex): 0.31. 1H NMR (400 MHz): 3.19 (d, J = 3.7, 0.5H), 3.17 (d, J = 3.7, 0.5H), 2.96
(dd, J = 0.7, 8.8, 1H), 2.58 (d, J = 12.4, 0.5H), 2.48 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.2,
0.5H), 2.22 (d, J = 12.2, 0.5H), 2.04-1.93 (3H), 1.76-1.48 (14H), 1.44 (d, J = 8.2, 3H),
1.41-1.24 (7H), 0.92 (t, J = 7.1, 3H). 13C (100 MHz): 107.8, 107.7, 85.9, 85.6, 72.0, 71.9,
57.8, 57.1, 40.3, 39.7, 37.7, 37.3, 33.3, 33.2, 28.3, 27.1, 26.6, 26.0, 23.2, 23.1, 22.5, 19.6,
19.1, 14.1, 14.0. HRMS (FAB): calc for C20H35O3: 323.2586; found: 323.2594.

((3,5-cis)(3,5-trans)-3-(1-(2-Adamantyl)methoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane
(125):
Method A:
To a vial containing 110 (198.3 mg, 1.14 mmol) in CH2Cl2 (11 mL) was added
sequentially 2-adamantanemethanol (755.2 mg, 4.5 mmol) and TsOH (22.4 mg, 0.12
mmol). After 72 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and 5 mL
H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 5% EA/hex to afford 125 as a yellow
oil (145.8 mg, 34%).
Method B:
To a vial containing 112 (72.9 mg, 0.30 mmol) in CH2Cl2 (5 mL) was added sequentially
2-adamantanemethanol (176.9 mg, 1.1 mmol) and TsOH (5 mg, 0.03mmol). After 1 hr,
the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted
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with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying
and purification with 5% EA/hex to afford 125 as a yellow oil (54.9 mg, 57%). Rf (5%
EA/hex): 0.41. 1H NMR (300 MHz): 3.72 (m, 1H), 3.45 (ddd, J = 2.1, 6.6, 9.2, 1H), 2.56
(d, J = 12.5, 0.5H), 2.46 (d, J = 12.4, 0.5H), 2.33, 2.33 (d, J = 12.4, 0.5H), 2.27 (d, J =
12.4, 0.5H), 2.05-1.67 (13H), 1.67-1.49 (4H), 1.46 (d, J = 6.3, 3H), 1.42-1.20 (7H), 0.91
(overlapping triplet, J = 7.1, 3H).

13

C (75 MHz): 107.9, 107.8, 86.0, 85.7, 63.6, 57.7,

57.2, 44.2, 44.1, 40.2, 39.0, 38.9, 38.8, 38.3, 37.6, 32.1, 31.8, 29.7, 29.2, 28.5, 28.0, 27.0,
26.6, 25.6, 23.2, 23.1, 22.3, 19.9, 19.4, 14.0, 13.96. HRMS (FAB): calc for C20H35O3:
323.2586; found: 323.2675.

O

C4H9
O

O

(3,5-cis)(3,5-trans)-3-(2-(1-Adamantyl)ethoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane
(126):
Method A:
To a vial containing 110 (54.4 mg, 0.30 mmol) in CH2Cl2 (5 mL) was added sequentially
1-adamantaneethanol (223.2 mg, 1.24 mmol) and TsOH (15.3 mg, 0.08 mmol). After 3
days, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and
extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to
standard drying and purification with 5% EA/hex to afford 126 as a yellow oil (191 mg,
43%).
Method B:
To a vial containing 112 (76.5 mg, 0.31 mmol) in CH2Cl2 (3 mL) was added sequentially
1-adamantaneethanol (153 mg, 0.85 mmol) and TsOH (10.1 mg, 0.05mmol). After 1 hr,
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the reaction was treated with sat. aq. NaHCO3 (3 mL) and H2O (5 mL) and extracted with
CH2Cl2 (2 x 5 mL). The combined organic layers were subjected to standard drying and
purification with 5% EA/hex to afford 126 as a yellow oil (75.5 mg, 72%). Rf (10%
EA/hex):0.7. 1H NMR (300 MHz): 3.67 (m, 1H), 3.46 (m, 1H), 2.54 (d, J = 12.4, 0.5H),
2.46 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.4, 0.5H), 2.23 (d, J = 12.4, 0.5H), 2-1.87 (3H),
1.78-1.58 (7H), 1.58-1.5 (5H), 1.47 (d, J = 6.4, 3H), 1.43-1.2 (9H), 0.92 (overlapping
triplets, J = 7.1, 3H). 13C (75 MHz): 108.1, 108, 86.2, 85.8, 57.9, 57.59, 57.55, 57.5, 44,
43.9, 42.7, 40, 37.6, 37.2, 31.8, 28.7, 27.2, 26.6, 25.3, 23.2, 23.1, 22.2, 20.1, 19.6, 14,
13.9. HRMS (FAB): calc for C21H36LiO3: 343.2824; found: 343.2839.

(3,5-cis)(3,5-trans)-3-(2-(2-Adamantyl)ethoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane
(127):
Method A:
To a vial containing 110 (220.3 mg, 1.27 mmol) in CH2Cl2 (5 mL) was added
sequentially 2-adamantaneethanol (614.3 mg, 3.4 mmol) and TsOH (30.6 mg, 0.16
mmol). After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5
mL) and extracted with CH2Cl2 (2 x 20mL). The combined organic layers were subjected
to standard drying and purification with 5% EA/hex to afford 127 as a yellow oil (99.1
mg, 23%).
Method B:
To a vial containing 112 (52.2 mg, 0.21 mmol) in CH2Cl2 (5 mL) was added sequentially
2-adamantaneethanol (128.3 mg, 0.71 mmol) and TsOH (7.1 mg, 0.04mmol). After 1 hr,
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the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with
CH2Cl2 (2 x 5 mL). The combined organic layers were subjected to standard drying and
purification with 5% EA/hex to afford 127 as a yellow oil (42.6 mg, 60%). Rf (10%
EA/hex): 0.37. 1H NMR (400 MHz): 3.62 (m, 1H), 3.44 (m, 1H), 2.54 (d, J = 12.6, 0.5),
2.45 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.6, 0.5H), 2.22 (d, J = 12.6, 0.5H), 1.97-1.57
(16H), 1.57-1.43 (5H), 1.41-1.22 (7H), 0.91 (overlapping triplets, J = 6.8, 3H). 13C (100
MHz): 108.1, 108.0, 86.3, 86.0, 60.4, 60.3, 57.9, 57.5, 41.1, 41.0, 40.3, 39.4, 39.3, 38.6,
37.8, 33.1, 33.0, 32.4, 32.0, 31.8, 31.5, 28.5, 28.3, 27.3, 26.8, 25.6, 23.4, 23.3, 22.4, 20.1,
19.6, 14.3, 14.2. HRMS (FAB): calc for C21H36LiO3: 343.2824; found: 343.2830.

(3,5-cis)(3,5-trans)-3-Butoxy-5-butyl-3,5-dimethyl-1,2-dioxolane (128):
Method A:
To a vial containing 110 (71 mg, 0.41 mmol) was added sequentially 1-butanol (3.25g, 44
mmol) and TsOH (7.1 mg, 0.04 mmol). After 2 days, the reaction was quenched with sat.
aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 20 mL). The
combined organic layers were subjected to standard drying and purification with 5%
EA/hex to afford 128 as a yellow oil (162 mg, 56%). Rf (5% EA/hex): 0.41. 1H NMR
(400 MHz): 3.62 (m, 1H), 3.44 (m, 1H), 2.57 (d, J = 12.6, 0.5H), 2.47 (d, J = 12.4, 0.5H),
2.35 (d, J = 12.4, 0.5H), 2.24 (d, J = 12.6, 0.5H), 1.76-1.53 (4H), 1.47 (d, J = 8.6, 3H),
1.44-1.24 (9H), 0.93 (m, 3H). 13C (100 MHz): 108.0, 107.8, 86.1, 85.8, 61.3, 57.8, 57.3,
40.1, 37.6, 32.13, 32.11, 27.1, 26.6, 25.4, 23.2, 23.1, 22.2, 20.0, 19.5, 19.4, 19.3, 14.1,
14.0, 13.9, 13.8. HRMS (EI): calc for C13H26O3: 230.1882; found: 230.1883.
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3-(1-Phenylmethoxy)-3,5,5-trimethyl-1,2-dioxolane (129):
Method A:
To a vial containing 107 (203.7 mg, 1.5 mmol) was added sequentially benzyl alcohol
(19.376 g, 108 mmol) and TsOH (28.53 mg, 0.15 mmol). After 3 hrs, the reaction was
treated with sat. aq. NaHCO3 (20 mL) and extracted with Et2O (30 mL). The combined
organic layers were washed with brine (30 mL) and subjected to standard drying and
purification with 10% EA/hex to afford 129 as a yellow oil (226.4 mg, 66%).
Method B:
To a vial containing 107-OTMS (110.7 mg, 0.54 mmol) in CH2Cl2 (5 mL) was added
sequentially benzyl alcohol (158 mg, 1.46 mmol) and TsOH (10 mg, 0.05mmol). After 5
min, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 129 as a yellow oil (89.2 mg, 74%).
Rf (10% EA/hex): 0.62. 1H NMR (500 MHz): 7.36 (m, 5H), 4.78 (d, J = 11.3, 1H), 4.54
(d, J = 11.3, 1H), 2.69 (d, J = 12.6, 1H), 2.42 (d, J = 12.6, 1H), 1.60 (s, 3H), 1.44 (s, 6H).
13

C (125 MHz): 138.8, 12.3, 127.7, 127.4, 108.7, 83.9, 64.1, 58.8, 27.7, 24.7, 20.1.

LRMS (ESI): calc for C13H18O3Na: 245.1; found: 245.1. HRMS (EI M-CH3): calc for
C12H15O3: 207.1021; found: 207.1012 (4.4 ppm).
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3-(Cyclohexylmethoxy)-3,5,5-trimethyl-1,2-dioxolane (130)
Method B:
To a vial containing 107-OTMS (202.8 mg, 0.99 mmol) in CH2Cl2 (10 mL) was added
sequentially cyclohexanemethanol (0.60 mL, 4.9 mmol) and TsOH (19 mg, 0.1mmol).
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and 5 mL H2O (5 mL)
and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to
standard drying and purification with 10% EA/hex to afford 130 as a yellow oil (180 mg,
79%). Rf (10% EA/hex): 0.52. 1H NMR (400 MHz): 3.39 (m, 1H), 3.22 (m, 1H), 2.53 (d,
J = 12.4, 1H), 2.31 (d, J = 12.4, 1H), 1.84-1.59 (5H), 1.58-1.47 (1H), 1.44 (s, 3H), 1.36
(s, 3H), 1.35 (s, 3H), 1.31-1.08 (3H), 1.0-0.86 (2H).

13

C (100 MHz): 108.3, 83.7, 76.9,

67.5, 58.8, 38.3, 30.3, 30.2, 27.8, 26.8, 26.1, 26.0, 24.8, 20.0. HRMS (ESI): calc for
C13H24O3Na: 251.1623; found: 251.1622 (1 ppm).

O

O

O

Ph

3-(2-phenylethoxy)-3,5,5-Trimethyl-1,2-dioxolane (131):
Method A:
To a vial containing 107 (190.9 mg, 1.44 mmol) was added sequentially 1-phenylethanol
(22 mL, 183 mmol) and TsOH (26.3 mg, 0.14 mmol). After 5 hrs, the reaction was
treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with Et2O (25 mL).
The combined organic layers were washed with brine (25 mL) and subjected to standard
drying and purification with 5% EA/hex to afford 131 as a yellow oil (234 mg, 73%). Rf
(5% EA/hex): 0.46. 1H NMR (500 MHz): 7.17 (m, 5H), 3.89 (m, 1H), 3.67 (m, 1H), 2.92
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(m, 2H), 2.55 (d, J = 12.4, 1H), 2.34 (d, J = 12.4, 1H), 1.47 (s, 3H), 1.39 (d, J = 6.2, 6H).
13

C (125 MHz): 139.2, 129.0, 128.3, 126.1, 108.4, 83.8, 62.7, 58.7, 36.7, 27.6, 24.6, 19.9.

HRMS (ESI): calc for C14H21O3: 237.1491; found: 237.1499 (0.8 ppm)

O

O

O

3-(2-Cyclohexylethoxy)-3,5,5-trimethyl-1,2-dioxolane (132)
Method B:
To a vial containing 107-OTMS (202.1 mg, 0.99 mmol) in CH2Cl2 (10 mL) was added
sequentially 2-cyclohexylethanol (0.69 mL, 4.9 mmol) and TsOH (19 mg, 0.1mmol).
After 2 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5 mL) and H2O
(5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 10% EA/hex to afford 132 as a yellow
oil (180 mg, 79%). Rf (10% EA/hex): 0.48. 1H NMR (400 MHz): 3.64 (m, 1H), 3.45 (m,
1H), 2.53 (d, J = 12.4, 1H), 2.32 (d, J = 12.4, 1H), 1.81-1.59 (5H), 1.54-1.33 (12H), 1.301.08 (3H), 0.98-0.82 (2H).

13

C (100 MHz): 108.4, 83.8, 59.8, 58.9, 34.7, 33.7, 33.2, 27.8,

26.8, 26.6, 26.5, 24.8, 20.1. HRMS (ESI): calc for C14H26O3Na: 265.1779; found:
265.1176 (1 ppm).

3-(3-phenylpropoxy)-3,5,5-Trimethyl-1,2-dioxolane (133)
Method A:
To a vial containing 107 (203.5 mg, 1.54 mmol) in CH2Cl2 (15 mL) was added
sequentially 3-phenyl-1-propanol (1 mL, 7.5 mmol) and TsOH (27 mg, 0.14 mmol).
After 2 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5 mL) and H2O
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(5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 10% EA/hex to afford 133 as a yellow
oil (272.2 mg, 71%). Rf (10% EA/hex): 0.5. 1H NMR (400 MHz): 7.34-7.17 (5H), 3.67
(m, 1H), 3.51 (m, 1H), 2.82-2.70 (2H), 2.59 (d, J = 12.5, 1H), 2.38 (d, J = 12.5, 1H), 2.01.89 (2H), 1.20 9s, 3H), 1.42 (s, 3H), 1.41 (s, 3H). 13C (100 MHz): 142.4, 128.7, 128.4,
125.8, 108.4, 83.8, 61.0, 58.9, 32.5, 31.9, 27.8, 24.8, 20.1. HRMS (ESI): calc for
C15H22O3Na: 273.14687; found: 273.1468 (<1 ppm).

3-(1-(1-Adamantyl)methoxy)-3,5,5-trimethyl-1,2-dioxolane (134):
Method A:
To a vial containing 107 (236.8 mg, 1.8 mmol) in dichloromethane (15 mL) was added
sequentially 1-adamantanemethanol (1.1228 g, 6.8 mmol) and TsOH (32 mg, 0.17
mmol). After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted
with Et2O (2 x 30 mL). The combined organic layers were washed with brine (30 mL)
and subjected to standard drying and purification with 5% EA/hex to afford 134 as a
yellow oil (164 mg, 33%).
Method B:
To a vial containing 107-OTMS (81.2 mg, 0.4 mmol) in CH2Cl2 (5 mL) was added
sequentially 1-adamantanemethanol (171 mg, 1.02 mmol) and TsOH (6.46 mg,
0.034mmol). After 3 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5
mL) and H2O (10 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification with 5% EA/hex to afford 134
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as a yellow oil (77.6 mg, 65%). Rf(5% EA/hex): 0.38. 1H NMR (400 MHz): 3.19 (d, J =
8.9, 1H), 2.99 (d, J = 8.9, 1H), 2.55 (d, J = 12.3, 1H), 2.56 (d, J = 12.3, 1H), 2.01-1.94
(3H), 1.78-1.63 (6H), 1.63-1.52 (7H), 1.45 (s, 3H), 1.38 (d, J = 5.6, 6H).

13

C (100 MHz):

108.1, 83.4, 72.0, 58.7, 39.7, 37.3, 33.3, 28.3, 27.7, 24.9, 19.6. HRMS (FAB): calc for
C17H28O3Li: 280.2030; found: 280.2038.

3-(1-(2-adamantyl)methoxy)-3,5,5-trimethyl-1,2-dioxolane (135):
Method A:
To a vial containing 107 (213 mg, 1.61 mmol) in CH2Cl2 (15 mL) was added sequentially
2-adamantanemethanol (1.2134 g, 7.3 mmol) and TsOH (20 mg, 0.11 mmol). After 2
days, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (5 mL) and extracted
with CH2Cl2 (2 x 10mL). The combined organic layers were subjected to standard drying
and purification with 10% EA/hex to afford 135 as a yellow oil (340.7 mg, 75%).
Method B:
To a vial containing 107-OTMS (81.2 mg, 0.40 mmol) in CH2Cl2 (5 mL) was added
sequentially 1-adamantanemethanol (171 mg, 1.03 mmol) and TsOH (6.4 mg,
0.03mmol). After 2 hrs, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (10
mL) and extracted with CH2Cl2 (2 x 10mL). The combined organic layers were subjected
to standard drying and purification with 5% EA/hex to afford 135 as a yellow oil (60.4
mg, 62%). Rf(10% EA/hex): 0.7. 1H NMR (500 MHz): 3.7 (apparent triplet, J = 8.4, 1H),
3.46 (m, 1H), 2.51 (d, J = 12.4, 1H), 2.3 (d, J = 12.4, 1H), 2.08-1.64 (13H), 1.54 (d, J =
12.6, 2H), 1.45 (s, 3H), 1.34 (m, 6H). 13C (100 MHz): 108.1, 83.4, 63.7, 58.6, 44.1, 39.0,
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38.8, 38.3, 32.1, 31.7, 29.6, 29.2, 28.4, 28.0, 27.6, 24.6, 19.8. HRMS (FAB): calc for
C17H29O3: 281.2117; found: 281.2206.

3-(2-(1-Adamantyl)ethoxy)- 3,5,5-trimethyl-1,2-dioxolane (136):
Method A:
To a vial containing 107 (262.2 mg, 1.99 mmol) in CH2Cl2 (15 mL) was added
sequentially 1-adamantaneethanol (837.2 mg, 4.7 mmol) and TsOH (31 mg, 0.16 mmol).
After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted with
Et2O (2 x 30 mL). The combined organic layers were and washed with brine (30 mL)
and subjected to standard drying and purification with 10% EA/hex to afford 136 as a
yellow oil (93 mg, 16%).
Method B:
To a vial containing 107-OTMS (76.2 mg, 0.37 mmol) in CH2Cl2 (5 mL) was added
sequentially 1-adamantaneethanol (184.6 mg, 1.02 mmol) and TsOH (5.4 mg,
0.03mmol). After 1 hr, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O
(10 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 5% EA/hex to afford 136 as a yellow
oil (83.1 mg, 76%). Rf (5% EA/hex): 0.38. 1H NMR (400 MHz): 3.60 (OT, J = 9.0, 1H),
3.51 (overlapping triplets, J = 9.0, 1H), 2.54 (d, J = 12.4, 1H), 2.34 (d, J = 12.4, 1H), 21.91 (3H), 1.75-1.63 (6H), 1.58-1.52 (6H), 1.49 (s, 3H), 1.46-1.30 (8H).

13

C (100 MHz):

108.3, 83.7, 58.8, 57.7, 44.0, 42.7, 37.1, 31.8, 28.7, 27.5, 24.6, 20.1. HRMS (EI): calc for
C18H30O3: 294.2195; found: 294.2196.
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3-(2-(2-Adamantyl)ethoxy)- 3,5,5-trimethyl-1,2-dioxolane (137):
Method A:
To a vial containing 107 (123.6 mg, 0.96 mmol) in CH2Cl2 (10 mL) was added
sequentially 2-adamantaneethanol (540 mg, 3.0 mmol) and TsOH (20.8 mg, 0.11 mmol).
After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted Et2O
(30 mL).

The combined organic layers were and washed with brine (30 mL) and

subjected to standard drying and purification with 5% EA/hex to afford 137 as a yellow
oil (161.9 mg, 59%). Rf (5% EA/hex): 0.37. 1H (400 MHz): 3.63 (m, 1H), 3.45 (m, 1H),
2.51 (d, J = 12.4, 1H), 2.3 (d, J = 12.4, 1H), 1.93-1.60 (15H), 1.53-1.43 (5H), 1.36 (d, J =
3.1, 6H). 13C (100 MHz): 108.2, 83.5, 60.3, 58.7, 41.0, 39.2, 39.1, 38.4, 32.8, 32.2, 31.8,
31.6, 31.4, 28.3, 28.0, 27.6, 24.6, 19.8. HRMS (FAB): calc for C18H31O3: 295.2273;
found: 295.2270.

3-Butoxy-3,5,5-trimethyl-1,2-dioxolane (138):
Method A:
To a vial containing 107 (201.4 mg, 1.53 mmol) was added sequentially 1-butanol
(13.2764 g, 179.1 mmol) and TsOH (46.6 mg, 0.25 mmol). After 3 hrs, the reaction was
treated with sat. aq. NaHCO3 (5 mL) and extracted with Et2O (2 x 30 mL).

The

combined organic layers were washed with brine (2 x 30 mL) and subjected to standard
drying and purification with 2.5% EA/hex to afford 138 as a yellow oil (162 mg, 56%).
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Method B:
To a solution of 107-OTMS (70.4 mg, 0.34 mmol) in CH2Cl2 (5 mL) in a vial was added
sequentially 1-butanol (75 mg, 1.02 mmol) and TsOH (6.3 mg, 0.03 mmol). After 1 h,
the reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted
with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying
and purification with 5% EA/hex to afford 138 as a yellow oil (33 mg, 51%). Rf (5%
EA/hex): 0.23.

1

H NMR (300 MHz): 3.6 (overlapping triplets, J = 6.5, 1H), 3.45

(overlapping triplets, J = 6.3, 1H), 2.54 (d, J = 12.4, 1H), 2.84 (d, J = 12.4, 1H), 1.56 (m,
2H), 1.48 (s, 3H), 1.70-1.34 (8H), 0.94 (t, J = 7.3, 3H). 13C (75 MHz): 108.4, 83.8, 61.6,
58.8, 32.3, 27.8, 24.8, 20.1, 19.5, 14.0. HRMS (CI): calc for C10H21O3: 189.1491; found:
189.1498 (3.9 ppm).

1-(Cyclohex-1-en-1-yl)propan-2-one (145):
To a 0 °C solution of methylene cyclohexane (5 g, 100 mmol) and acetaldehyde (3.8 mL,
68 mmol) in CH2Cl2 (174 mL) in a flame-dried RBF was added Me2AlCl (68 mL, 68
mmol, nominally 1M in hexanes). The reaction was allowed to stir at 0 °C for 2 hr and
then brought to rt. After two more hours of stirring, the reaction was treated with sat. aq.
Na2HPO4 (20 mL) and aq. 2N HCl (10 mL) and extracted with CH2Cl2 (2 x 50 mL). The
combined organic layers were subjected to standard drying and purification with 20 %
EA/hex to afford 1-cyclohexenyl-2-propanol as a yellow oil (6.619g, 90%). Rf (20%
EA/hex): 0.30. 1H NMR: 5.54 (s, 1H), 3.87 (m, 1H), 2.14-1.83 (4H), 1.76 (d, J = 2.2,
1H), 1.70-1.50 (6H), 1.19 (d, J = 6.3, 3H).

13

C: 135.0, 125.1, 65.0, 48.5, 28.5, 25.4, 23.0,
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22.9, 22.5. HRMS (ESI): calc for C9H16NaO: 163.1099; found: 163.1098 (0.6 ppm).
The NMR spectra matched those previously reported.114
To a -78 °C solution of oxalyl chloride (0.96 mL, 12 mmol) in CH2Cl2 (72 mL) in
a flame-dried RBF containing was added DMSO (1.3 mL, 19 mmol) in CH2Cl2 (20 mL)
drop wise via an addition funnel and allowed to stir for 20 min. 1-cyclohexenyl-2propanol (1.35 g, 9.6 mmol) in CH2Cl2 (20 mL) was added drop wise via an addition
funnel and the reaction allowed to stir at -78oC for 1 hr. Et3N (7 mL, 48 mmol) was next
added and the reaction stirred at -78oC for 30 min and rt for 1 hr. The reaction was then
treated with H2O (30 mL) and extracted with CH2Cl2 (2 x 30 mL). The combined
organic layers were subjected to standard drying and purification with 5% EA/hex to
afford 145 as a yellow oil (1.0833g, 81%). Rf (10% EA/hex): 0.27.

1

H NMR (300

MHz): 5.61-5.53 (1H), 3.00 (s, 2H), 2.09-2.00 (2H), 1.96-1.87 (2H), 1.70-1.51 (4H).

13

C

(75 MHz): 208.1, 131.9, 126.5, 53.6, 29.2, 28.8, 25.6, 22.9, 22.2. IR: 2925, 2836, 1710,
1437, 1354. HRMS (CI): calc for C9H15O: 139.1123; found: 139.1123 (0.1 ppm).
OH
O

O

3-Methyl-1,2-dioxaspiro[4.5]decan-3-ol (146):
In a RBF containing cobalt (II) acetylacetonate (77.4 mg, 0.30 mmol) in 1,2dichloroethane (29 mL) was added 145 (404.2 mg, 2.93 mmol) and triethylsilane (0.96
mL, 5.8 mmol) and the solution placed under an atmosphere of O2 (balloon). The
reaction was stirred overnight and treated with sat. aq. NH4Cl (10 mL) and extracted with
CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to standard drying and
purification with 40% Et2O/pent to afford 146 as a colorless oil (262.9 mg, 52 %). Rf
(30% EA/hex): 0.30. 1H NMR (600 MHz): 3.32 (s, 1H), 2.4 (d, J = 12.8, 1H), 2.36 (d, J
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= 12.8, 1H), 1.80-1.53 (6H), 1.52 (s, 3H), 1.44-1.31 (4H).

13

C (150 MHz): 105.7, 86.0,

57.1, 36.0, 34.9, 25.2, 24.2, 23.4, 23.2. IR: 3452, 2933, 2858, 1447, 1256. HRMS
(ESI): calc for C9H16NaO3: 195.0997; found: 195.0990 (3.5 ppm).

3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (147):
To a flame-dried RBF containing 146 (960.7 mg, 5.6 mmol) in CH2Cl2 (56 mL) was
added imidazole (1.1 g, 17 mmol) and chlorotrimethylsilane (1.1 mL, 8.4 mmol) and the
reaction was stirred at rt for 1 hr. The reaction was treated with H2O (20 mL) and
extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were subjected to
standard drying and purification with 5 % EA/hex to afford 147 as a yellow oil (1.2255 g,
90%). Rf (5% EA/hex): 0.48. 1H NMR (600 MHz): (2.46 (d, J = 12.3, 1H), 2.34 (d, J =
12.3, 1H), 1.80-1.53 (6H), 1.51 (s, 3H), 1.44-1.43 (4H), 0.19 (9H).

13

C (75 MHz): 107.0,

85.7, 59.8, 36.5, 35.0, 25.5, 25.4, 24.4, 23.4, 1.7. HRMS (ESI): calc for C12H24NaO3Si:
267.1392; found: 267.1398 (2.2 ppm).

3-Methyl-3-(1-phenylethoxy)-1,2-dioxaspiro[4.5]decane (148):
To a vial containing a solution of 147 (102.6 mg, 0.42 mmol) in CH2Cl2 (8 mL) was
added sequentially 2-phenylethanol (250 mg, 2.0 mmol) and TsOH (8.0 mg, 0.04 mmol)
and the solution stirred for 2 hr. The reaction was then treated with sat. aq. NaHCO3 (8
mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 5% EA/hex to afford 148 as a yellow
oil (99.3 mg, 86%). Rf (5% EA/hex): 0.43.

1

H NMR (300 MHz): 7.36-7.12 (5H), 3.92
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(dt, J = 9.2, 7.2, 1H), 3.69 (dt, J = 9.2, 7.2), 3.04 (2H), 2.49 (d, J = 12.5, 1H), 2.31 (d, J =
12.5, 1H), 1.90-1.30 (13H).

13

C (75 MHz): 139.3, 129.1, 128.3, 126.2, 107.9, 85.6, 62.7,

57.3, 36.8, 36.4, 34.6, 25.3, 24.3, 23.3, 20.0.

HRMS (ESI): calc for C17H24NaO3:

299.1623; found: 299.1615 (2.6 ppm).

3-Methyl-3-(1-phenylmethoxy)-1,2-dioxaspiro[4.5]decane (149):
To a vial containing a solution of 147 (202.9mg, 0.83 mmol) in CH2Cl2 (8 mL) was
added sequentially benzyl alcohol (0.42 mL, 4.1 mmol) and TsOH (16 mg, 0.08 mmol)
and the solution stirred for 1 hr. After which the reaction was treated with sat. aq.
NaHCO3 (8 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers
were concentrated in vacuo, and the residue was purified via column chromatography.
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The
residue obtained upon concentration was purified by column chromatography with 10%
EA/hex to afford 149 (123.6 mg, 57%). Rf (5% EA/hex): 0.54.

1

H NMR (300 MHz):

7.48-7.25 (5H), 4.77 (d, J = 11.4, 1H), 4.51 (d, J = 11.4, 1H), 2.59 (d, J = 12.5, 1H), 2.37
(d, J = 12.5, 1H), 1.91-1.54 (9H), 1.50-1.33 (4H).

13

C (75 MHz): 139.0, 128.5, 127.9,

127.5, 108.2, 85.8, 64.1, 57.3, 36.6, 34.7, 25.4, 24.4, 23.4, 20.2. HRMS (ESI): calc for
C16H22O3Na: 285.1467; found: 285.1466 (0.4 ppm).

3-Methyl-3-(1-phenylpropoxy)-1,2-dioxaspiro[4.5]decane (150):
To a vial containing a solution of 147 (201.2 mg, 0.82 mmol) in CH2Cl2 (8 mL) was
added sequentially 3-phenyl-1-propanol (0.55 mL, 4.1 mmol) and TsOH (11.5 mg, 0.06
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mmol) and the solution stirred for 2 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification 10% EA/hex to afford 150 as a
yellow oil (209.7 mg, 88%). Rf (10% EA/hex): 0.48.

1

H NMR (400 MHz): 7.33-7.17

(5H), 3.67 (m, 1H), 3.48 (m, 1H), 2.75 (m, 2H), 2.50 (d, J = 12.5, 1H), 2.33 (d, J = 12.5,
1H), 1.99-1.55 (8H), 1.51-1.35 (7H). 13C (100 MHz): 142.5, 128.7, 128.4, 125.8, 107.9,
85.6, 61.0, 57.3, 36.5, 34.7, 32.6, 31.9, 25.4, 24.4, 23.4, 20.0. HRMS (ESI): calc for
C18H26O3Na: 313.1780; found: 313.1770 (3 ppm).

3-Methyl-3-(1-phenylbutoxy)-1,2-dioxaspiro[4.5]decane (151):
To a vial containing 147 (202.3 mg, 0.83 mmol) in CH2Cl2 (8 mL) was added
sequentially 4-phenyl-1-butanol (0.63 mL, 4.1 mmol) and TsOH (16 mg, 0.08 mmol) and
the solution stirred for 3 hrs. After which the reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification with column chromatography,
ozonolysis, column chromatography and HPLC with 10% EA/hex to afford 151 as a
yellow oil (188.9 mg, 72%). Rf (10% EA/hex): 0.59.

1

H NMR (600 MHz): 7.28-7.14

(5H), 3.62 (m, 1H), 3.45 (m, 1H), 2.64 (m, 2H), 2.42 (d, J = 12.4, 1H), 2.27 (d, J = 12.4,
1H), 1.81-1.50 (10 H), 1.46-1.32 (7H). 13C (150 MHz): 142.9, 128.6, 128.4, 125.8, 107.8,
85.6, 61.5, 57.3, 36.5, 35.8, 34.7, 29.8, 28.2, 25.4, 24.4, 23.4, 20.1. HRMS (ESI): calc
for C19H28O3Na: 327.1936; found: 327.1926.
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3-(2-Cyclohexylethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (152):
To a vial containing a solution of 147 (198.9 mg, 0.82 mmol) in CH2Cl2 (8 mL) was
added sequentially 2-cyclohexaneethanol (0.57 mL, 4.1 mmol) and TsOH (16 mg, 0.08
mmol) and the solution stirred for 2 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 152
as a yellow oil (185.8 mg, 81%). Rf (10% EA/hex): 0.56. 1H NMR (400 MHz): 3.39 (dd,
J = 9.0, 6.8, 1H), 3.21 (dd, J = 9.0, 6.8, 1H), 2.43 (d, J = 12.4, 1H), 2.26 (d, J = 12.4, 1H),
1.84-0.82 (26H).. 13C (100 MHz): 107.8, 85.5, 59.6, 57.3, 37.6, 36.6, 34.72, 34.70, 33.72,
33.2, 26.8, 26.6, 26.5, 25.4, 24.4, 23.4, 20.0. HRMS (ESI): calc for C17H30O3Na:
305.2093; found 305.2091 (1 ppm).

3-(2-Cyclohexylmethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (153):
To a vial containing a solution of 147 (195.9 mg, 0.80 mmol) in CH2Cl2 (8 mL) was
added sequentially 2-cyclohexanemethanol (0.5 mL, 4 mmol) and TsOH (16 mg, 0.08
mmol) and the solution stirred for 2 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 153
as a yellow oil (181.5 mg, 84%). Rf (10% EA/hex): 0.6. 1H NMR (600 MHz): 3.7 (m,
1H), 3.47 (m, 1H), 2.44 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 1.84-0.81 (24H).

13

C

(100 MHz): 107.8, 85.6, 67.5, 57.3, 38.3, 36.6, 34.7, 30.3, 30.2, 26.9, 26.1, 26.0, 25.4,
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24.4, 23.4, 20.0. HRMS (ESI): calc for C16H28O3Na: 291.1936; found 291.1922 (4.8
ppm).

3-(1-(1-Adamantyl)ethoxy))-3-methyl-1,2-dioxaspiro[4.5]decane (154):
To a vial containing a solution of 147 (202.1 mg, 0.83 mmol) in CH2Cl2 (8 mL) was
added sequentially 1-adamantaneethanol (735.8 mg, 4.1 mmol) and TsOH (16 mg, 0.08
mmol) and the solution stirred for 24 hrs. The reaction was treated with sat. aq. NaHCO3
(20 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were
subjected to standard drying and the residue was purified via column chromatography.
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The
residue obtained upon concentration was purified by column chromatography and HPLC
with 5% EA/hex to afford 154 as a yellow oil (185.8 mg, 81%). Rf (5% EA/hex): 0.4. 1H
NMR (600 MHz): 3.67 (m, 1H), 3.49 (m, 1H), 2.42 (d, J = 12.5, 1H), 2.29 (d, J = 12.5,
1H), 1.63 (s, 3H), 1.84-1.28 (27H).

13

C (150 MHz): 107.9, 85.6, 57.8, 57.4, 44.2, 42.9,

37.3, 36.5, 34.7, 32.0, 28.9, 25.4, 24.4, 23.4, 20.2. HRMS (ESI): calc for C21H34O3Na:
357.2406; found: 357.2399 (2.0 ppm).

3-(1-(1-Adamantyl)methoxy))-3-methyl-1,2-dioxaspiro[4.5]decane (155):
To a vial containing a solution of 147 (101.5mg, 0.42 mmol) in CH2Cl2 was added
sequentially 1-adamantanemethanol (350.8 mg, 2.11 mmol) and TsOH (11.3 mg, 0.06
mmol) and the solution stirred for 2 hrs. The reaction was treated with sat. aq. NaHCO3
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(8 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 5% EA/hex to afford 155 as a white
solid (116.7 mg, 89%). Rf (5% EA/hex): 0.21. MP = 36-38 oC.

1

H NMR (300 MHz):

3.17 (d, J = 8.9, 1H), 2.95 (d, J = 8.9, 1H), 2.44 (d, J = 12.4, 1H), 2.24 (d, J = 12.4, 1H),
2.0-1.90 (3H), 1.80-1.45 (17H), 1.45-1.30 (6H). 13C (75 MHz): 107.6, 85.4, 72.1, 57.3,
39.8, 37.5, 36.7, 34.8, 33.4, 28.5, 25.4, 24.4, 23.4, 19.7.

HRMS (ESI): calc for

C20H32NaO3: 343.2249; found: 343.2255 (2 ppm).

3-(4-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (156):
To a vial containing a solution of 147 (197.7 mg, 0.81 mmol) in CH2Cl2 (10 mL) was
added sequentially 4-chlorophenethyl alcohol (0.51 mL, 4.1 mmol) and TsOH (16 mg,
0.08 mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification and was purified via
column chromatography. The semi purified product was dissolved in CH2Cl2 and treated
with O3 (O3/O2). The residue obtained upon concentration was purified by column
chromatography and HPLC with 10% EA/hex to afford 156 as a yellow oil (152.6 mg,
61%). Rf (10% EA/hex): 0.56. 1H NMR (400 MHz): 7.30-7.18 (4H), 3.87 (dt, J = 9.3,
7.0, 1H), 3.63 (dt, J = 9.3, 7.0, 2.94-2.82 (2H), 2.43 (d, J = 12.5, 1H), 2.28 (d, J = 12.5,
1H), 1.89-1.31 (13H).

13

C (100 MHz): 138.0, 132.0, 130.5, 128.5, 107.9, 85.7, 62.3,

36.5, 36.0, 34.7, 25.4, 24.3, 23.4, 19.9. HRMS (ESI): calc for C17H23O3NaCl: 333.1233;
found: 333.1218 (4.5 ppm).
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3-(4-Methoxyphenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (157):
To a vial containing a solution of 147 (201.7 mg, 0.83 mmol) in CH2Cl2 (8 mL) was
added sequentially 4-methoxyphenethyl alcohol (663.5 mg, 4.4 mmol) and TsOH (16 mg,
0.08 mmol) and the solution stirred for 24 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification and was purified via
column chromatography. The semi purified product was dissolved in CH2Cl2 and treated
with O3 (O3/O2). The residue obtained upon concentration was purified by column
chromatography and HPLC with 10% EA/hex to afford 157 as a yellow oil (98.2 mg,
39%). Rf (10% EA/hex): 0.47. 1H NMR (600 MHz): 7.18 (d, J = 8.7, 2H), 6.84 (d, J =
8.7, 2H), 3.84 (m, 1H), 3.79 (s, 3H), 3.61(m, 1H), 2.84 (m, 2H), 2.44 (d, J = 12.6, 1H),
2.28 (d, J = 12.6, 1H), 1.81-1.51 (6H), 1.45-1.33 (7H).

13

C (150 MHz): 158.2, 131.4,

130.0, 113.8, 107.9, 85.7, 63.0, 57.3, 55.4, 36.5, 35.9, 34.6, 25.4, 24.4, 23.4, 20.1.
HRMS (ESI): calc for C18H26O4Na: 329.1729; found 329.1721 (2.4 ppm).

3-Methyl-3-(4-methylphenethoxy)-1,2-dioxaspiro[4.5]decane (158):
To a vial containing a solution of 147 (197 mg, 0.81 mmol) in CH2Cl2 (8 mL) was added
sequentially 4-methylphenethyl alcohol (0.57 mL, 4.1 mmol) and TsOH (16 mg, 0.08
mmol) and the solution stirred for 2 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification and was purified via column
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chromatography. The semi purified product was dissolved in CH2Cl2 and treated with O3
(O3/O2).

The residue obtained upon concentration was purified by column

chromatography with 5% EA/hex to afford 158 (155.7 mg, 65%). Rf (10% EA/hex):
0.43.

1

H NMR (600 MHz): 7.19-7.05 (4H), 3.85 (m, 1H), 3.62 (m, 1H), 2.87 (m, 2H).

2.45 (d, J = 12.4, 1H), 2.35-2.25 (4H), 1.84-1.49 (6H), 1.48-1.29 (7H).

13

C (150 MHz):

136.2, 135.7, 129.1, 129.0, 107.9, 85.7, 63.0, 57.3, 36.5, 36.4, 34.6, 25.4, 24.4, 23.4, 21.2,
20.1. HRMS (ESI): calc for C18H26O3Na: 313.1780; found: 313.1766 (4.47 ppm).

3-(3,4-Dichlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (159):
To a vial containing a solution of 147 (203 mg, 0.83 mmol) in CH2Cl2 (8 mL) was added
sequentially 3,4-dichlorophenethyl alcohol (0.59 mL, 4.1 mmol) and TsOH (17.1 mg,
0.08 mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification and was purified via
column chromatography. The semi purified product was dissolved in CH2Cl2 and treated
with O3 (O3/O2). The residue obtained upon concentration was purified by column
chromatography and HPLC (x2) with 5% EA/hex to afford 159 (63.7 mg, 22%). Rf (10%
EA/hex): 0.3. 1H NMR (600 MHz): 7.39 (d, J = 1.9, 1H), 7.34 (d, J = 8.3, 1H), 7.10 (dd,
J = 8.3, 1.8, 1H), 3.86 (m, 1H), 3.62 (m, 1H), 2.84 (t, J = 6.8, 2H), 2.4 (d, J = 12.5, 1H),
2.27 (d, J = 12.5, 1H), 1.80-1.50 (6H), 1.40-1.32 (7H).

13

C (150 MHz): 140.0, 132.2,

131.2, 130.2, 130.1, 128.7, 107.9, 85.7, 61.8, 57.4, 36.5, 35.7, 34.7, 25.3, 24.3, 23.3, 19.8.
HRMS (ESI): calc for C17H22O3NaCl2: 367.0344; found: 367.0843 (3.0 ppm).
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3-(3-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (160):
To a vial containing a solution of 147 (249.1 mg, 1.02 mmol) in CH2Cl2 (10 mL) was
added sequentially 3-chlorophenethyl alcohol (0.66 mL, 5 mmol) and TsOH (19 mg, 0.1
mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
layers were subjected to standard drying and purification via column chromatography.
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The
residue obtained upon concentration was purified by column chromatography and HPLC
with 5% EA/hex and HPLC with 2.5% EA/hex to afford 160 (117.2 mg, 37%). Rf (10%
EA/hex): 0.56. 1H NMR (600 MHz): 7.30-7.09 (5H), 3.86 (m, 1H), 3.63 (m, 1H), 2.87
(m, 2H), 2.42 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 1.81-1.50 (6H), 1.45-1.30 (7H).
13

C (150 MHz): 141.6, 134.1, 129.6, 129.4, 127.4, 126.4, 107.9, 85.7, 62.2, 57.4, 36.5,

36.4, 34.6, 25.4, 24.4, 23.4, 19.9.

HRMS (ESI): calc for C17H23O3NaCl: 333.1233;

found: 333.1223 (3.0 ppm).

3-(4-Fluorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (161):
To a vial containing a solution of 147 (200 mg, 0.82 mmol) in CH2Cl2 (8 mL) was added
sequentially 4-fluorophenethyl alcohol (0.51 mL, 4.1 mmol) and TsOH (16 mg, 0.08
mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq. NaHCO3
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic
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layers were subjected to standard drying and purification via column chromatography.
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The
residue obtained upon concentration was purified by column chromatography and HPLC
with 10% EA/hex to afford 161 (144.5 mg, 71%). Rf (10% EA/hex): 0.55.

1

H NMR

(600 MHz): 7.24-7.19 (2H), 7.0-6.94 (2H), 3.85 (m, 1H), 3.61 (m, 1H), 2.42 (d, J = 12.5,
1H), 2.28 (d, J = 12.5, 1H), 1.82-1.51 (6H), 1.47-1.33 (7H).

13

C (150 MHz): 162.5,

160.9, 135.1, 135.1, 130.6, 130.5, 115.2, 115.0, 107.9, 85.7, 62.6, 57.4, 57.3, 36.5, 35.9,
24.7, 25.4, 24.4, 23.4, 20.0.
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F (376 MHz): -117.52, -117.53, -117.54, -117.56, -117.57,

-117.58, -117.6. HRMS (ESI): calc for C17H23O3NaF: 317.1529; found: 317.1521 (2.5
ppm).

3-(4-(tert-Butyl)phenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (162):
To a vial containing a solution of 147 (204.2 mg, 0.84 mmol) in CH2Cl2 (8 mL) was
added sequentially 4-t-butylphenethyl alcohol (0.75 mL, 4.1 mmol) and TsOH (16 mg,
0.08 mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification via column
chromatography. The semi purified product was dissolved in CH2Cl2 and treated with O3
(O3/O2).

The residue obtained upon concentration was purified by column

chromatography with 5% EA/hex to afford 162 (176.3 mg, 65%). Rf (10% EA/hex):
0.35. 1H NMR (300 MHz): 7.36-7.3 (2H), 7.24-7.17 (2H), 3.87 (m, 1H), 3.65 (m, 1H),
3.65 (m, 1H), 2.80 (m, 2H), 2.46 (d, J = 12.5, 1H), 2.30 (d, J = 12.5, 1H), 1.86-1.51 (6H),
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1.50-1.27 (16H).

13

C (75 MHz): 149.0, 136.2, 128.8, 125.3, 107.9, 85.7, 62.9, 57.3, 36.5,

36.5, 36.2, 34.6, 34.5, 31.6, 25.4, 24.4, 23.3, 20.1. HRMS (ESI): calc for C21H32O3Na:
355.2249; found: 355.2253 (1.1 ppm).

3-(4-Hydroxyphenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (163):
To a flame-dried RBF containing a solution of 147 (1.2513 g, 5.1 mmol) in CH2Cl2 (51
mL) was added sequentially 2-[4-(tert-butyldimethylsilanyloxy)phenyl]ethanol (3.8872 g,
15.4 mmol) and TsOH (97 mg, 0.51 mmol) and the solution stirred for 2 hrs. The
reaction was treated with sat. aq. NaHCO3 (8 mL) and extracted with CH2Cl2 (2 x 10
mL). The combined organic layers were subjected to standard drying and purification
with 5% EA/hex to afford 3-((tert-butyldimethyl(phenoxy)silane)ethoxy)-3-methyl-1,2dioxaspiro[4.5]decane (1.2919 g, 62%). Rf (10% EA/hex): 0.62. 1H NMR (400 MHz):
7.12-7.08 (2H), 6.78-6.72 (2H), 3.82 (m, 1H), 3.6 (m, 1H), 2.82 (m, 2H), 2.44 (d, J =
12.6, 1H), 2.27 (d, J = 12.6, 1H), 1.83-1.50 (6H), 1.46-1.32 (7H), 0.99 (s, 9H), 0.19 (s,
6H). 13C (100 MHz): 154.1, 133.0, 130.0, 120.0, 108.0, 85.7, 63.0, 57.3, 36.5, 36.0, 34.7,
25.9, 25.4, 24.4, 23.4, 20.1, 18.4, -4.2. HRMS (ESI):; calc for C23H38O4NaSi: 429.2437;
found: 429.2427 (2.3ppm).
To

a

flame-dried

vial

containing

a

solution

of

3-((tert-

butyldimethyl(phenoxy)silane)ethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (1.1509 g,
2.8 mmol) in THF (15 mL) was added TBAF (3.4 mL, 3.4 mmol, 1M in THF). After 30
min the reaction was treated with H2O (30 mL) and extracted with Et2O (3 x 30 mL).
The combined organic layers were subjected to standard drying and purified twice by
column chromatography with 30% EA/hex to afford 163 (790.5 mg, 96%). Rf (30%
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EA/hex): 0.48. 1H NMR (400 MHz): 7.11 (d, J = 8.5, 2H), 6.76 (m, 2H), 4.85 (s, 1H),
3.82 (m, 1H), 3.60 (m, 1H), 2.82 (m, 2H), 2.45 (d, J = 12.5, 1H), 2.29 (d, J = 12.5, 1H),
1.82-1.52 (7H), 1.47-1.32 (6H). 13C (100 MHz): 154.1, 131.5, 130.2, 115.3, 108.0, 85.8,
63.1, 57.3, 36.5, 35.9, 34.6, 25.4, 24.4, 23.4, 20.1. HRMS (ESI): calc for C17H24O3Na:
315.1572; found: 315.1562 (3.2 ppm).

3-(2-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (164):
To a vial containing a solution of 147 (200.1 mg, 0.82 mmol) in CH2Cl2 (8 mL) was
added sequentially 2-chlorophenethyl alcohol (0.54 mL, 4.1 mmol) and TsOH (16 mg,
0.08 mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification via column
chromatography. The semi purified product was dissolved in CH2Cl2 and treated with O3
(O3/O2).

The residue obtained upon concentration was purified by column

chromatography and HPLC with 10% EA/hex to afford 164 (146 mg, 57%). Rf (10%
EA/hex): 0.50. 1H NMR (600 MHz): 7.37-7.32 (2H), 7.21-7.12 (2H), 3.88 (m, 1H), 3.71
(m, 1H), 3.03 (m, 2H), 2.43 (d, J = 12.5, 1H), 2.28 (d, J = 12.5, 1H), 1.82-1.52 (6H),
1.48-1.32 (7H).

13

C (150 MHz): 136.8, 134.2, 131.3, 129.3, 127.6, 126.6, 107.9, 85.5,

60.8, 57.1, 36.3, 34.5, 34.3, 25.2, 24.2, 23.2, 19.9. HRMS (ESI): calc for C17H23O3NaCl:
333.1233; found: 333.1231 (0.6 ppm).
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3-(4-Bromophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (165):
To a vial containing a solution of 147 (203.5 mg, 0.83 mmol) in CH2Cl2 (8 mL) was
added sequentially 4-bromophenethyl alcohol (0.57 mL, 4.1 mmol) and TsOH (16 mg,
0.08 mmol) and the solution stirred for 3 hrs. The reaction was treated with sat. aq.
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined
organic layers were subjected to standard drying and purification via column
chromatography. The semi purified product was dissolved in CH2Cl2 and treated with O3
(O3/O2).

The residue obtained upon concentration was purified by column

chromatography and HPLC with 10% EA/hex to afford 165 (140.1 mg, 47%). Rf (10%
EA/hex): 0.52. 1H NMR (600 MHz): 7.40 (d, J = 8.3, 2H), 7.14 (d, J = 8.3, 2H), 3.85 (m,
1H), 3.61 (m, 1H), 2.85 (m, 1H), 2.40 (d, j = 12.5, 1H), 2.32 (d, J = 12.5, 1H), 1.81-1.51
(6H), 1.44-1.32 (7H).

13

C (150 MHz): 138.5, 131.4, 131.0, 120.0, 107.9, 85.7, 62.2, 57.4,

36.5, 36.1, 34.6, 25.4, 24.3, 23.4, 19.9. HRMS (ESI): calc for C17H23O3NaBr: 377.0728;
found: 377.0715 (3.0 ppm).

1-(Cyclopent-1-en-1-yl)propan-2-one (168):
To a flame-dried RBF containing a 0 °C solution of acetaldehyde (1.7 mL, 29 mmol) and
methylene cyclopentane (2.3 mL, 22 mmol) in CH2Cl2 (106 mL) was added Me2AlCl (28
mL, 28 mmol, nominally 1M in hexanes). The resulting solution was stirred at 0 °C for 2
hrs and allowed to warm to rt. After stirring an additional 3 hrs, the reaction was treated
with sat. aq. NaH2PO4 (20 mL) and aq. 2N HCl until clear. The resulting suspension was
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extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were subjected to
standard drying and purification with 30% EA/hex to afford 1-(cyclopent-1-en-1yl)propan-2-ol (2.15 g, 78%). Rf (30% EA/hex): 0.53. 1H NMR (400 MHz): 5.51-5.48
(1H), 3.97-3.88 (1H), 2.37-2.15 (6H), 1.88 (m, 2H), 1.70 (s, 1H), 1.20 (d, J = 6.1, 3H).
13

C (100 MHz): 141.5, 127.3, 65.7, 41.5, 35.3, 32.7, 23.6, 23.1.
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (1.5 mL, 18

mmol) in CH2Cl2 (90 mL) was added a solution of DMSO (2.2 mL, 30 mmol) in CH2Cl2
(30 mL) via an addition funnel. The resulting solution was stirred at -78 oC for 30 min,
after which 1-(cyclopent-1-en-1-yl)propan-2-ol (1.89 g, 15 mmol) in CH2Cl2 (30 mL)
was added via an addition funnel. The reaction was stirred for 1 hr, after which Et3N (11
mL, 75 mmol) was added. The reaction was stirred at -78 °C for 30 min and then allowed
to warm to rt. After 30 min, the reaction was quenched with H2O (50 mL) and extracted
with CH2Cl2 (2 x50 mL). The combined organic layers were subjected to standard drying
and purification with 20% Et2O/pent to 30% Et2O/pent to afford 168 (1.48 g, 82%). Rf
(20% EA/hex): 0.61.

1

H NMR (300 MHz): 5.53 (s, 3H), 3.20 (s, 2H), 2.39-2.21 (4H),

2.15 (s, 3H), 1.96-1.89 (1H).

13

C (75 MHz): 207.3, 137.3, 128.9, 46.7, 35.4, 32.8, 29.5,

23.7. IR: 2925, 2836, 1710. HRMS (CI): calc for C8H13O: 125.0966; found: 125.0967
(0.5 ppm).
O

1-(Cyclododec-1-en-1-yl)propan-2-one (169):
To a flame-dried RBF containing a 0 °C solution of acetaldehyde (0.47 mL, 8.4 mmol)
and 1-methylidenecyclododecane (1.1642g, 6.5 mmol) in CH2Cl2 (33 mL) was added
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Me2AlCl (8.4 mL, 8.4 mmol, nominally 1M in hexanes). The resulting solution was
stirred at 0 °C for 2 hrs and allowed to warm to rt. After stirring an additional 3hrs, the
reaction was treated with sat. aq. NaH2PO4 (20 mL) and aq. 2N HCl until clear. The
resulting suspension was extracted with CH2Cl2 (3 x 20 mL). The combined organic
layers were subjected to standard drying and purification with 20% EA/hex to afford 1(cyclododec-1-en-1-yl)propan-2-ol (1.15 g, 79%). Rf (20% EA/hex): 0.44. 1H NMR (300
MHz): 5.57-5.46 (1H), 3.88 (m, 1H), 2.44-1.88 (6H), 1.71 (s, 1H), 1.65-1.11 (18H).

13

C

(75 MHz): 134.7, 131.8, 66.3, 38.8, 36.0, 27.7, 26.7, 26.6, 26.0, 25.5, 25.0, 24.7, 24.66,
24.63, 24.0, 23.1. HRMS (ESI): calc for C15H28ONa: 247.2038; found: 247.2037 (0.4
ppm).
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (0.45 mL,
5.4 mmol) in CH2Cl2 (30 mL) was added a solution of DMSO (0.64 mL, 9 mmol) in
CH2Cl2 (10 mL) via an addition funnel. The resulting solution was stirred at -78 oC for
30 min, after which 1-(cyclododec-1-en-1-yl)propan-2-ol (930 mg, 4.2 mmol) in CH2Cl2
(10 mL) was added via an addition funnel. The reaction was stirred for 1 hr, after which
Et3N (3.1 mL, 23 mmol) was added. The reaction was stirred at -78 °C for 30 min and
then allowed to warm to rt. After 30 min, the reaction was quenched with H2O (50 mL)
and extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to
standard drying and purification with 5% EA/hex to afford 169 (789.7 mg, 86%). Rf (5%
EA/hex): 0.48. 1H NMR (600 MHz): 5.56 (t, J = 7.7, 1H), 3.15 (s, 2H), 2.18-2.02 (7H),
1.56-1.13 (16H).

13

C (75 MHz): 207.2, 132.1, 131.1, 44.8, 36.5, 29.3, 28.1, 27.0, 26.4,

26.1, 25.4, 25.0, 24.5, 24.2, 24.1.

IR: 2924, 2855, 1708 HRMS (ESI): calc for

C15H26ONa: 245.1881; found: 245.1873 (3.3 ppm).
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3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.4]-nonane (170):
To a RBF containing a solution of cobalt (II) acetylacetonate (247 mg, 0.96 mmol) in 1,2dichloroethane (96 mL) was added sequentially 168 (1.1936 g, 9.6 mmol), triethylsilane
(3.1 mL, 19.2 mmol), and t-BuOOH (1.75 mL, 9.6 mmol, 5.5M in decane). The resulting
solution was stirred under an atmosphere of O2 (balloon). After 24 hrs the reaction was
diluted with NH4Cl (20 mL) and extracted with CH2Cl2 (3 x 30mL). The combined
organic layers were subjected to standard drying and purification with 30% EA/hex to
afford 3-methyl-1,2-dioxaspiro[4.4]nonan-3-ol (979.4 mg, 65%).

1

H NMR (300 MHz):

3.01 (s, 1H), 2.69 (d, J = 13.0, 1H), 2.57 (d, J = 13.0, 1H), 2.26 (1H), 1.94-1.37 (10H).
13

C (75 MHz): 105.9, 94.6, 56.7, 38.7, 34.9, 24.5, 24.4, 23.4. HRMS (ESI): calc for

C8H14O3Na: 181.0841; found: 181.0839 (1.1 ppm).
To a flame-dried RBF containing a solution of 3-methyl-1,2-dioxaspiro[4.4]nonan-3-ol
(853.6 mg, 5.4 mmol) in CH2Cl2 (23 mL) was added sequentially imidazole (1.1 g, 16
mmol) and chlorotrimethylsilane (1.0 mL, 8.1 mmol) and the reaction was allowed to stir
for 1 hr. The reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 20
mL). The combined organic layers were subjected to standard drying and purification
with column chromatography with 5% EA/hex to afford 170 (1.0401 g, 89%). Rf (5%
EA/hex): 0.38. 1H NMR (400 MHz): 2.73 (d, J = 12.6, 1H), 2.54 (d, J = 12.6, 1H), 2.222.13 (1H), 1.92-1.85 (2H), 1.77-1.39 98H), 0.20 (s, 9H).

13

C (100 MHz): 107.3, 94.5,

59.3, 38.5, 34.7, 25.8, 24.6, 24.3, 1.7. HRMS (ESI): calc for C1H22O3Na: 253.1236;
found: 253.1240 (1.6 ppm).
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3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.4]-hexadecane (171):
To a RBF containing a solution of cobalt (II) acetylacetonate (85 mg, 0.32 mmol) in 1,2dichloroethane (32 mL) was added sequentially 169 (720.7 mg, 3.2 mmol), triethylsilane
(1.1 mL, 6.4 mmol), and t-BuOOH (0.6 mL, 3.2 mmol, 5.5M in decane). The resulting
solution was stirred under an atmosphere of O2. After 24 hrs the reaction was diluted
with NH4Cl (20 mL) and extracted with CH2Cl2 (3 x 30mL). The combined organic
layers were subjected to standard drying and purification with 30% EA/hex to afford 3methyl-1,2-dioxaspiro[4.11]hexadecan-3-ol (645.1 mg, 78%). 1H NMR (400 MHz): 3.00
(s, 1H), 2.47 (d, J = 12.9, 1H), 2.37 (d, J = 12.9, 1H), 1.86-1.74 (2H), 1.62-1.27 (24H).
13

C (100 MHz): 105.8, 100.2, 89.4, 57.2, 32.1, 31.6, 26.6, 26.4, 26.1, 23.5, 22.7, 22.6,

22.4, 22.2, 20.7, 19.7. HRMS (ESI): calc for C15H28O3Na: 279.1936; found: 279.1927
(3.2 ppm).
To

a

flame-dried

RBF

containing

a

solution

of

3-Methyl-1,2-

dioxaspiro[4.11]hexadecan-3-ol (587.3 mg, 2.3 mmol) in CH2Cl2 (23 mL) was treated
sequentially with imidazole (0.80 g, 12 mmol) and chlorotrimethylsilane (0.9 mL, 7
mmol) and was allowed to stir for 1 hr. After which the reaction was treated with H2O
(20 mL) and extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were
subjected to standard drying and purification with column chromatography twice with
5% EA/hex to afford 171 (688.3 mg, 91%). Rf (10% EA/hex): 0.57. 1H NMR (400
MHz): 2.50 (d, J = 12.4, 1H), 2.31 (d, J = 12.4, 1H), 1.88-138 (1H), 1.63-1.22 (24H),
0.18 (s, 9H).

13

C (100 MHz): 107.1, 89.1, 59.9, 32.4, 31.3, 26.7, 26.4, 26.1, 25.6, 22.7,
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22.6, 22.4, 22.2, 20.8, 19.7, 1.7. HRMS (ESI): calc for C18H36O3NaSi: 351.2331; found:
351.2328 (0.85 ppm).

3-Methyl-3-phenethoxy-1,2-dioxaspiro[4.4]nonane (172):
To a vial containing a solution of 170 (202 mg, 1.5 mmol) in CH2Cl2 (9 mL) was added
sequentially 2-phenethanol (0.73 mL, 4.4 mmol) and TsOH (17 mg, 0.09 mmol) and the
solution stirred for 3 hrs. The reaction was then treated with sat. aq. NaHCO3 (5 mL) and
H2O (5 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were
subjected to standard drying and purification via column chromatography. The semi
purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The residue
obtained upon concentration was purified by column chromatography (5% EA/hex) and
HPLC (x3 with 5% EA/hex) to afford 172 (141.8 mg, 62%). Rf (5% EA/hex): 0.40. 1H
NMR (400 MHz): 7.36-7.18 (5H), 3.87 (m, 1H), 3.70 (m, 1H), 2.93 (m, 2H), 2.74 9d, J =
12.4, 1H), 2.48 (d, J = 12.4, 1H), 2.24-2.15 (1h), 1.94-1.43 (10H).

13

C (100 MHz): 138.3,

129.2, 128.4, 126.3, 108.2, 94.4, 63.2, 56.4, 38.7, 36.9, 34.7, 24.6, 24.3, 20.4. HRMS
(ESI): calc for C16H22O3Na: 285.1467; found: 285.1472 (1.8 ppm).

O

O

O

Ph

3-Methyl-3-phenethoxy-1,2-dioxaspiro[4.11]hexadecane (173):
To a vial containing a solution of 171 (501.2 mg, 1.5 mmol) in CH2Cl2 (15 mL) was
added sequentially 2-phenethanol (0.90 mL, 7.5 mmol) and TsOH (29 mg, 0.15 mmol)
and the solution stirred overnight. After which the reaction was treated with sat. aq.
NaHCO3 (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers
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were subjected to standard drying and purification via column chromatography. The
semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2). The residue
obtained upon concentration was purified by column chromatography and HPLC with
10% EA/hex to afford 173 (132.8 mg, 24%). Rf (10% EA/hex): 0.46.

1

H NMR (600

MHz): 7.34-7.16 (5H), 3.87 (m, 1H), 3.65 (m, 1H), 2.91 (m, 2H), 2.48 (d, J = 12.5, 1H),
2.26 (d, J = 12.5, 1H), 1.83-1.70 (2H), 1.59-1.24 (23H).

13

C (150 MHz): 139.4, 129.2,

128.4, 126.3, 108.1, 89.2, 62.8, 57.2, 36.9, 32.5, 31.0, 26.7, 26.4, 26.1, 22.7, 22.6, 22.5,
22.3, 20.8, 20.1, 19.7. HRMS (ESI): calc for C23H36O3Na: 383.2562; found: 383.2574
(3.1 ppm).
OH
Bn

1-(Cyclohex-1-en-1-yl)-3-phenylpropan-2-ol (177):
To a flame-dried RBF containing a 0 °C solution of phenylacetaldehyde (1.2443 g, 10.3
mmol) and methylenecyclohexane (1.0873 g, 11.3 mmol) in CH2Cl2 (30 mL) was added
Me2AlCl (13 mL, 13 mmol, nominally 1M in hexanes). The resulting solution was
stirred at 0 °C for 2 hrs and then allowed to warm to rt. After stirring an additional 1 hr,
the reaction was treated with sat. aq. NaH2PO4 (10 mL) and aq. 2N HCl (5 mL) and
extracted with CH2Cl2 (2x30 mL). The combined organic layers were subjected to
standard drying and purification with 20% EA/hex to afford 177 as a yellow oil (1.7025
g, 76%). Rf (20% EA/hex): 0.44. 1H NMR (300 MHz): 7.40-7.20 (5H), 5.58 (s, 1H),
3.96 (m, 1H), 2.80 (s, 1H), 2.77 (s, 1H), 2.26-1.78 (7H), 1.70-1.52 (4H).

13

C (75 MHz):

139.0, 134.8, 129.6, 128.6, 126.5, 125.2, 70.0, 46.1, 43.7, 28.6, 25.6, 25.5, 23.0, 22.5.
IR: 3424, 2922, 2855, 2833, 1495. HRMS (CI): calc for C15H19O: 215.1436; found:
215.1437 (0.5ppm).
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1-(Cyclohex-1-en-1-yl)-4-phenylbutan-2-ol (178):
To a flame-dried RBF containing a 0 °C solution of 3-phenyl-1-propanal (1.4592 g, 10.9
mmol) and methylenecyclohexane (1.0562 g, 11 mmol) in CH2Cl2 (30 mL) was added
Me2AlCl (13 mL, 13 mmol, nominally 1M in hexanes). The resulting solution was
stirred at 0 °C for 2 hrs and allowed to warm to rt. After stirring an additional hour, the
reaction was treated with sat. aq. NaH2PO4 (10 mL) and aq. 2N HCl (5 mL) and extracted
with CH2Cl2 (2 x 30 mL). The combined organic layers were subjected to standard
drying and purification with 20% EA/hex to afford 178 (2.0325 g, 89%). Rf (20%
EA/hex): 0.48. 1H NMR (400 MHz): 7.34-7.14 (5H), 5.55 (s, 1H), 3.76-3.65 (1H), 2.892.63 (2H), 2.22-1.47 (13H).

13

C (100 MHz): 142.3, 134.6, 128.4, 128.3, 125.7, 125.2,

67.9, 46.6, 38.7, 32.2, 28.4, 25.3, 22.9, 22.3.

HRMS (FAB): calc for C16H22ONa:

253.1568; found: 253.1566 (0.7 ppm).

1-(Cyclohex-1-en-1-yl)-3-phenylpropan-2-one (179):
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (0.76 mL, 9 mmol)
in CH2Cl2 (36 mL) was added a solution of DMSO (1.1 mL, 15 mmol) in CH2Cl2 (15
mL) via an addition funnel. The resulting solution was stirred at -78 oC for 30 min, after
which 177 (1.6192g, 7.5 mmol) in CH2Cl2 (15 mL) was added via an addition funnel.
The reaction was stirred for 1h, after which Et3N (5.3 mL, 37 mmol) was added. The
reaction was stirred at -78 °C for 30 min and then allowed to warm to rt. After 30 min,
the reaction was quenched with H2O (50 mL) and extracted with CH2Cl2 (2 x5 0 mL).
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The combined organic layers were subjected to standard drying and purification with 5%
EA/hex to afford 179 as a yellow oil (1.5189 g, 95%). Rf (20% EA/hex): 0.64. 1H NMR
(600 MHz): 7.36-7.30 (2H), 7.27 (m, 1H), 7.23-7.19 (2H), 5.55 (s, 1H), 3.72 (s, 2H),
3.06 (s, 2H), 2.07-2.01 (2H), 1.89-1.83 (2H), 1.63-1.53 (4H).

13

C (150 MHz): 207.0,

134.5, 131.7, 129.7, 128.8, 127.1, 126.8, 51.9, 48.9, 28.7, 25.6, 22.9, 22.2. IR: 2942,
2856, 2834, 1711, 1495. HRMS (CI): calc for C15H19O: 215.1436; found: 215.1441 (2.4
ppm).

1-(Cyclohex-1-en-1-yl)-4-phenylbutan-2-one (180):
To a flame-dried RBF containing a -78 oC solution of oxalyl chloride (0.84 mL, 10
mmol) in CH2Cl2 (40 mL) was added a solution of DMSO (1.2 mL, 16.6 mmol) in
CH2Cl2 (17 mL) via an addition funnel. The resulting solution was stirred at -78 oC for
30 min, after which 178 (1.909 g, 8.3 mmol) in CH2Cl2 (17 mL) was added via an
addition funnel. The reaction was stirred for 1 hr, after which Et3N (6 mL, 42 mmol) was
added. The reaction was stirred at -78 °C for 30 min and then allowed to warm to rt.
After 30 min, the reaction was quenched with H2O (50 mL) and extracted with CH2Cl2 (2
x 50 mL).

The combined organic layers were subjected to standard drying and

purification with 5% EA/hex to afford 180 (1.8667 g, 99%). Rf (10% EA/hex): 0.54. 1H
NMR (600 MHz): 7.32-7.13 (5H), 5.54 (s, 1H), 3.00 (s, 2H), 2.92-2.88 (2H), 2.81-2.76
(2H), 2.05-2.00 (2H), 1.91-1.86 (2H), 1.66-1.53 (4H).

13

C (150 MHz): 208.7, 141.2,

131.6, 128.4, 128.3, 126.4, 126.1, 52.8, 43.1, 29.8, 28.6, 25.4, 22.7, 22.0. IR: 2924,
2857, 1710. HRMS (FAB): calc for C16H21O: 229.1592; found: 229.1589 (1.5 ppm).
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3-Benzyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (181):
To a RBF containing a solution of cobalt (II) acetylacetonate (179 mg, 0.7 mmol) in 1,2dichloroethane (70 mL) were added sequentially 179 (1.4915 g, 7 mmol) and
triethylsilane (2.3 mL, 14 mmol). The solution was stirred under an atmosphere of O2
(balloon). After 2 hrs it was noticed that the reaction had not begun so t-BuOOH (1.3
mL, 7 mmol, 5.5M in decane) was added and the reaction allowed to stir overnight. The
reaction was quenched with NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL). The
combined organic layers were subjected to standard drying and purification with 20%
EA/hex to afford 3-benzyl-1,2-dioxaspiro[4.5]decan-3-ol as a light green solid (1.0111 g,
58%). The green color is presumably due to some residual cobalt and the sample
contains an alkene impurity <5% which could not be separated by column
chromatography. Rf (20% EA/hex): 0.32. 1H NMR (400 MHz): 7.36-7.25 (5H), 3.14 (d,
J = 14, 1H), 3.09 (d, J = 14, 1H), 2.88 (bs, 1H), 2.44 (d, J = 12.6, 1H), 2.35 (d, J = 12.6,
1H), 1.78-1.56 (5H), 1.45 -1.22 (5H).

13

C (100 MHz): 135.1, 130.7, 128.6, 127.4,

106.7, 85.7, 55.2, 43.2, 35.9, 35.0, 25.3, 24.3, 23.3. IR: 3471, 2987, 2926, 1394, 1111.
HRMS (ESI): calc for C15H20NaO3: 271.1310; found: 271.1297 (4.7 ppm).
To a flame-dried RBF containing a solution of 3-benzyl-1,2-dioxaspiro[4.5]decan-3-ol
(393.6 mg, 1.59 mmol) in CH2Cl2 (16 mL) was treated sequentially with imidazole (129
mg, 1.9 mmol) and chlorotrimethylsilane (0.25 mL, 1.9 mmol) and was allowed to stir for
1 hr. The reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 20 mL).
The combined organic layers were subjected to standard drying and purification with 5%
EA/hex to afford 181 as a white solid (423.8 mg, 84%). Rf (5% EA/hex): 0.42. MP: 58-
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59 oC. 1H NMR (300 MHz): 7.34-7.20 (5H), 3.01 (s, 2H), 2.45 (d, J = 12.5, 1H), 2.25 (d,
13

J = 12.5, 1H), 1.72-1.12 (10H), 0.18 (s, 9H).

C (75 MHz): 136.5, 130.8, 128.2, 126.9,

108.7, 85.6, 56.9, 44.7, 35.9, 35.0, 25.3, 24.4, 23.3, 1.8. HRMS (ESI):

calc for

C18H28NaO3Si: 343.1705; found: 343.1712 (2.0 ppm).
Bn
OTMS
O

O

3-Phenethyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (182):
To a RBF containing a solution of cobalt (II) acetylacetonate (205 mg, 0.8 mmol) in 1,2dichloroethane (80 mL) were added sequentially 180 (1.821 g, 8 mmol), triethylsilane
(2.7 mL, 16 mmol) and t-BuOOH (5.5M in decane, 1.45 mL, 8 mmol). The solution was
placed under an atmosphere of O2 (balloon) and the reaction allowed to stir overnight.
The reaction was quenched with NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 50mL).
The combined organic layers were subjected to standard drying and purification with
15% EA/hex to afford 3-phenethyl-1,2-dioxaspiro[4.5]decan-3-ol (1.5071 g, 72%) that
was carried through to the next reaction.
To

a

flame-dried

RBF

containing

a

solution

of

3-phenethyl-1,2-

dioxaspiro[4.5]decan-3-ol (767.5 mg, 2.92 mmol) in CH2Cl2 (30 mL) was treated
sequentially with imidazole (0.6 g, 9 mmol) and chlorotrimethylsilane (1.1 mL, 9 mmol)
and was allowed to stir for 30 min. The reaction was treated with H2O (20 mL) and
extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to
standard drying and purification with column chromatography twice with 5% EA/hex to
afford 182 (530.3 mg, 54%). Rf (5% EA/hex): 0.34. 1H NMR (300 MHz): 7.36-7.17
(5H), 2.77 (m, 1H), 2.38 (s, 2H), 2.17-1.21 912h), 0.22 (s, 9H).

13

C (75 MHz): 141.7,
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128.6, 128.5, 126.2, 108.6, 85.5, 57.9, 40.3, 36.5, 35.0, 21.8, 31.7, 25.4, 24.4, 23.4, 1.8.
HRMS (ESI): calc for C19H30O3SiNa 357.1862, found 357.1877 (4 ppm).

4-Methyl-1-phenylpent-3-en-2-ol (185):
To a flask containing a 0oC solution of 3-phenyl-1-propanal (606.2 mg, 5 mmol) in THF
(25 mL) was added 2-methyl-1-propenylmagnesium bromide (12 mL, 6 mmol, 0.5 M in
THF). The reaction was stirred for 7 hrs and then treated with sat. aq. NH4Cl (30 mL)
and extracted with Et2O (2 x 30 mL). The combined organic layers were subjected to
standard drying and purification with column chromatography with 30% EA/hex to
afford 185 (609 mg, 69%). Rf (30% EA/hex): 0.45. 1H NMR (600 MHz): 7.39-7.19 (5H),
5.27-5.23 (1H), 4.60-4.55 (1H), 2.81 (m, 2H), 1.71 (s, 3H), 1.60 (s, 3H), 1.49 (d, J = 3.3,
1H).

4-Methyl-1-phenylpent-3-en-2-one (186):
To a flame-dried RBF containing a solution of 185 (557.7 mg, 3.1 mmol) in DMF (15
mL) was added PDC (1.4 g, 3.8 mmol) and was stirred overnight. The reaction was
treated with H2O (20 mL) and extracted with Et2O (2 x 20 mL). The combined organic
layers were washed with brine (20 mL) and subjected to standard drying and purification
with column chromatography with 10% EA/hex to afford 186 (277.8, 50%). Rf (10%
EA/hex): 0.44. 1H NMR (400 MHz): 7.40-7.20 (5H), 6.13 (s, 1H), 3.71 (s, 2H), 2.17 (s,
3H), 1.88 (s, 3H). The NMR spectra matched that previously reported.127
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N-Methoxy-N-methylbenzeneacetamide (190):
In a flame-dried RBF containing a solution of phenylacetic acid (2.7 g, 20 mmol) in
CH2Cl2 (50 mL) was added 1,1’-carbonyldiimidazole (4.3 g, 26.5 mmol) portion wise
and stirred for 1 hr. N,O-Dimethylhydroxylamine hydrochloride (3.8 g, 40 mmol) was
added and stirred overnight. The reaction flask was treated with H2O (50 mL) and
extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to
standard drying and purification with 50% EA/hex to afford 190 as a colorless oil (3.4345
g, 97%). Rf (50% EA/hex): 0.36. 1H NMR (400 MHz): 7.36-7.21 (5H), 3.78 (s,2H),
3.61 (s, 3H), 3.2 (s, 3H).

13

C (75 MHz): 172.5, 135.1, 129.4, 128.6, 126.9, 61.4, 39.5,

32.3. HRMS (CI): calc for C10H14NO2: 180.1025; found: 180.1019 (3.1 ppm).

N-Methoxy-N-methyl-3-phenylpropanamide (191):
In a flame-dried RBF containing a solution of 3-phenylpropanoic acid (3.03 g, 20 mmol)
in CH2Cl2 (54 mL) was added 1,1’-carbonyldiimidazole (3.8g, 24 mmol) in small
portions.

The reaction was stirred for 1 hr and N,O-Dimethylhydroxylamine

hydrochloride (3.8g, 40 mmol) was added and stirred overnight. The reaction flask was
treated with H2O (50 mL) and extracted with CH2Cl2 (2 x 20 mL). The combined
organic layers were subjected to standard drying and purification with 50% EA/hex to
afford 191 (3.7778 g, 97%). Rf (50% EA/hex): 0.50. 1H NMR (400 MHz): 7.37-7.18
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(5H), 3.62 (s, 3H), 3.20 (s, 3H), 3.01-2.95 (2H), 2.82-2.71 (2H). The NMR spectra
matched those previously reported.128
O
Bn

4-Methyl-1-phenyl-4-penten-2-one (189):
A solution of 190 (1.0056 g, 5.6 mmol) in THF (56 mL) in a flame-dried RBF was cooled
to 0 oC and 2-methylallylmagnesium chloride (13.5 mL, 6.8 mmol, 0.5M in 2methylTHF) was added. The reaction was stirred at 0 oC for 30 min and rt for 1 hr. The
reaction was quenched with H2O (20 mL) and aq. 2N HCl (2 mL) and extracted with
ether (2 x 20mL). The combined organic layers were subjected to standard drying and
purification with 10% EA/hex to afford 189 as a yellow oil (797.1 mg, 82%). Rf (10%
EA/hex): 0.48. 1H NMR: 7.37-7.17 (5H), 4.97 (m, 1H), 4.82 (m, 1H), 3.74 (s, 2H), 3.16
(s, 2H), 1.73 (s, 3H).

13

C: 206.2, 139.2, 134.3, 129.7, 128.9, 127.2, 115.4, 51.4, 49.2,

22.8. IR: 1709, 890, 657. HRMS (CI): calc for C12H15O: 175.1123; found: 175.1115
(4.5 ppm).

5-Methyl-1-phenylhex-5-en-3-one (192):
A solution of 191 (970.4g, 5 mmol) in THF (25 mL) in a flame-dried RBF was cooled to
0 oC and 2-methylallylmagnesium chloride (12 mL, 6 mmol, 0.5 M in 2-methylTHF) was
added and stirred at 0 oC for 30 min and rt for 1 hr. The reaction was quenched with H2O
(20 mL) and aq. 2N HCl (10 mL) and extracted with Et2O (2 x 20mL). The combined
organic layers were subjected to standard drying and purification with 10% EA/hex to
afford 192 (844.2 mg, 89%). Rf (10% EA/hex): 0.48. 1H NMR (400): 2.33-2.27 (2H),
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7.29-7.19 (3H), 4.95 (m, 1H), 4.82-4.80 (1H), 3.11 (s, 2H), 2.92 (m, 2H), 2.81 (m, 2H),
1.79 (s, 3H). 13C (100 MHz): 208.0, 141.2, 139.3, 128.5, 126.3, 115.2, 52.6, 43.5, 29.9,
22.8. HRMS (FAB): calc for C13H17O: 189.1279; found: 189.1274 (2.85 ppm).
Bn
OH
O

O

3-Benzyl-5,5-dimethyl-1,2-dioxolan-3-ol (187):
To a RBF containing a solution of cobalt (II) acetylacetonate (103 mg, 0.40 mmol) in 1,2dichloroethane (40 mL) was added sequentially 189 (697.1 mg, 4 mmol), triethylsilane
(1.3 mL, 8 mmol), and t-BuOOH (0.73 mL, 4 mmol, 5.5 M in decane). The resulting
solution was placed under an atmosphere of O2 (balloon). After 24 hrs the reaction was
diluted with sat. aq. NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL). The
combined organic layers were subjected to standard drying and purification with 30%
EA/hex to afford 187 as a golden oil (715.3 mg, 86%). Rf (10% EA/hex): 0.43. 1H NMR
(300 MHz): 7.43-7.22 (5H), 3.12 (m, 2H), 2.98 (s, 1H), 2.47 (m, 2H), 1.39 (s, 3H), 1.20
(s, 3H).

13

C (75 MHz): 135.0, 130.7, 128.6, 127.4, 107.3, 83.9, 56.9, 43.2, 27.2, 25.0.

IR: 3443, 3031, 2975, 1604, 1367. HRMS (ESI): calc for C12H16NaO3: 231.0997; found:
231.0989 (3.0 ppm).

5,5-Dimethyl-3-phenethyl-3-trimethylsiloxy-1,2-dioxolane (193):
To a RBF containing a solution of cobalt (II) acetylacetonate (101.3 mg, 0.40 mmol) in
1,2-dichloroethane (40 mL) was added sequentially 192 (751.3 mg, 4 mmol),
triethylsilane (1.3 mL, 8 mmol), and t-BuOOH (0.72 mL, 4 mmol, 5.5 M in decane). The
resulting solution was placed under an atmosphere of O2 (balloon). After 24 hrs the
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reaction was diluted with sat. aq. NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL).
The combined organic layers were subjected to standard drying and purification with
30% EA/hex to afford 5,5-dimethyl-3-phenethyl-1,2-dioxolan-3-ol (435.4 mg, 49%).
To a flame-dried RBF containing a solution of 5,5-dimethyl-3-phenethyl-1,2dioxolan-3-ol (388.7 mg, 1.75 mmol) in CH2Cl2 (18 mL) was added imidazole (174.4
mg, 2.6 mmol) and chlorotrimethylsilane (0.33 mL, 2.6 mmol).

The reaction was

allowed to stir for 1 hr. The reaction was treated with H2O (20 mL) and extracted with
CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to standard drying and
purification with column chromatography twice with 10% EA/hex to afford 193 (261 mg,
51%). Rf (10% EA/hex): 0.57. 1H NMR (400 MHz): 7.44-7.07 (5H), 2.82 (m, 1H), 2.71
(m, 1H), 2.47 (d, J = 12.5, 1H), 2.42 (d, J = 1H), 2.10 (m, 1H), 1.87 (m, 1H), 1.40 (s, 3H),
1.36 (s, 3H), 0.23 (s, 9H).

13

C (100 MHz): 141.7, 128.7, 128.5, 126.2, 109.3, 83.7, 59.7,

40.3, 31.8, 27.7, 25.0, 17.8. HRMS (ESI); calc for C16H26O3SiNa: 317.1549; found:
317.1547 (1 ppm).

1-Cyclohexyl-3-methylbut-2-en-1-ol (195):
To a flask containing a -78oC solution of cyclohexanecarboxaldehyde (553.6 mg, 4.9
mmol) in THF (25 mL) was added 2-methyl-1-propenylmagnesium bromide (12 mL, 6
mmol, 0.5M in THF). After stirring for 3 hrs the reaction was treated with H2O (100 mL)
and extracted with Et2O (2 x 20 mL). The combined organic layers were washed with
brine (20 mL) and subjected to standard drying and purification with column
chromatography with 20% EA/hex to afford 195 (608.2 mg, 73%). Rf (20% EA/hex):
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0.43. 1H NMR (500 MHz): 5.18 (d, J = 9.1, 1H), 4.06 (t, J = 8.2, 1H), 1.97-1.89 (1H),
1.82-1.61 (10H), 1.40-0.85 (6H).

1-Cyclohexyl-3-methylbut-2-en-1-one (196):
To a flame-dried RBF containing a solution of 195 (390.1 mg, 2.3 mmol) in DMF (10
mL) was added PDC (1.09g mg, 2.9 mmol). After stirring overnight the reaction was
treated with H2O (50 mL) and extracted with Et2O (2 x 20 mL). The combined organic
layers were washed with brine (20 mL) and subjected to standard drying and purification
with column chromatography with 5% EA/hex to afford 196 (196.5 mg, 51%). Rf (5%
EA/hex): 0.53. 1H NMR (400 MHz): 6.04-6.01 (1H), 2.25-2.16 91H), 2.04 (s, 3H), 2.04
(s, 3H), 1.76-1.51 (6H), 1.78-1.02 (6H).

13

C (100 MHz): 203.9, 155.1, 122.9, 51.5, 28.5,

27.6, 25.9, 25.7, 20.6.

3-Cyclohexyl-5,5-dimethyl-1,2-dioxolan-3-ol (197):
To a RBF containing a suspension of cobalt (II) acetylacetonate (110.3 mg, 0.43 mmol)
in 1,2-dichloroethane (41 mL) was added sequentially 196 (688.3 mg, 4.1 mmol) and
triethylsilane (1.4 mL, 8 mmol). The resulting solution was placed under an atmosphere
of O2 (balloon). After 24 hrs the reaction was diluted with sat. aq. NH4Cl (20 mL) and
extracted with CH2Cl2 (2 x 20mL). The combined organic layers were subjected to
standard drying and purification with 20% EA/hex to afford 197 (75.2 mg, 9%). Rf (20%
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EA/hex): 0.25. 1H NMR (400 MHz): 2.73 (s, 1H), 2.45 (d, J = 12.8, 1H), 2.34 (d, J =
12.8, 1H), 1.93-1.59 (6H), 1.42 (s, 3H), 1.36 (s, 3H), 1.32-1.05 (5H).

13

C (100 MHz):

109.7, 100.2, 83.4, 55.8, 44.7, 28.3, 27.7, 27.5, 26.3, 26.2, 26.1, 25.4.

1-Cyclohexyl-1-trimethylsiloxyspiro[2.5]octane (199):
In a flame-dried RBF dicyclohexylketone (5g, 25.7 mmol) was dissolved in THF (100
mL). LiHMDS (39 mL, 39 mmol, 1M in THF) was added and the reaction was allowed
to stir for 30 min before chlorotrimethylsilane (3.9 mL, 31 mmol) was added. After 30
min the reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 50 mL).
The combined organic layers were subjected to standard drying and purification with
2.5% EA/hex to afford 1-cyclohexyl-1-trimethylsiloxy-methylenecyclohexane as a
colorless oil (6.2954g, 92%). Rf (2.5% EA/hex): 0.38. 1H NMR (400 MHz): 2.46 (m,
1H), 2.17-2.05 (4H), 1.82-1.04 (16H), 0.21 (s, 9H).

13

C (75 MHz): 146.4, 116.5, 39.6,

30.9, 29.5, 28.5, 28.4, 27.6, 27.2, 26.8, 26.4, 1.3. HRMS (EI): calc for C16H30OSi:
266.2066; found: 266.2058 (3.0 ppm).
In a flame-dried RBF, 1-cyclohexyl-1-trimethylsiloxy-methylenecyclohexane (6
g, 23 mmol) was dissolved in CH2Cl2 (225 mL) and the solution was cooled to 0 oC. To
the flask via an addition funnel was added drop wise ZnEt2 (45 mL, 45 mmol, 1M in
hexanes) followed by addition of CH2I2 (5.4 mL, 67.5 mmol) in one portion and stirred at
0 oC for 1 hr and rt for 1 hr. After which the reaction was treated with H2O (100 mL) and
extracted with CH2Cl2 (4 x 100 mL). The combined organic layers were subjected to
standard drying and purification with 2.5% - 10% EA/hex to afford 199 as a white solid

141
(4.8426 g, 77%). Rf (5% EA/hex): 0.75. MP: 29-30 oC. 1H NMR (400 MHz): 2.46 (m,
1H), 2.28-2.03 (4H), 1.81-1.05 (16H), 0.22 (s, 9H).

13

C (100 MHz): 69.0, 43.0, 32.2,

31.3, 30.2, 29.7, 28.5, 27.2, 27.0, 26.8, 26.7, 25.9, 25.6, 23.9, 2.24. HRMS (ESI): calc for
C17H32NaOSi 303.2120, found 303.2112 (0.1 ppm). Also isolated from the reaction was
1-cyclohexylspiro[2.5]octan-1-ol, 270, (481.4 mg, 10%).

1-Cyclohexylspiro[2.5]octan-1-ol (200)
To a flame-dried RBF containing a solution of 199 (4.0 g, 14 mmol) in THF (70 mL) was
added TBAF (17.2 mL, 17.2 mmol, 1 M in THF) and stirred for 2 hrs. The reaction was
treated with H2O (20 mL) and extracted with Et2O (3 x 50 mL). The combined organic
layers were subjected to standard drying and purification to afford 200 as a colorless oil
(2.9354 g, 99%). Rf (10% EA/hex): 0.47. 1H NMR (400 MHz): 1.88-1.01 (22H), 0.37
(d, J = 5.3, 1H), 0.18 (d, J = 5.3, 1H).

13

C (100 MHz): 66.3, 42.1, 31.8, 30.7, 30.2, 29.1,

28.8, 27.0, 26.9, 26.7, 26.6, 26.0, 25.7, 24.1. IR: 3369, 2922, 2848, 1444, 1243. HRMS
(FAB): calc for C14H23O2: 223.1698; found: 223.1692 (2.8 ppm).

OH
O

O

3-Cyclohexyl-1,2-dioxaspiro[4.5]decan-3-ol (201):
A vial containing a solution of 200 (493.2 mg, 2.4 mmol) in benzene (10 mL) was placed
under an atmosphere of O2 (balloon) and stirred for 3 days. After which the solvent was
removed in vacuo and was purified via column chromatography with 20% EA/hex to
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afford 201 as a yellow oil that slowly crystallizes to a white solid (360 mg, 81% BRSM).
Rf (40% EA/hex): 0.5. MP: 61-32 oC. 1H NMR (300 MHz): 2.82 (s, 1H), 2.37 (d, J =
12.8, 1H), 2.23 (d, J = 12.8, 1H), 1.93-1.03 (23H).

13

C (75 MHz): 109.0, 85.1, 54.0, 44.6,

36.3, 35.3, 28.2, 27.5, 26.3, 26.2, 26.1, 25.3, 24.4, 23.3. IR: 3453, 2930, 2854, 1448,
1168. HRMS (ESI): calc for C14H24NaO3: 263.1623; found: 263.1636 (4.9 ppm).
OH

1-adamantan-2-yl-2-cyclohexylideneethanol (204):
To a flame-dried RBF containing a -78oC solution of bromomethylene cyclohexane
(1.0655 g, 6 mmol) in THF (65 mL) was added t-BuLi (3.9 mL, 6.2 mmol, 1.6 M in
pentane). After the solution had stirred for 1 hr 2-adamantanecarboxaldehyde (953 mg,
5.7 mmol, impure) was added in THF (5 mL) and allowed to warm to rt and stirred for 3
hrs. The reaction was treated with sat. aq. NH4Cl (20 mL) and the resulting suspension
was extracted with Et2O (3 x 20 mL). The combined organic layers were subjected to
standard drying and purification with 10% EA/hex to afford 204 (450.3 mg, 30%). Rf
(10% EA/hex): 0.29.

1

H NMR (400 MHz): 5.05-5.01 (1H), 4.65 (t, J = 9.8, 1H), 2.33-

1.35 (25H).

1-adamantan-2-yl-2-cyclohexylideneethyl acetate (205):
To a flame-dried RBF containing a solution of 204 (450.3 mg, 1.73 mmol) in pyridine
(10 mL) was added sequentially Ac2O (353 mg, 3.46 mmol) and DMAP (21 mg, 0.2

143
mmol). After 3 hrs the reaction was treated with 2N HCl (20 mL) and the resulting
suspension was extracted with Et2O (3 x 30 mL). The combined organic layers were
washed with brine (30 mL) and subjected to standard drying and purification with 5%
EA/hex to afford 205 (483.1 mg, 92%). Rf (10% EA/hex): 0.74. 1H NMR (400 MHz):
5.90 (t, J = 10.3, 1H), 4.93 (d, J = 9.7, 1H), 2.41-1.42 (28H).

13

C (100 MHz): 170.4,

145.8, 120.0, 70.9, 47.9, 39.0, 28.6, 38.1, 37.2, 32.2, 31.9, 29.9, 29.0, 28.7, 28.03, 28.01,
28.0, 27.6, 26.7, 21.3.
Ph
OMe
O

O

3-Benzyl-3-methoxy-5,5-dimethyl-1,2-dioxolane (207):
In a vial containing a solution of 187 (190 mg, 0.91 mmol) in CH2Cl2 (5 mL) and
methanol (5 ml) was added TsOH (16 mg, 0.08 mmol) and the solution stirred for 3 days.
After which the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and
extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to
standard drying and purification with 10% EA/hex to afford 207 as a yellow oil (147.7
mg, 73%). Rf (10% EA/hex): 0.50. 1H NMR (300 MHz): 7.37-7.20 (5H), 3.45 (s, 3H),
3.07 (2H), 2.42 (d, J = 12.8, 1H), 2.34 (d, J = 12.8, 1H), 1.34 (s, 3H), 1.06 (s, 3H). 13C
(75 MHz): 136.1, 130.5, 128.5, 127.0, 110.4, 83.8, 55.4, 49.5, 38.1, 27.2, 24.8. HRMS
(ESI): calc for C13H18NaO3: 245.1154; found: 245.1144 (4 ppm).
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Bn
OMe
O

O

3-Methoxy-5,5-dimethyl-3-phenethyl-1,2-dioxolane (208):
In a vial containing a solution of 193 (130.2 mg, 0.44 mmol) in CH2Cl2 (2 mL) and
methanol (4 ml) was added TsOH (10 mg, 0.05 mmol) and the solution stirred overnight.
The reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 208 (103.1 mg, 99%). Rf (10%
EA/hex): 0.44. 1H NMR (500 MHz): 7.34-7.30 (2H), 7.25-7.20 (3h), 3.37 (s, 3H), 2.77
(m, 1H), 2.67 (m, 1H), 2.48 (d, J = 12.6, 1H), 2.39 (d, J = 12.6, 1H), 2.25 (m, 1H), 1.89
(m, 1H), 1.42 (s, 3H), 1.40 (s, 3H).

13

C (125 MHz): 141.2, 128.6, 128.4, 126.3, 110.2,

83.7, 56.5, 49.2, 33.9, 31.2, 27.8, 24.7. HRMS (ESI): calc for C14H20O3Na: 259.1310;
found: 259.1307 (1.5 ppm).

3,3-Dimethyl-5-phenethoxy-5-phenethyl-1,2-dioxolane (209):
In a vial containing a solution of 193 (101.1 mg, 0.34 mmol) in CH2Cl2 (5 mL) was
sequentially 2-phenylethanol (0.2 mL, 1.7 mmol) and TsOH (6 mg, 0.03 mmol). After
the reaction had stirred for 5 hrs, it was treated with sat. aq. NaHCO3 (8 mL) and H2O (8
mL) and extracted with CH2Cl2 (2 x 10 mL).

The combined organic layers were

subjected to standard drying and purification with 10% EA/hex to afford 209 (60 mg,
55%). Rf (10% EA/hex): 0.57. 1H NMR (400 MHz): .7.38-7.11 (10H), 3.96 (m, 1H),
3.70 (m, 1H), 2.98 (m, 1H), 2.65 (m, 1H), 2.49 (d, J = 12.5, 1H), 2.36 (d, J = 12.5, 1H),
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2.22 (m, 1H), 1.90 (m, 1H), 1.42 (s, 3H), 1.41 (s, 3H).

13

C (100 MHz): 141.4, 139.5,

129.2, 128.6, 128.4, 126.3, 126.2, 110.1, 83.7, 62.5, 56.8, 36.8, 34.7, 31.2, 27.9, 24.8.
HRMS (ESI): calc for C21H26O3Na: 349.1780; found: 349.1785 (0 ppm).

3-Benzyl-3-methoxy-1,2-dioxaspiro[4.5]decane (210):
To a vial containing a solution of 181 (105.1 mg, 0.33 mmol) in CH2Cl2 (1 mL) was
added sequentially methanol (3.1 mL) and TsOH (12.6 mg, 0.07 mmol) and the reaction
was stirred overnight. The reaction was treated with sat. aq. NaHCO3 (8 mL) and H2O (8
mL) and extracted with CH2Cl2 (2 x 8 mL). The combined organic layers were subjected
to standard drying and purification with 10% EA/hex to afford 210 as a yellow oil (89.5
mg, 93%). Rf (10% EA/hex): 0.38.

1

H NMR (500 MHz): 7.40-7.23 (5H), 3.64 (s, 3H),

3.1 (d, J = 12.5, 1H), 3.04 (d, J = 12.5, 1H), 2.39 (d, J = 12.6, 1H), 2.25 (d, J = 12.6, 1H),
1.74-1.12 (10H).

13

C (125 MHz): 136.1, 130.4, 128.4, 126.9, 109.7, 85.6, 53.4, 49.4,

38.0, 35.8, 34.6, 25.2, 24.4, 23.2. HRMS (ESI): calc for C16H22NaO3: 285.1467; found:
285.1463 (2 ppm).

3-Methoxy-3-phenethyl-1,2-dioxaspiro[4.5]decane (211):
To a vial containing a solution of 182 (205.9 mg, 0.61 mmol) in CH2Cl2 (2 mL) was
added sequentially methanol (6 mL) and TsOH (10.1 mg, 0.05 mmol) and was stirred for
5 hrs. The reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and
extracted with CH2Cl2 (2 x 30 mL). The combined organic layers were subjected to
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standard drying and purification with 10% EA/hex to afford 211 (111.4 mg, 66%). Rf
(10% EA/hex): 0.37. 1H NMR (300 MHz): 7.35-7.12 (5H), 3.36 (s, 3H), 2.71 (m, 2H),
2.39 (d, J = 12.7, 1H), 2.33 (d, J = 12.7, 1H), 2.22 (m, 1H), 1.91-1.25 (11H).

13

C (75

MHz): 141.3, 128.7, 128.4, 126.3, 109.6, 85.6, 55.0, 49.2, 36.5, 34.7, 33.9, 31.3, 25.4,
24.4, 23.3. HRMS (ESI): calc for C17H24O3Na: 299.1623; found: 299.1629 (2 ppm).

3-Phenethoxy-3-phenethyl-1,2-dioxaspiro[4.5]decane (212):
To a vial containing a solution of 182 (209.5 mg, 0.6 mmol) in CH2Cl2 (6 mL) was added
sequentially 2-phenylethanol (0.36 mL, 3 mmol) and TsOH (10.4 mg, 0.06 mmol). After
stirring for 6 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (8 mL)
was added and extracted with CH2Cl2 (2 x 30 mL). The combined organic layers were
subjected to standard drying and purification with 5% EA/hex to afford 212 (151.4 mg,
66%). Less than 5% of uncharacterized impurities were present by 1H NMR and the
sample was submitted for in vitro testing. A pure sample can be obtained by subjecting
212 to ozonolysis and re-purification prior to the etherification, Rf (10% EA/hex): 0.48.
1

H NMR (500 MHz): 7.34-7.10 (10H), 3.92 (m, 1H), 3.64 (m, 1H), 2.92 (m, 1H), 2.61

(m, 1H), 2.37 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 2.21-2.14 (1H), 1.87-1.32 (11H).
13

C (100 MHz): 141.4, 139.5, 129.2, 128.6, 128.4, 126.3, 126.2, 109.5, 85.5, 62.5, 55.2,

36.7, 34.7, 34.6, 31.3, 25.4, 24.4, 23.4. HRMS (ESI): calc for C24H30O3Na: 389.2093;
found: 289.2074 (<5 ppm).
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3-Cyclohexyl-3-methoxy-1,2-dioxaspiro[4.5]decane (213):
To a vial containing a solution of 201 (360 mg, 1.5 mmol) in CH2Cl2 (5 mL) and
methanol (10 mL) was added TsOH (29.5 mg, 0.16 mmol) and was stirred overnight.
The reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard
drying and purification with 10% EA/hex to afford 213 as a white solid (344.8 mg, 90%).
Rf (10% EA/hex): 0.57. MP: 44 oC. 1H NMR (400 MHz): 3.28 (s, 3H), 2.39 (d, J = 12.7,
1H), 2.16 (d, J = 12.7, 1H), 1.90-0.85 (21H).

13

C (100MHz): 111.8, 85.0, 51.5, 48.7,

38.8, 36.3, 34.9, 28.6, 28.2, 26.5, 26.4, 26.1, 25.4, 24.5, 23.4. HRMS (ESI): calc for
C15H26NaO3: 277.1779; found: 277.1774 (1 ppm).
O
OTBS

5-(tert-Butyldimethylsilanyloxy)pentanal (222):
To a flame-dried RBF containing a solution of 5-hexen-1-ol (1.9878 g, 20 mmol) in THF
(40 mL) was added sequentially imidazole (3.22 g, 47 mmol) and TBSCl (3.72 g, 25
mmol) in THF (10 mL) and stirred overnight. The reaction was treated with H2O (50
mL) and extracted with Et2O (3 x 50 mL). The combined organic layers were subjected
to

standard

drying

and

purification

with

2.5%

EA/hex

to

afford

6-tert-

1

H NMR

butyldimethylsiloxy)hex-1-ene (3.8385 g, 90%). Rf (2.5% EA/hex): 0.42.

(400 MHz): 5.02 (ddt, J = 17.0, 10.1, 6.9, 1H). 5.07-4.90 (2H), 3.62 (t, J = 6.4, 2H), 2.07
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(m, 2H), 1.68-1.37 (4H), 0.90 (s, 9H), 0.06 (s, 6H). The NMR spectra matched those
previously reported.129
To

a

flame-dried

RBF

containing

a

0o C

solution

of

6-tert-

butyldimethylsiloxy)hex-1-ene (3.7776 g, 17.6 mmol) in acetone (120 mL) and Sudan
Red (trace) was passed O3 until disappearance of the red color. The flask was purged
with O2 for 2 min. The contents of the flask were concentrated in vacuo and the residue
obtained upon concerntation was purified via column chromatography with 10% EA/hex
to afford 222 (2.859 g, 75%). Rf (10% EA/hex): 0.41. 1H NMR (400 MHz): 9.78 (t, J =
1.8, 1H), 3.64 (t, J = 6.2, 2H), 2.47 (dt, J = 1.8, 6.8, 2H), 1.75-1.65 (2H), 1.62-1.51 (2H),
0.90 (s, 9H), 0.05 (s, 6H). The NMR spectra matched those previously reported.130

HO
OTBS

6-((tert-Butyldimethylsilyl)oxy)-1-(cyclohex-1-en-1-yl)hexan-2-ol (223):
To a flame-dried RBF containing a 0oC solution of methylene cyclohexane (2.5 mL, 20
mmol) and 222 (3.68 g, 17 mmol) was added Me2AlCl (22 mL, 22 mmol, 1 M in
hexanes) and stirred for 3 hrs. The reaction was treated with sat. aq. NaH2PO4 (20 mL)
and 2 N HCl was added until the solution became clear and was extracted with Et2O (3 x
50 mL). The combined organic layers were subjected to standard drying and purification
with 20 % EA/hex to afford 223 (4.2695 g, 81%). Rf (20% EA/hex): 0.38. (400 MHz):
5.55-5.50 (1H), 3.71-3.59 (3H), 2.17-1.30 (17H), 0.090 (s, 9H), 0.05 (s, 6H).

13

C (100

MHz): 135.0, 125.2, 68.7, 63.4, 46.7, 37.0, 33.0, 28.5, 26.2, 25.5, 23.1, 22.5, 22.2, 18.6, 5.1. IR: 3399, 2927, 2856. HRMS (FAB): calc for C18H36O2SiLi: 319.2645; found:
319.2654 (2.9 ppm).
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6-((tert-Butyldimethylsilyl)oxy)-1-(cyclohex-1-en-1-yl)hexan-2-one (224):
To a flame-dried RBF containing a -78 °C solution of oxalyl chloride (1.024 g, 8 mmol)
in CH2Cl2 (30 mL) was added DMSO (0.9 mL, 12.8 mmol) in CH2Cl2 (13 mL) dropwise
via an addition funnel and allowed to stir for 20 min. After which 223 (1.35g, 9.6 mmol)
in CH2Cl2 (13 mL) was added dropwise via an addition funnel and allowed to stir at -78
o

C for 1 hr and Et3N (4.4 mL, 32 mmol) was added and stirred at -78oC for 30 min and rt

for 1 hr. The reaction was treated with H2O (30 mL) and extracted with CH2Cl2 (2 x 20
mL). The combined organic layers were subjected to standard drying and purification
with 5% EA/hex to afford 224 a yellow oil (1.8971 g, 93%). Rf (10% EA/hex): 0.317.
1

H NMR (400 MHz): 5.54 (bs, 1H), 3.61 (t, J = 6.1, 2H), 3.00 (s, 2H), 2.46 (t, J = 7.3,

2H), 2.07-2.00 (2H), 1.94-1.88 (2H), 1.67-1.46 (8H), 0.89 (s, 9H), 0.05 (s, 6H).

13

C (100

MHz): 209.8131.8, 126.1, 62.9, 52.5, 41.5, 32.2, 28.6, 26.0, 25.4, 22.8, 22.0, 20.3, 18.3, 5.3. IR: 2927, 2856, 1713. HRMS (FAB): calc for C18H34O2SiLi: 317.2488; found:
317.2500 (3.9 ppm).

2-(Cyclohex-1-en-1-ylmethyl)-2-hydroperoxytetrahydro-2H-pyran (219):
To a flame-dried RBF containing a solution of 224 (3.672 g, 11.8 mmol) in THF (118
mL) was cooled to 0oC and TBAF (13 mL, 13 mmol, 1 M in THF) was added. After 4
hrs the reaction was treated with sat. aq. NH4Cl (50 mL) and extracted with Et2O (2 x 50
mL). The combined organic layers were subjected to standard drying and purified twice
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by column chromatography with 50% EA/hex to afford 2-(cyclohex-1-en-1ylmethyl)tetrahydro-2H-pyran-2-ol (2.0815 mg, 90%).
To

a

flame-dried

RBF

containing

a

solution

of

2-(cyclohex-1-en-1-

ylmethyl)tetrahydro-2H-pyran-2-ol (567 mg, 2.9 mmol) in THF (50 mL) was added
sequentially urea hydrogen peroxide (1.9 g, 20 mmol) and camphor sulfonic acid (2 g, 9
mmol) and stirred for 24 hrs. The reaction was diluted with H2O (30 mL) and extracted
with Et2O (3 x 30 mL). The combined organic layers were washed with brine (30 mL).
The combined organic layers were dried with Na2SO4 and the residue obtained upon
concentration in vacuo was purified by column chromatography with 30 % EA/hex to
afford 219 (472.3 mg, 78%). Rf (50 % EA/hex): 0.74.

1

H NMR (300 MHz): 7.56 (s,

1H), 5.51 (bs, 1H), 3.90-3.69 (2H), 2.60 (d, J = 14.0, 1H), 1.72 (d, J = 14.0, 1H), 1.771.47 (10H).

13

C (75 MHz): 133.4, 126.1, 104.5, 61.9, 44.8, 29.8, 29.2, 25.6, 24.8, 23.1,

22.3, 18.7. IR: 3296, 2925, 2854, 2831. HRMS (ESI): calc for C12H20O3Na: 235.1310;
found: 235.1319 (3.8 ppm).

8-bromomercurial-1,2,4-trioxaspiro[5.4.5]pentadecane (218):
To a flame-dried RBF containing a solution of 219 (326 mg, 1.6 mmol) in CH2Cl2 (60
mL) was added Hg(OAc)2 (542, 1.7) and stirred for 3 days. The reaction was treated
with H2O (50 mL) and KBr (200 mg, 1.7 mmol) and strirred for 2 hrs. The suspension
was extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to
standard drying and purification with 20% EA/hex to afford 218 (464.3 mg, 60%). Rf
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(20% EA/hex): 0.45.

1

H NMR (400 MHz): 4.04-3.91 (1H), 3.75-3.65 (1H), 2.73-2.63

(1H), 2.48 (d, J = 13.2, 1H), 2.39-1.15 (15H).

13

C (100 MHz): 106.8, 88.7, 66.1, 62.5,

57.7, 37.2, 31.2, 30.8, 28.0, 25.0, 24.5, 20.4. HRMS (ESI); calc for C12H19O3NaHgBr:
513.0091; found: 513.0089 (0.1 ppm).

Epoxide byproduct (225):
Isolated via HPLC with 10 % EA/hex from the HSnBu3 reduction of 218. 1H NMR (400
MHz): 4.14-4.04 (2H): 3.09-3.06 (1H), 2.71 (d, J = 15.4, 1H), 2.36 (d, J = 15.4, 1H),
1.99-1.17 (12H), 0.92 (t, J = 7.4, 3H). 13C (100 MHz): 170.7, 64.7, 58.7, 57.2, 43.8, 30.8,
28.4, 24.7, 20.2, 19.3, 19.2, 13.8.

8-iodo-1,2,4-trioxaspiro[5.4.5]pentadecane (231):
To a flame-dried RBF containing a solution of 219 (221.0 mg, 1 mmol) in CH2Cl2 (30
mL) was added sequentially I2 (280, 1.1 mmol) and potassium tert-butoxide (128 mg, 1
mmol). After 10 min the reaction was treated with sat. aq. Na2S2O3 (20 mL). The
resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The combined organic
layers were washed with H2O (20 mL) and subjected to standard drying and purification
with 20% EA/hex to afford 231 (239.5 mg, 68%). Rf (30% EA/hex): 0.80.

1

H NMR

(500 MHz): 4.636-4.56 (1H), 4.00-3.89 (1H), 3.76-3.65 (1H), 2.82-2.63 (1H), 2.42-2.09
(3H), 1.96-1.93 (12H).

13

C (150 MHz): 106.8, 106.3, 86.2, 62.6, 62.5, 41.0, 34.4, 32.01,

32.00, 31.8, 30.9, 24.7, 24.6, 23.0, 22.1, 20.4, 20.3. HRMS (ESI); calc for C12H19O3INa:
361.0277; found: 361.0263 (3.8 ppm).
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One-Pot Procedure:
1,2,4-trioxaspiro[5.4.5]pentadecane (143):
To a flame-dried RBF containing a solution of 219 (206.6 mg, 1 mmol) in CH2Cl2 (30
mL) was added sequentially I2 (289.2 mg, 1.1) and potassium tert-butoxide (138.8 mg,
1.1 mmol). After 30 min. the reaction was treated with sat. aq. Na2S2O3 (30 mL). The
resulting suspension was extracted with CH2Cl2 (2 x 30 mL). The combined organic
layers were washed with H2O (20 mL), dried with MgSO4, and filtered through a silica
plug. The residue obtained upon concentration in vacuo was dissolved in HSnBu3 (1.8
mL, 10 mmol) and stirred overnight. The contents of the reaction were purified directly
via column chromatography twice with 1 x 10% EA/hex and 1 x 20% EA/hex. The
isolated product was dissolved in THF (5 mL) in a vial and LiAlH4 (21.8mg) was added
and stirred overnight.

H2O (10 mL) was added and the resulting suspension was

extracted with Et2O (2 x 10 mL) and subjected to standard drying and purification with
20% EA/hex to afford 143 (85.2 mg, 41%). 1H NMR (400 MHz): 4.01-3.90 (1H), 3.723.62 (1H), 2.30 (d, 12.6, 1H), 2.17 (d, 12.6, 1H), 1.91-1.26 (16H).

13

C (100 MHz): 106.3,

84.9, 62.6, 57.4, 36.2, 34.7, 32.1, 25.3, 24.8, 24.2, 23.2, 20.5. HRMS (FAB): calc for
C12H21O3: 213.1491; found: 213.1490 (0.2 ppm).

O

O

O

3-(But-3-en-1-yloxy)-3,5,5-trimethyl-1,2-dioxolane (228):
To a flame-dried vial containing a solution of 107-OTMS (3.3724g, 16.5 mmol) in
CH2Cl2 (160 mL) was added sequentially 3-buten-1-ol (4.2 mL, 48 mmol) and TsOH
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(313 mg, 1.65 mmol). After 3 hrs the reaction was treated with sat. aq. NaHCO3 (40 mL)
and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The combined
organic layers were subjected to standard drying and purification with 10% EA/hex to
afford 228 (2.2212 g, 74%). Rf (10% EA/hex): 0.48. 1H NMR (300 MHz): 5.86 (ddt, J =
17.1, 10.3, 6.8, 1H), 5.07 (m, 2H), 3.68 (m, 1H), 3.49 (m, 1H), 2.55 (d, J = 12.5, 1H),
2.40-2.28 (3H) 1.47 (s, 3H), 1.37 (s, 6H). 13C (75 MHz): 135.7, 116.3, 108.5, 83.9, 61.3,
58.9, 34.7, 27.8, 24.8, 20.1. HRMS (ESI):

calc for C10H18O3Na: 209.1154; found:

209.1163 (4 ppm).
O

O

O

O

OMe

Methyl 3-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)propanoate (229):
A flame-dried RBF containing a solution of 228 (503.7 mg, 2.7 mg) in MeOH (0.6 mL)
and CH2Cl2 (20mL) was cooled to -78oC. A nominally 1% solution of O3/O2 was
bubbled into the reaction flask solution until the solution was blue in color. The reaction
mixture was purged with O2 for 2 min and allowed to warm to rt. To the flask was added
sequentially acetonitrile (11 mL) and Ca(OCl)2 (0.76g, 5.4 mmol). After 20 min the
reaction was filtered through a pad of silica, concentrated in vacuo, and purified by flash
chromatography twice with 30% EA/hex to afford 229 as a yellow oil (359.6 mg, 61%).
Rf (30% EA/hex): 0.5. 1H NMR (300 MHz): 3.84 (m, 2H), 3.70 (s, 3H), 2.61 (m, 2H),
2.55 (d, J = 12.7, 1H), 2.32 (d, J = 12.7, 1H), 1.48 (s, 3H), 1.36 (s, 6H). 13C (75 MHz):
108.6, 83.9, 58.7, 57.7, 51.8, 35.5, 27.8, 24.7, 19.9. IR: 2976, 1736. HRMS (ESI): calc
for C10H18O5Na: 241.1052; found: 241.1045 (3 ppm).
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3-(Hex-5-en-1-yloxy)-3,5,5-trimethyl-1,2-dioxolane (231)
To a flame-dried vial containing a solution of 107-OTMS (2.67 g, 13.1 mmol) in CH2Cl2
(130 mL) was added sequentially 5-hexen-1-ol (4.7 mL, 39.3 mmol) and TsOH (247 mg,
1.3 mmol). After 3 hrs the reaction was treated with sat. aq. NaHCO3 (40 mL) and the
resulting suspension was extracted with CH2Cl2 (3 x 50 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 231
(2.1497 g, 77%). Rf (10% EA/hex): 0.50. 1H NMR (300 MHz): 5.82 (ddt, J = 16.9, 10.2,
6.8), 5.0 (m, 2H), 3.61 (m, 1H), 3.45 (m, 1H), 2.54 (d, J = 12.5, 1H), 2.41 (d, J = 12.5,
1H), 2.15-2.02 (2H), 1.70-1.44 (7H), 1.37 (s, 6H).

13

C (75 MHz): 139.1, 114.6, 108.4,

83.8, 61.7, 58.9, 33.7, 29.6, 27.8, 25.7, 24.8, 20.1. HRMS (ESI): calc for C12H22O3Na:
237.1467; found: 237.1474 (3 ppm).

O

O

O

3,3,5-Trimethyl-5-(undec-10-en-1-yloxy)-1,2-dioxolane (232):
To a flame-dried vial containing a solution of 107-OTMS (2.5713 g, 12.6 mmol) in
CH2Cl2 (126 mL) was added sequentially 10-undecen-1-ol (7.6 mL, 37.8 mmol) and
TsOH (247 mg, 1.3 mmol). After 4 hrs the reaction was treated with sat. aq. NaHCO3
(40 mL) and the resulting suspension was extracted with CH2Cl2 (3 x 40 mL). The
combined organic layers were subjected to standard drying and purification with 5%
EA/hex to afford 232 (2.7486 g, 77%). Rf (5% EA/hex): 0.34. 1H NMR (400 MHz): 5.78
(ddt, J = 17.0, 10.0, 6.9, 1H), 4.97 (m, 2H), 3.59 (m, 1H), 3.43 (m, 1H), 2.53 (d, J = 12.5,
1H), 2.32 (d, J = 12.5, 1H), 2.05 (m, 2H), 1.58 (2H), 1.47 (s, 3H), 1.42-1.24 (12H), 1.37
(d, J = 2.5, 6H).

13

C (100 MHz): 139.5, 114.2, 108.4, 83.8, 62.0, 58.8, 34.0, 30.2, 29.7,
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29.6, 29.5, 29.3, 29.1, 27.8, 26.3, 24.8, 20.2. HRMS (ESI): calc for C17H32O3Na:
307.2249; found: 307.2250 (0.3 ppm).

methyl 5-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)pentanoate (233):
A solution of 231 (501.8 mg, 2.3 mmol) in MeOH (0.5 mL, 12 mmol) and CH2Cl2
(15mL) was cooled to -78oC in a flame-dried RBF. A 1% solution of O3/O2 was bubbled
into the reaction flask until the solution was blue in color. At this time the reaction
mixture was purged with O2 for 2 min and allowed to warm to rt. The contents of the
flask were concentrated in vacuo and purified by flash chromatography with 40%
EA/hex. A solution of the isolated hydroperoxyacetal (473.6 mg, 1.8 mmol) in MeCN
(7.2 mL) in a RBF was added Ca(OCl)2 (511 mg, 3.6 mmol). After 20 min the reaction
was filtered through a pad of silica, concentrated in vacuo, and the residue purified via
flash chromatography with 20% EA/hex to afford 233 (349.8 mg, 61%). Rf (20%
EA/hex): 0.45. 1H NMR (400 MHz): 3.63 (s, 3H), 3.58 (m, 1H), 3.42 (m, 1H), 2.49 (d, J
= 12.6, 1H), 2.33 (at, J = 7.4, 2H), 2.29 (d, J = 12.6, 1H), 1.70 (m, 2H), 1.58 (m, 2H),
1.43 (s, 3H), 1.33 (s, 6H). 13C (100 MHz):174.3, 108.3, 83.8, 61.1, 58.7, 51.5, 33.8, 29.4,
27.7, 24.7, 21.8, 20.0. HRMS (ESI): calc for C12H22O5Na: 269.1365; found: 269.1353
(4.5 ppm).

Methyl 10-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)decanoate (234):
A flame-dried RBF containing a solution of 232 (599.2 mg, 2.1 mmol) in MeOH (0.43
mL, 10.6 mmol) and CH2Cl2 (14 mL) was cooled to -78oC. A 1% solution of O3/O2 was
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bubbled into the reaction flask until the solution was blue in color. At this time the
reaction mixture was purged with O2 for 2 min and allowed to warm to rt. The contents
of the flask were concentrated in vacuo and the residue was purified by flash
chromatography with 30% EA/hex. To a RBF containing a solution of the isolated
hydroperoxyacetal (398.9 mg, 1.2 mmol) in MeCN (10 mL) was added Ca(OCl)2 (340
mg, 2.4 mmol).

After 20 min the reaction was filtered through a pad of silica,

concentrated in vacuo, and the residue purified by flash chromatography with 20%
EA/hex and with 10% EA/hex to afford 233 (273.5 mg, 41%). Rf (10% EA/hex): 0.25. 1H
NMR (600 MHz): 3.67 (s, 3H), 3.59 (m, 1H), 3.44 (m, 1H), 2.53 (d, J = 12.4, 1H), 2.352.27 (3H), 1.66-1.51 (4H), 1.47 (s, 3H), 1.38 (s, 3H), 1.37 (s, 3H), 1.39-1.25 (10).

13

C

(150 MHz): 174.5, 108.4, 83.8, 61.9, 58.9, 51.6, 34.3, 30.2, 29.6, 29.5, 29.4, 29.3, 27.8,
26.3, 25.1, 24.8, 20.2. HRMS (ESI): calc for C17H32O5Na: 339.2147; found: 339.2140 (2
ppm).

3,5,5-trimethyl-3-(4-acetyl-phenylmethoxy)-1,2-dioxolane (236):
To a flame-dried vial containing a suspension of Re2O7 (8.1 mg, 0.02 mmol) in CH2Cl2
(10 mL) was added sequentially 107-OTMS (206.6 mg, 1.0 mmol) and methyl 4(hydroxymethyl)benzoate (837 mg, 5.0 mmol). After 5 hrs the reaction was concentrated
in vacuo and the residue purified sequentially by flash chromatography and HPLC with
20% EA/hex to afford 236 (174.8 g, 61%). Rf (20% EA/hex): 0.40. 1H NMR (400
MHz):8.01 (d, J = 8.3, 2H), 7.46 (d, J = 8.3, 2H), 4.79 (d, J = 12.5, 1H), 4.56 (d, J = 12.5,
1H), 3.91 (s, 3H), 2.66 (d, 12.6, 1H), 2.41 (d, J = 12.6, 1H), 1.57 (s, 3H), 1.41 (s, 6H). 13C
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(100 MHz): 167.2, 144.4, 129.8, 129.2, 127.4, 108.9, 84.1, 63.7, 58.9, 52.2, 27.9, 24.8,
20.2. HRMS (ESI): calc for C15H20O5Na: 303.1203; found: 303.1219 (3.6 ppm).

3-(Allyloxy)-3,5,5-trimethyl-1,2-dioxolane (237):
To a RBF containing a solution of 107 (189.0 mg, 1.43 mmol) in CH2Cl2 (15 mL) was
added sequentially allyl alcohol (0.52 mL, 7.6 mmol) and TsOH (28.5 mg, 0.15 mmol).
After 24 hrs the reaction was treated with sat. NaHCO3 (5 mL) and the resulting
suspension was extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were
subjected to standard drying and purification with 10% EA/hex to afford 237 (127.5 mg,
49%). Rf (5% EA/hex): 0.34. 1H NMR (500 MHz): 5.95 (m, 1H), 5.30 (apparent doublet
of quartets, J = 17.2, 1.7, 1H), 5.15 (apparent doublet of quartets, J = 10.4, 1.7, 1H), 4.18
(m, 1H), 4.01 (m, 1H), 2.60 (d, J = 12.6, 1H), 2.37 (d, J = 12.6, 1H), 1.50 (s, 3H), 1.39 (s,
3H), 1.38 (s, 3H). 13C (MHz): 135.5, 116.3, 108.7, 83.4, 63.3, 58.9, 27.7, 24.7, 20.3.
HRMS (ESI): calc for C9H16O3Na: 195.0997; found: 195.1003 (2 ppm).

3-(Allyloxy)-3-methyl-1,2-dioxaspiro[4.5]decane (238):
To a flame-dried RBF containing a solution of 146 (661 mg, 3.8 mmol) in CH2Cl2 (385
mL) was added sequentially allyl alcohol (1.3 mL, 19 mmol) and TsOH (72 mg, 0.38
mmol). After 17 hrs the reaction was treated with sat. aq. NaHCO3 (20 mL) and the
resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 238
(374 mg, 46%). Rf (10% EA/hex): 0.44. 1H NMR (300 MHz): 5.98 (m, 1H), 5.3 (m, 1H),
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5.15 (m, 1H), 4.19 (m, 1H), 4.01 (m, 1H), 2.51 (d, J = 12.6, 1H), 2.32 (d, J = 12.6, 1H),
1.87-1.28 (13H).

13

C (75 MHz): 135.5, 116.2, 108.1, 85.7, 63.2, 57.3, 36.5, 34.6, 25.4,

24.4, 23.4, 20.3. HRMS (ESI): calc for C12H20O3Na: 235.1310; found: 235.1304 (3
ppm).

3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propane-1,2-diol (239):
To a flame-dried RBF containing a solution of 237 (200.1 mg, 1.2 mmol) and NMO (168
mg, 1.44 mmol) in acetone (60 mL) was added OsO4 (0.16M in H2O, 0.15 mL, 0.024
mmol). After 24 hrs the reaction was treated with sat. NaHSO3 (20 mL) and stirred for
30 min.

The solution was diluted with sat. aq. NH4Cl (50 mL) and the resulting

suspension was extracted with CH2Cl2 (10 x 100 mL). The combined organic layers
were subjected to standard drying and purification with 100% EA to afford 239 (176.6
mg, 74%). Rf (100% EA): 0.32. 1H NMR (400 MHz): 3.89-3.54 (5H), 3.10 (s, 0.5H), 2.85
(ad, J = 6.3, 0.5H), 2.56 (dd, J = 12.6, 5.8, 1H), 2.44 (bs, 0.5H), 2.36 (d, J = 12.6, 1H),
2.28 (bs, 3H), 1.48 (s, 3H), 1.39 (s, 3H), 1.38 (s, 3H). 13C (100 MHz):108.9, 108.8, 84.4,
84.3, 70.8, 70.7, 64.3, 64.1, 63.8, 63.0, 58.7, 58.7, 28.0, 27.9, 24.9, 24.8, 19.3, 19.1.
HRMS (ESI): calc for C9H18O5Na: 229.1052; found: 229.1042 (4 ppm).

O

O

OH

O
OH

3-((3-methyl-1,2-dioxaspiro[4.5]decan-3-yl)oxy)propane-1,2-diol (240):
To a flame-dried RBF containing a solution of 238 (197.4 mg, 0.9 mmol) and NMO (132
mg, 1.1 mmol) in acetone (47 mL) was added OsO4 (0.16 M in H2O, 0.12 mL, 0.028
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mmol). After 24 hrs the reaction was treated with sat. NaHSO3 (20 mL) and stirred for
30 min.

The solution was diluted with sat. aq. NH4Cl (50 mL) and the resulting

suspension was extracted with CH2Cl2 (10 x 100 mL). The combined organic layers
were subjected to standard drying and purification with 100% EA to afford 240 (164.1
mg, 72%). Rf (100% EA): 0.31. 1H NMR (400 MHz): 3.88-3.48 (5H), 3.20 (s, 0.5H), 2.93
(s, 0.5H), 2.57-2.24 (3H), 1.86-1.32 (13H). 13C (150 MHz): 108.29, 108.27, 86.3, 26.2,
70.8, 70.7, 64.3, 64.1, 63.8, 63.0, 57.1, 36.7, 36.6, 34.8, 25.2, 25.1, 24.3, 23.3, 19.2,, 19.0.
HRMS (ESI): calc for C12H22O5Na: 285.1104; found: 285.1115 (3 ppm).

3,5,5-Trimethyl-3- (3-t-butyl-diphenylsilyloxy-propoxy1,2-dioxolane (242):
To a flame-dried vial containing a solution of 107-OTMS (508.2 mg, 2.5 mmol) in
CH2Cl2 (25 mL) was added sequentially 3-[(tert-butyldiphenylsilyl)oxy]-1-propanol (3 g,
7.3 mmol) and TsOH (48 mg, 0.25 mmol). After 2 hrs the reaction was treated with sat.
aq. NaHCO3 (5 mL) and H2O (20 mL) and the resulting suspension was extracted with
CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to standard drying and
purification with 10% EA/hex to afford 242 (704.7 mg, 66%). Rf (10% EA/hex): 0.60. 1H
NMR (400 MHz): 7.73-7.66 (4H), 7.46-7.35 (6H), 3.85-3.61 (4H), 2.52 (d, J = 12.4, 1H),
2.32 (d, J = 12.4, 1H), 1.85 (quintet, J = 6.3, 2H), 1.48 (s, 3H), 1.37 (s, 3H), 1.34 (s, 3H),
1.06 (9H). 13C (100 MHz):135.8, 134.25, 134.21, 129.7, 127.8, 127.7, 108.5, 83.8, 61.1,
58.7, 33.2, 27.7, 27.0, 24.7, 20.2, 19.4. HRMS (ESI): calc for C25H36O4NaSi: 451.2281;
found: 451.2273 (1.8 ppm).
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3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propan-1-ol (243):
To a flame-dried vial containing a solution of 242 (669.8 mg, 1.6 mmol) in THF (16 mL)
was added TBAF (1M in THF, 1.8 mL, 1.8 mmol). After 3 hrs the reaction was treated
with H2O (50 mL) and the resulting suspension was extracted with Et2O (3 x 50 mL).
The combined organic layers were subjected to standard drying and purification with
50% EA/hex to afford 243 (242.2 mg, 80%). Rf (50% EA/hex): 0.47. 1H NMR (400
MHz): 3.87-3.69 (3H), 3.62 (m, 3H), 2.59 (bs, 1H), 2.52 (d, J = 12.6, 1H), 2.34 (d, J =
12.6, 1H), 1.89-1.70 (2H), 1.48 (s, 3H), 1.37 (s, 6H).

13

C (75 MHz): 108.6, 84.2, 61.2,

60.0, 58.9, 32.0, 27.9, 24.8, 19.4. IR: 3430, 2940, 2880, 1447. HRMS (ESI): calc for
C9H18O4Na: 213.1103; found: 213.1100 (1.4 ppm).

5-((3-Methyl-1,2-dioxaspiro[4.5]decan-3-yl)oxy)pentan-1-ol (244):
To a flame-dried vial containing a solution of 147 (504.1 mg, 2 mmol) in CH2Cl2 (10
mL) was added sequentially 1,5-pentanediol (0.09 mL, 0.87 mmol) and TsOH (16 mg,
0.087 mmol). After 2 hrs the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O
(20 mL) and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The
combined organic layers were subjected to standard drying and purification sequentially
with flash chromatography and HPLC with 30% EA/hex to afford 244 (95 mg, 19%). Rf
(20% EA/hex): 0.08. 1H NMR (400 MHz): 3.72-3.56 (3H), 3.50 (m, 1H), 2.43 (d, J =
12.5, 1H), 2.28 (d, J = 12.5, 1H), 1.83-1.30 (20H). 13C (75 MHz):107.8, 85.7, 63.1, 61.5,
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57.3, 36.5, 34.6, 32.5, 29.7, 25.4, 24.4, 23.3, 22.4, 20.0. IR: 3374, 2933, 2859, 1446.
HRMS (ESI): calc for C14H26O4Na: 281.1729; found: 281.1725 (1.4 ppm).

3-(2-(Benzyloxy)ethoxy)-3,5,5-trimethyl-1,2-dioxolane (245):
To a flame-dried vial containing a solution of 107-OTMS (200 mg, 1 mmol) in CH2Cl2
(10 mL) was added sequentially 2-(Benzyloxy)ethanol (0.76 mL, 5 mmol) and TsOH (19
mg, 0.1 mmol). After 2 hrs the reaction was treated with sat. NaHCO3 (20 mL) and H2O
(5 mL) and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The
combined organic layers were subjected to standard drying and purification with 20%
EA/hex to afford 245 (157.2 mg, 68%). Rf (20% EA/hex): 0.55. 1H NMR (400 MHz): 7.3
(m, 5H), 4.62 (dd, J = 18.1,12.2, 2H), 3.86-3.61 (4H), 2.64 (d, J = 12.5, 1H), 2.35 (d, J =
12.5, 1H), 1.51 (s, 3H), 1.40 (d, J = 1.7, 6H). 13C (100 MHz): 138.6, 128.5, 127.9, 127.7,
102.7, 84.0, 73.3, 69.7, 61.5, 58.7, 27.7, 24.7, 20.2. HRMS (ESI): calc for C15H22O4Na:
289.1416; found: 289.1415 (0.3 ppm).

3,3,5-trimethyl-5-(4-(oxiran-2-yl)butoxy)-1,2-dioxolane (246):
To a flame-dried vial containing a solution of 231 (501.6 mg, 2.3 mmol) in CH2Cl2 (23
mL) was added sequentially NaHCO3 (252 mg, 3 mmol) and mCPBA (739.2 mg, 3
mmol)). After 24 hrs the reaction was treated with H2O (50 mL) and the resulting
suspension was extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were
washed with sat. aq. NaHSO3 (50 mL) and subjected to standard drying and purification
with 20% EA/hex to afford 246 (346.7 mg, 65%). Rf (20% EA/hex): 0.50. 1H NMR (300
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MHz): 3.62 (m, 1H), 3.46 (m, 1H), 2.98-2.88 (1H), 2.75 (dd, J = 4.8, 4.3, 1H), 2.53 (d, J
= 12.5, 1H), 2.48 (m, 1H), 2.33, (d, J = 12.5, 1H), 1.71- 1.50 (6H), 1.47 (s, 3H), 1.37 (s,
6H). 13C (75 MHz): 108.4, 83.8, 61.6, 61.4, 58.9, 58.8, 52.5, 52.4, 47.3, 47.2, 32.4, 32.3,
29.9, 29.8, 27.8, 24.81, 24.8, 22.8, 22.7, 20.1, 20.0. HRMS (ESI): calc for C12H22O4Na:
253.1416; found: 253.1409 (2.7 ppm).

3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propanenitrile (247):
To a flame-dried vial containing a solution of 107-OTMS (202.3 mg, 1 mmol) in CH2Cl2
(10 mL) was added sequentially 2-cyanoethanol and TsOH (19 mg, 0.1 mmol). After 1
hr the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and the
resulting suspension was extracted with CH2Cl2 (2 x 20 mL). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 247
(121.9 mg, 66%). Rf (30% EA/hex):0.28. 1H NMR (400 MHz): 3.79 (m, 1H), 3.65 (m,
1H), 2.65 (m, 2H), 2.55 (d, J = 12.6, 1H), 2.33 (d, J = 12.6, 1H), 1.40 (s, 3H), 1.34 (d, J =
5.9, 6H).

13

C (75 MHz): 118.2, 108.7, 84.1, 58.6, 57.0, 27.7, 24.6, 19.6, 19.5. HRMS

(ESI): calc for C9H15O3Na: 208.0950; found: 208.0942 (3 ppm).
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Chapter 3
1,2,4-Trioxepanes as potential antimalarials

This chapter details my synthesis of 1,2,4-trioxepanes and their investigation as
potential antimalarials.

Section 1: Previous synthesises
Section 2: Rationale
Section 3: Results and Discussion
Section 4: Antimalarial results
Section 5: Experimentals
Section 6: References
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Section 1
Previous synthesis
When discussing trioxepanes it is important to first understand the nomenclature
that is used.

There are two isomeric forms of trioxepane peroxides that can exist

depending on the relative positions of the oxygens in the ring. The first is a 1,2,4trioxepane exemplified by 1. The second is 1,2,5-trioxepane which is represented by 2.

The synthesis of 1,2,4-trioxepanes is well established in the literature. All of the
methods rely upon a similar acid catalyzed ketalization to close the trioxepane ring. The
key intermediate employed by all the routes proceed through is typified by 3hydroperoxyalkanol 3, which undergoes an acid catalyzed ketalization with ketone 4 to
afford trioxepane 5. The difference in individual routes reflects the strategy employed for
the synthesis of hydroperoxide intermediate 3.

Acid displacement
The first synthesis of 1,2,4-trioxepanes was described by Adam and Duran in
1972.1

The diol precursor 6 was formed via a Reformatsky reaction, on the

corresponding ketone, which is followed by a LiAlH4 reduction on the resulting ester.
Selective substitution of the tertiary alcohol of 6 with ethereal H2O2 under acidic
conditions afforded the desired hydroperoxide intermediate 7, which readily undergoes
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acid catalyzed ketalization to afford 8. In the course of this study Adam and Durran also
conducted some initial stability studies on 7 and 8, finding that H2 and Pd/C reduced both
hydroperoxide 7 and trioxepane 8 to diol 6.

Cobalt-mediated peroxidation
To appreciate the usefulness of this approach, it is first necessary to understand
what makes cobalt peroxidation so different from other methodologies. The use of cobalt
for the synthesis of hydroperoxides from alkenes was first reported by Mukaiyama in
1989.2 In this seminal work Mukaiyama showed that alkene 9 was readily converted to
peroxide 10 in a variety of solvents in good yield. Although the reaction is shown here
only for Co(acac)2 and a terminal alkene the reaction was shown to work with a variety of
cobalt (II) sources and alkenes.

In 1990, Isayama was exploring this reaction on styrene and found that the
reaction required a long initiation time, and proceeded with low conversion.3 He reported
that the initiation time can be decreased and yield increased with the use a peroxide
initiator. This effect was most dramatic for cobalt (II) acetylacetone, Co(acac)2. Though
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Isayama did not give a rationale for this peroxide effect, he postulated that the peroxide
most likely speeds up the initiation reaction.

CHP = Cumyl hydroperoxide
An initial investigation of cobalt peroxide complexes was reported by Weiss in
1985.4

Weiss drew upon the work of Kochi who had studied cobalt-mediated

epoxidation of alkenes.5 Weiss found that cyclohexene and ethylbenzene gave large
amounts of the alkyl peroxides while styrene and norbornene gave the epoxide. Weiss
postulated that a radical addition of t-butyl peroxy radical to alkene 13 afforded
intermediate 14. As there is no effective hydrogen atom donor, the newly formed radical,
undergoes SH substitution to generate epoxide 15.

A 2002 mechanistic study by Nojima postulated a mechanism, building upon the
work of Weiss.6 Nojima initially postulated that there was a cobalt peroxide complex
present in the reaction.

The support for this came from the work of Isayama

demonstrating the importance of the peroxide formed, and Weiss’s observation of the
ability of cobalt peroxide complexes to perform the proposed reaction.

Nojima

synthesized peroxide complex 17 and reacted it with an excess of alkene 16 under
standard peroxidation conditions. Observing that peroxide 18 was formed in very good
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yield. In contrast, if 17 was treated with triethylsilane under argon with no alkene
present, silylperoxide 19 was isolated in high yield, suggesting the intermediacy of a
cobalt triethylsilane complex.

With this information Nojima proposed a complete mechanism. The postulated
key intermediate a hydrido cobalt (II) species (20), which complexes to the alkene and
delivers a hydride to provide intermediate 22. Loss of CoII generates radical 23 which
readily traps O2 to form 25. Finally, displacement with triethylsilane affords the product
26 and regenerates 20, restarting the cycle. O’Neill later provided further support for the
intermediacy of a carbon radical by performing the reaction with a chiral cobalt catalyst.7
The lack of asymmetric induction suggests that O2 attacks an achiral intermediate, such
as 23, after loss of a chiral cobalt catalyst.

In 2004, Dussault reported the use of cobalt peroxidation on homoallyl alcohols
as a different method to synthesize 1,2,4-trioxepanes.8 This work built upon work by Oh
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who, isolated the triethylsilyl peroxide of 28.9 Unlike what would be expected under
these conditions, Dussault found that the free hydroperoxide 28 was formed as the major
product instead of the triethylsilyl analog. Though this peroxidation was performed only
on alcohol 27, this strategy could be applied to any number of homoallyl alcohols as a
approach to 1,2,4-trioxepanes. Dussault found that the ketones with varying electronics
can be ketalized with 28 to afford trioxepanes 29.

Dussault became interested in trioxepanes as potential protecting groups for
carbonyl compounds.

Thus, trioxepane 30 was tested against a variety of reaction

conditions to determine its stability. Peroxides are often quite reactive and therefore
would not be expected to make a good protecting group. However, Dussault found that
30 exhibited remarkable stability to various reducing agents. The exception was n-BuLi
which caused decomposition even at -78oC. Dussault reported that deprotection to the
carbonyl was achieved with a dissolving metal reduction by either Zn/HOAc or
Mg/MeOH.
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9-decenyl

30
O

O

Reagent
PPh3
NaBH4
H2CrO4
DDQ
Et3N
10% NaOH/MeOH
TsOH/MeOH
n-BuLi (3 eq) -78o

t1/2
>24h
>24h
>24h
>24h
>24h
>24h
>24h
0.25h

Oxetane opening
In 2002, Dussault reported the synthesis of enantiomerically enriched 1,2,4trioxepanes that were derived from chiral oxetanes.10 It was found that the oxetane could
be opened with ethereal H2O2 and a variety of Lewis acids. The choice of Lewis acid
was found to be important in that BF3.OEt2, ZnCl2, and MgCl2 produced no reaction, but
the use of TMSOTf, Yb(OTf)3, and Sc(OTf)3 afforded the desired hydroperoxide, 32, in
varying yields. The main issue that was encountered in the opening was the extent of
inversion of the stereocenter. The final ketalization step proceeded in moderate yield to
afford 33.
The solvation of the H2O2 was also found to be important to the course of the
reaction. When H2O2 in CH2Cl2 was formed by iterative addition and evaporation from
ethereal H2O2, the inversion product was formed exclusively, even at -78oC. In contrast,
the use of H2O2 in CH2Cl2 obtained from direct extraction of H2O2 with CH2Cl2 led to
elimination giving the homoallyl alcohol. Dilution of the CH2Cl2-extracted H2O2 with an
equal volume of ether leads the suppression of inversion.
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O
C16H33

Lewis acid

C16H33

TMSOTf
Yb(OTf)3
Sc(OTf)3

OH
32

T(oC)

t(h)

0.4 -25 - 0
0.1 -25 - 0
0.1 -25 - 0

0.5
2
3

eq

O

OMe

31
Lewis Acid

O

OOH

anhydrous H2O2

CSA (trace)
50%

C16H33

O
33

yield (% inver.)
48% (>90)
60%
50%

Thiol-Olefin Co-Oxygenation
The use of thiol-olefin co-oxygenation to synthesize trioxepanes was reported by
O’Neill in 2006.11 The mechanism for this reaction is reliant upon the generation of a
thiyl radical. The reaction is typically initiated by an agent such as AIBN. The synthesis
of the 1,2,4-trioxepane was then readily accomplished by ketalization with a variety of
ketones to afford 1,2,4-trioxepane 38.

In attempts to make more water soluble 1,2,4-trioxepanes a variety of
manipulations were successfully carried on trioxepane 38. The oxidation of sulfide 38 to
the corresponding sulfone and sulfoxide was readily accomplished with mCPBA.
Treatment of the sulfoxide under Pummerer conditions afforded aldehyde 40. Aldehyde
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40 successfully underwent Wittig olefination to afford amide 41 and ester 42.

A

reductive amination of aldehyde 40 with morpholine was attempted, but led to peroxide
decomposition.

Singlet oxygen
In 2006, Singh reported that singlet oxygenation of homoallylic alcohols is an
effective method for the generation of a 3-hydroperoxy-4-alken-1-ol 44.12 This route
starts with alcohol 43, that is readily synthesized in two steps from commercial starting
materials. The formation of the final 1,2,4-trioxepanes was accomplished by ketalization
of 44 with either acetone, cyclopentanone, or cyclohexanone.

In 2008, Singh synthesized a new series of 1,2,4-trioxepanes in the pursuit of a
potentially new antimalarial treatment.13 In the course of this work he furthered the
knowledge of 1,2,4-trioxepanes by performing reactions that are typically not compatible
with peroxides. Singh reported successful a reductive amination with a variety of aryl
amines to form substituted 1,2,4-trioxepanes represented by 47.

This result was

unexpected given the issues that had been reported by O’Neill on a similar substrate.11
Though not discussed, the success of this reaction could be due to the use of the less
active NaBH(OAc)3.

Trioxepane 48 was also stable towards Horner-Wadsworth-

Emmons (HWE) homologation conditions to afford 49. The low yield for the HWE
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reaction was not discussed by Singh and it is unclear if the lower yield is inherent to the
olefination of a ketone or if peroxide decomposition occurred.
O

O

Ph

O

O

O
ArNH2, NaBH(OAc)3
benzene, rt

O

O

O

EtO
EtO

Ph

Ph

O

O
P

NHAr

O
47

46

O

Ar = Ph
84%
Ar = 4-F-Ph
85%
Ar = 4-CF3-Ph 65%

O
O
OEt

O
CO2Et

Ph

O

NaH, THF, 58%

48

49

Electrophilic cyclization
Electrophilic cyclization was discussed in full in Chapter 2 Section 2.1.

A brief

discussion relevant to 1,2,4-trioxepanes follows.
In 1996, Dussault reported that it was possible to use electrophilic cyclization of a
hydroperoxide onto an alkene to afford 1,2,4-trioxepanes.14 The peroxymercuration of 50
with Hg(OAc)2 was successful, while the corresponding peroxyiodination was not.
Dussault reported that trioxepane 51 lacked stability, though no explanation was given.
This lack of stability is possibly due to the hydrogen present in the 7 and the potential for
E1CB decomposition. Nojima reported that cyclization of hydroperoxy acetal similar to
50 with NIS resulted in a low yield and complex mixture of isomers.15
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Ozonolysis
In 1997, Nojima reported that the closure of a hydroperoxy acetal onto an epoxide
could be used to synthesize 1,2,4-trioxepanes.16 Hydroperoxide acetal 52, which was
formed through ozonolysis, was subjected to epoxidation conditions to yield 53. As
would be expected acidic treatment of 53 resulted in cyclization at the more hindered site
to give 54. If 53 was subjected to basic conditions, then cyclization occurred at the less
hindered site to afford 55.

Nojima reported in 1997 that the ozonolysis of an alkene in the presence of a
hydroperoxy acetal would result in intramolecular trapping to give a 7-hydroperoxy1,2,4-trioxepane.17

When hydroperoxy acetal 56 is subjected to ozonolysis,

hydroperoxytrioxepane 57 was produced in good yield. Nojima found that the choice of
solvent was important for this reaction. A 2: 1 mixture of ether/trifluoroethanol gave
optimal yields, while the use of ether alone resulted in the ozonide of 56 forming as a
major byproduct. The use of trifluoroethanol as a solvent resulted in only 57 forming,
but in decreased yield.
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Section 2
Rationale
The following work has largely been published.18

Given the high activity of selected 1,2,4-trioxolanes against P. falciparum in situ
and as potential antimalarial drugs, we became interested in determining the effect that
ring size has on activity. This work was done in collaboration of the Vennerstrom group
at the University of Nebraska Medical Center. It was decided that I would synthesize
four 1,2,4-trioxepanes (58 - 61) and their activity against P. falciparum would be
determined.

The Vennerstrom group would synthesize the corresponding 1,2,4-

trioxolanes and 1,2,4-trioxanes. The hypothesis is that as the ring size increased the
peroxide bond would be less accessible and antimalarial activity would diminish.
Nonetheless it was necessary to synthesize this series to determine if that theory was
valid.

Retro-synthetically it was envisioned that a parallel synthesis would be employed,
using a common hydroperoxyalkanol as a common intermediate and that final
differentiation between 58/59 and 60/61 would occur at the ketalization step. Given the
work that has been done previously, I envisioned that hydroperoxide 63 would be formed
via a Mukaiyama cobalt peroxidation from an allyl alcohol 64. In the case of the
cyclohexyl derivative, is available via a Horner-Wadsworth-Emmons olefination of
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cyclohexanone. While in the case of the phenyl propanol derivative, hydroperoxide 63,
the precursor of 1,2,4-trioxepanes 60 and 61, would be formed from cinnamyl alcohol.

Section 3
Results and discussion
Although the olefination of cyclohexanone to form ester 66 was uneventful, the
subsequent reduction was found to be problematic. Initially, LiAlH4 was employed as
the reducing agent however this led to an inseparable mixture of saturated and
unsaturated 67.
with Dibal-H.

19

It was found that this issue was readily circumvented by reduction

Allyl alcohol 67 was then subjected to Mukaiyama cobalt-mediated

peroxidation using several solvents (1,2-dichloroethane, EtOH) and cobalt complexes
(Co(acac)2

and

Cobalt(II)

(2,2,6,6-tetramethyl-3,5-heptanedionate

(Co(THD)2).

However, it was found that all tested conditions gave a poor yield to the desired peroxide
and always as part of an inseparable mixture. This outcome is not entirely surprising
when the earlier Dussault work is considered.8

Alcohol 67 is expected to be a

problematic substrate which will react to mainly furnish the free hydroperoxide and not
the triethylsilyl peroxide. Therefore, it would have been prudent to perform a model
reaction on a known substrate as a model, but this was not done.
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Given these synthetic issues I decided that the use of an oxetane as the peroxide
precursor might be a more successful strategy. Our lab has previously reported the
opening of oxetanes similar to 70 with hydrogen peroxide as a route to hydroperoxides
71.20 It was envisioned that the desired oxetane (70) could be formed by a intramolecular
nucleophilic displacement of the primary tosylate formed from diol 69.

The synthesis of oxetane 70 began with a Reformatsky reaction of cyclohexanone
to afford ester 72 which underwent LiAlH4 reduction to provide diol 69. Closure of the
oxetane could be accomplished by formation of the primary tosylate followed by an
intramolecular displacement. This approach, however, provided the desired oxetane 70
in poor yield and this route was abandoned.

At this point, I decided that it would be beneficial to employ a modified version of
the Corey-Chaukovski reaction to obtain the oxetane in one-step from the ketone. I
investigated the oxetane in one-step formation of oxetane as reported by Okuma.21
Though the yield for this reaction is not exemplary, it provided the desired product in a
one-pot one step procedure.
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O

S+
56%
65

70

With the oxetane in hand, I attempted to perform the opening with hydrogen
peroxide as was previously reported by Dussault.20 However, when I attempted the
opening I ran into significant trouble with every condition attempted. The reason for this
failure is unclear although most of the earlier examples are in acyclic substrates.
With these troubles I returned to investigations of the Mukaiyama cobaltmediated peroxidation. I thought that the use of a protecting group on the alcohol might
improve the outcome of the cobalt-mediated dioxygenation. Initially, it was planned that
the TMS or TES ether would be employed, as deprotection and ketalization could be
accomplished in one-step.

Attempts to form the OTMS ether were unsuccessful, but the

OTES ether was successfully prepared.

Unfortunately cobalt peroxidation was

unsuccessful. In hindsight, the use of the bulkier OTBS ether would have been more
prudent as it would be less likely to undergo deprotection during the cobalt peroxidation.

I thought that this strategy merited further investigation using a protecting group
that would not be labile under cobalt-mediated peroxidation conditions. A paper by Wu
reporting the selective reduction of esters in the presence of a dialkyl peroxide
encouraged me to utilize a ester protecting group.22 To my delight, the acetate derived
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from alcohol 67 underwent cobalt-mediated peroxidation to yield silyl peroxide 74,
which underwent Dibal-H reduction to afford the long sought after peroxyalkanol 68.
Finally, ketalization with either 2-adamantanone or cyclohexanone proceeded in
moderate yield to afford the desired 1,2,4-trioxepanes 58 and 59 respectively.

The same chemistry was used to prepare the cinnamyl analog (77), the 3-peroxy3-phenylpropanol in good yield.

Ketalization of 77 with 2-adamantanone or

cyclohexanone afforded trioxepanes 60 or 61, respectively in moderate yield.
OOSiEt3
OH
75

1. Ac2O 89%
2. Co(acac)2
TESH, 43%

OAc
76

Dibal-H
O
O
OOSiEt3

O

O
OH

Ph
O

O
61

HF, 39%

77

Ph
HF, 21%

O
60

O
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Section 4
Antimalarial results
The desired 1,2,4-trioxepanes were subjected to in vitro testing against P.
falciparum and were compared against structural analogs 1,2,4-trioxolanes and 1,2,4trioxoanes (Table 3.1).23,24 There was a decrease in activity as the peroxide ring size
increased, 5>6>7. The trioxepanes that I synthesized showed no activity. Although we
had expected little activity, we had not expected a complete absence of activity. Previous
work showed that the difference in Fe (II) reactivity between 79 and 80 could be
correlated with the accessibility of the peroxide bond to FeII.25 I believe that this same
rationale can be extended to the lack of activity for the 1,2,4-trioxepanes.

Our

collaborators investigated the degradation of trioxepane 58 by soluble Fe(II) and found
no reaction after 24 hrs, conditions that would have resulted in complete degradation of a
1,2,4-trioxolane or a 1,2,4-trioxane. The results show there is a tradeoff between stability
and activity.
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O
81
O

O
Ph
O O
60

O O
58

O
Ph

O

O O

O O
59
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Compound
78
79
80
81
58
59
60
61

IC50 (nM)
>1000
5.3
66
158
>1000
>1000
>1000
>1000

Table 3.1
Section 5
Experimentals
All reagents were used as received from commercial vendors, with the exception of
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from
sodium/benzophenone. All reactions were conducted under an atmosphere of N2 except
where noted; “RBF” indicates round-bottom flask. Thin layer chromatography (TLC)
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized
with a hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium
molybdate in 10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-p-
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phenylenediamine solution in 1:20:100 acetic acid/water/methanol (specific for
peroxides);26 1% aq. KMnO4 (for unsaturated compounds).

“Standard drying and

purification” refers to drying of organic extracts over Na2SO4, removal of solvent under
vacuum, and purification by flash chromatography using the indicated eluting solvent.
1

H/13C NMR spectra were obtained in CDCl3 unless otherwise indicated; peaks are

reported as: chemical shift (multiplicity, J couplings in Hz, number of protons). Infrared
spectra were recorded as neat ATR films with selected absorbances reported in
wavenumbers (cm-1).
CO2Et

Ethyl 2-cyclohexylideneacetate (66):
A suspension containing sodium hydride (2.3g, 57 mmol, 60% in mineral oil) in a flamedried RBF was washed with pentane (2 x 20 mL). The residue was suspended in THF
(90 mL) and the suspension cooled to 0oC.

Following the drop wise addition of

triethylphosphonoacetate (13.72 g, 61 mmol), the reaction was allowed to warm to rt and
stirred at this temperature for 90 min. Cyclohexanone (5g, 51 mmol) was then added
drop wise and the reaction allowed to stir overnight. The reaction was diluted with H2O
(100 mL) and extracted with Et2O (3 x 100 mL). The combined organic layers were
washed with brine (2 x 100 mL), dried with Na2SO4.

The residue obtained upon

concentration in vacuo was purified by chromatography with 10% EA/hex to afford 66
(8.0992g, 94 %) as a colorless oil. Rf (10% EA/hex) = 0.68. 1H NMR (300 MHz): 5.60
(s, 1H), 4.15 (q, 2H, J=7), 2.83 (apparent t, 2H, J=6), 2.20 (apparent t, 2H, J=6), 1.721.54 (6H), 1.28 (t, 3H, J=7.12). The NMR spectra matched those previously reported.27
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OH

2-Cyclohexylideneethanol (67)
In a flame-dried RBF containing a 0oC solution of 5 (7.62 g, 45 mmol) in Et2O
(150 mL) was added Dibal-H (91 mL, 91 mmol, 1 M). The reaction was stirred for 2 hrs
and then was treated with sat. aq. Rochelle’s salt (30 mL) followed by H2O (500 mL).
The resulting suspension was extracted with Et2O (2 x 500 mL) and the combined
organic layers were washed with brine (500 mL) and dried with Na2SO4. The residue
obtained upon concentration in vacuo was purified via column chromatography with 30%
Et2O/pent to afford 67 (4.4458 g, 79%) as a colorless oil. 1H (300 MHz): 5.36 (m, 1H),
4.15 (m, 2H), 2.2-2.03 (4H), 1.62-1.45 (6H), 1.25 (s, 1H). The NMR spectra matched
those previously reported.27

1-Carboethoxymethyl-1-cyclohexanol (72):
Cyclohexanone (5 g, 51 mmol) and ethyl bromoacetate (8.52g, 51 mmol) were
dissolved in a mixture of benzene (60 mL) and toluene (50 mL) in a RBF. To a separate
flame-dried RBF were added sequentially Zn dust (3.31g, 51 mmol) and 25 mL of the
solution from the other RB. The reaction was heated to reflux at which point the
remainder of the first solution was added. The reaction was held at reflux for 2 hrs after
which dilute H2SO4 (50 mL) was added and the resulting suspension filtered. The
organic layer was washed with brine (2 x 15 mL) and dried with Na2SO4. The residue
obtained upon concentration in vacuo was purified by column chromatography with 10%
EA/hex to afford 72 (4.683 g, 48%). Rf (10 % EA/hex): 0.43. 1H (300 MHz): 4.13(q, J =
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7.1, 2H), 3.40 (s, 1H), 2.42 (s, 2H), 1.72-1.33 (10H), 1.23 (t, J = 7.1, 3H). The NMR
spectra matched those previously reported.28

1-(2-Hydroxyethyl)cyclohexanol (69):
A suspension of LiAlH4 (306 mg, 38 mmol) in Et2O was cooled to 0oC in a flame-dried
RBF. To the suspension was added 72 (500 mg, 2.68 mmol) in Et2O (10 mL). The
reaction was stirred for 30 min and then quenched by sequential addition of H2O (0.3
mL), 10% aq. NaOH (0.3 mL) and H2O (0.9 mL). The suspension was filtered and the
aq. layer extracted with Et2O (3 x 15 mL). The combined organic layers were dried with
Na2SO4 and the residue obtained upon concentration in vacuo was purified via column
chromatography with 30% Et2O/hex. As the subsequent oxetane closure proceeded in
very low yield, this route was not pursued further.
O

1-Oxaspiro[3.5]nonane (70):
(Corey-Chaukovski method)21
To a flame-dried RBF was added sequentianlly trimethylsulfoxonium iodide (8.8 g, 40
mmol), potassium t-butoxide (4.75 g, 40 mmol), and t-butanol (40 mL). The slurry was
allowed to stir at 50oC for 30 min. A solution of cyclohexanone (1g, 10 mmol) in tbutanol (10 mL) was added and the reaction was allowed to stir at 50oC for 3 days. The
reaction was then treated with H2O (100 mL) and the suspension was extracted with
pentane (3 x 60 mL). The combined organic layers were washed with brine (2 x 80 mL)
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and subjected to standard drying and purification with 7.5% Et2O/pent to afford 70 (706.1
mg, 56%).

1

H NMR (300 MHz): 4.49 (t, J = 7.8, 2H), 2.33 (t, J = 7.8, 2H), 1.90-1.75

(10H). The NMR contained approximately 10% Et2O but otherwise matched those
previously reported.21

2-(1-((Triethylsilyl)peroxy)cyclohexyl)ethyl acetate (74):
To a flame-dried RBF was added sequentially 67 (4.4458 g, 35 mmol), pyridine (50 mL),
Ac2O (3.88 mL, 52 mmol), and DMAP (437.8 mg, 3.5 mmol). The reaction was stirred
for 2 hrs and then quenched by addition of 2N aq. HCl (75 mL). The suspension was
extracted with Et2O (3 x 50 mL). The combined organic layers were washed sequentially
with 2N HCl (75 mL), sat. aq. NaHCO3 (50 mL), and brine (50 mL). The organic layer
was dried with Na2SO4 and the residue upon concentration in vacuo was purified via
column chromatography with 10 % EA/hex to afford 2-cyclohexylideneethyl acetate
(5.1477 g, 88%). Rf (10% EA/hex) = 0.62. 1H NMR (300 MHz): 5.28 (dt, J = 7.3, 1.1,
1H), 4.57 (d, J = 7.3, 2H), 2.24-2.06 (4H), 2.04 (s, 3H), 1.61-1.44 (6H). The NMR
spectra matched those previously reported.29
To a flame-dried RBF containing Co(acac)2 (437 mg, 1.7 mmol) was added

2-

cyclohexylideneethyl acetate (2.9883 g, 17 mmol) in EtOH (60 mL) and Et3SiH (3.9 g,
34 mmol). The reaction was placed under an atmosphere of O2 (balloon) and allowed to
stir overnight. The reaction was then concentrated in vacuo and the residue subjected to
column chromatography with 5 % EA/hex to afford 74 (2.2596 g, 42%). Rf (5%
EA/hex): 0.44. 1H NMR (300 MHz): 4.19 (t, J = 7.3, 0.8H), 4.1 (t, J = 6.9, 1.2H), 3.69
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(q, J = 7.0, 1H), 2.03 (d, J = 3.1, 3H), 1.93 (t, J = 1.96, 1H), 1.83-1.08 (13H), 1.06-0.83
(8H), 0.75-0.53 (4H).

2-(1-((Triethylsilyl)peroxy)cyclohexyl)ethanol (68):
A flame-dried RBF containing 74 (2.25 g, 6.9 mmol) in CH2Cl2 (60 mL) was cooled to 78oC and Dibal-H (13.9 mL, 13.9 mmol, 1M) was added. The reaction was allowed to
stir for 3 hrs after which the reaction was treated with sat. Rochelle’s salt (60 mL). The
suspension was extracted with Et2O (3 x 40 mL) and the combined organic fractions were
washed with brine (2 x 100 mL) and dried over Na2SO4. The residue obtained upon
concentration in vacuo was purified via column chromatography with 30 % Et2O/pent to
afford 68 (1.2355g, 65%). Rf (30% Et2O/pent): 0.52.

1

H (300 MHz): 3.78-3.61 (3H),

1.90 (t, J = 6.9, 1H), 1.83-1.09 (14H), 1.04-0.83 (8H), 0.78-0.54 (4H).

13

C (75 MHz):

83.8, 61.0, 58.6, 58.5, 40.6, 39.2, 34.4, 33.54, 33.52, 26.7, 26.4, 22.3, 18.8, 6.9, 6.8, 4.6,
4.0.

Adamantane-2-spiro-3’-7’-cyclohexyl-1’,2’,4’-trioxepane (58)
To a flame-dried RBF containing 68 (509.9 mg, 1.83 mmol) in CH2Cl2 (2 mL) was added
sequentially 2-adamantanone (301 mg, 2 mmol) and HF (48% in H2O, 1 mL). After
stirring for 1 hr the reaction was quenched with sat. aq. NaHCO3 (30 mL) and the
resulting suspension was extracted with CH2Cl2 (3 x 20 mL). The combined organic
fractions were washed with brine (2 x 20 mL) and dried with Na2SO4. The residue
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obtained upon concentration in vacuo was purified via column chromatography with 10
% EA/hex. Subsequent purification through HPLC with 10 % EA/hex afforded the
desired product 58 (79.5 mg, 15 %). Rf (5% EA/hex):0.28. 1H NMR (400 MHz): 3.90
(apparent pentet (probably dt), J = 6.2, 12.2 1H), 3.69 (dt, J = 3.7, 12.4, 1H), 2.40 (br, s,
1H), 2.15-2.02 (m, 2H), 2.02-1.9 (m, 3H), 1.86-1.30 (20H).

13

C NMR (100 MHz,

CDCl3): 107.5, 81.7, 58.1, 42.3, 37.5, 35.7, 34.6, 34.2, 33.8, 33.8, 33.7, 33.6, 32.9, 27.3,
26.0, 22.4, 22.0. HRMS (FAB); calc for C18H29O3: 293.2117; found: 293.2103.

Cyclohexane-2-spiro-3’-7’-cyclohexyl-1’,2’,4’-trioxepane (59)
To a flame-dried RBF containing 68 (267 mg, 1 mmol) in CH2Cl2 (5 mL) was added
sequentially cyclohexanone (139 mg, 1.4 mmol) and HF (48% in H2O, 2 mL). The
reaction was stirred for 1 hr after which sat. aq. NaHCO3 (30 mL) was added. The
suspension was extracted with CH2Cl2 (3 x 20 mL). The combined organic fractions
were washed with brine (2 x 20 mL) and dried with Na2SO4. The residue obtained upon
concentration in vacuo was purified via column chromatography with 5 % EA/hex.
Subsequent purification through HPLC with 5 % EA/hex afforded the desired product 59
(92 mg, 39 %). Rf (5% EA/hex): 0.48. 1H NMR (400 MHz): 3.60 (m, 1H), 3.66 (m, 1H),
2.15-2.04 (1H), 1.95-1.72 (21H).

13

C NMR (100 MHz): 105.9, 82.0, 58.5, 42.8, 35.9,

33.4, 32.8, 32.2, 26.0, 25.7, 23.3, 22.9, 22.4, 22.0. HRMS (EI); calc forC14H24O3:
240.1725; found: 240.1723.
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OAc

3-Phenyl-3-(triethylsilylperoxy)propyl acetate (76):
To a flame-dried RBF containing cinnamyl alcohol (2.46 g, 18.4 mmol) in pyridine (30
mL) was added sequentially Ac2O (2 mL, 23.6 mmol) and DMAP (226 mg, 1.84 mmol).
The reaction was allowed to stir for 1 hr after which 2N aq. HCl (40 mL) was added. The
suspension was extracted with Et2O (3 x 30 mL) and washed with sat. aq. NaHCO3 (2 x
40 mL). The combined organic layers were dried with Na2SO4 and the residue obtained
upon concentration in vacuo purified via column chromatography with 5% EA/Hex to
afford cinnamyl acetate (2.8754 g, 89%) as a yellow oil. 1H NMR (300 MHz): 7.75-7.24
(5H), 6.68 (d, J = 16.4, 1H), 6.30 (dt, J = 15.9, 6.5, 1H), 4.78 (apparent doublet, J = 6.4,
2H), 2.12 (s, 3H).

13

C (75 MHz): 170.9, 136.3, 134.3, 128.7, 128.2, 126.7, 123.3, 65.2,

21.1.
To a flame-dried RBF containing Co(acac)2 (146 mg, 0.57 mmol) was added a solution of
cinnamyl acetate (1.03 g, 5.7 mmol) in EtOH (20 mL) and Et3SiH (1.32 g, 11.3 mmol).
The reaction was placed under an atmosphere of O2 (balloon) and allowed to stir
overnight. The reaction was then concentrated in vacuo and the residue obtained was
purified via column chromatography with 5 % EA/hex to afford 76 (815.7 mg, 43%). Rf
(5% EA/hex): 0.43. 1H NMR (300 MHz): 7.41-7.24 (5H), 4.97 (t, J = 6.8, 1H), 4.24-3.98
(2H), 2.30 (m, 1H), 2.01 (m, 1H), 2.02 (s, 3H), 0.94 (t, J = 7.6, 9H), 0.64 (aq, 6H).
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3-Phenyl-3-(triethylsilylperoxy)propan-1-ol (77):
A flame-dried RBF containing 76 (815.7 mg, 2.5 mmol) in CH2Cl2 (20 mL) was cooled
to -78oC and Dibal-H (5 mL, 5 mmol, 1M) was added. The reaction was stirred for 3 hrs
and then treated with sat. aq. Rochelle’s salt (30 mL). The resulting suspension was
extracted with Et2O (3 x 40 mL). The combined organic layers were washed with brine
and dried with Na2SO4. The residue obtained upon concentration (672.4 mg, 95%) was
used in the subsequent reactions without purification.
O
O

O

Adamantane-2-spiro-3’-7’-phenyl-1’,2’,4’-trioxepane (60)
To a flame-dried RBF containing 77 (320.2 mg, 1.13 mmol) in CH2Cl2 (10 mL) was
added sequentially 2-adamantanone (165 mg, 1.1 mmol) and HF (48% in H2O, 2 mL).
After stirring for 1 hr the reaction was quenched with sat. aq. NaHCO3 (30 mL) and the
resulting suspension was extracted with CH2Cl2 (3 x 20 mL). The combined organic
fractions were washed with brine (2 x 20 mL) and dried with Na2SO4. The residue
obtained upon concentration in vacuo was purified via column chromatography with 7.5
% Et2O/pent. Subsequent purification through HPLC with 10 % EA/hex afforded the
desired product 60 (70 mg, 21 %). Rf (55% EA/Hex):0.65.

1

H NMR (400 MHz):7.40-

7.29 (m, 5H), 5.14 (dd, J = 11.5, 3.5, 1H), 4.13 (app t, J = 11.3, 1H), 3.85 (dt, J = 3.4,
12.2, 1H), 2.4-2.2 (m, 2H), 2.14-1.9 (m, 6H), 1.86-1.79 (m, 2H), 1.75-1.6 (m, 6H).

13

C

NMR (75.5 MHz):138.5, 128.5, 128.4, 127.3, 108.6, 86.1, 76.6, 60.0, 39.4, 37.5, 35.0,
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34.7, 34.1, 33.9, 33.6, 33.1, 27.2, 27.1. HRMS (FAB); calc for C19H25O3: 301.1804;
found: 301.1809.

Cyclohexane-2-spiro-3’-7’-phenyl-1’,2’,4’-trioxepane (61):
To a flame-dried RBF containing 77 (285.0 mg, 1 mmol) in CH2Cl2 (10 mL) was added
sequentially cyclohexanone (0.11 g, 1.1 mmol) and HF (48% in H2O, 2 mL). After
stirring for 1 hr the reaction was treated with sat. aq. NaHCO3 (30 mL) and the resulting
suspension was extracted with CH2Cl2 (3 x 20 mL). The combined organic fractions
were washed with brine (2 x 20 mL) and dried with Na2SO4. The residue obtained upon
concentration in vacuo was purified via column chromatography with 10 % EA/hex.
Subsequent purification through HPLC with 10 % EA/hex afforded the desired product
61 (95.5 mg, 39 %). 1H NMR (400 MHz)7.41-7.29 (5H), 5.14 (dd, J = 11.4, 5.15, 1H),
4.20-4.08 (1H), 3.84 (dt, J = 12.5, 3.4, 1H), 2.37-1.20 (12H).

13

C (75 MHz): 138.5,

128.7, 128.6, 127.5, 106.9, 86.3, 60.5, 39.4, 34.2, 31.9, 25.6, 23.3, 22.9. HRMS (FAB):
calc for C15H21O3: 249.1492; found: 249.1489.

200
Section 6
References
(1)

Adam, W.; Duran, N. J. Chem. Soc., Chem. Commun. 1972, 798.

(2)

Isayama, S.; Mukaiyama, T. Chem. Lett. 1989, 573.

(3)

Isayama, S. Bull. Chem. Soc. Jpn. 1990, 63, 1305.

(4)

Saussine, L.; Brazi, E.; Robine, A.; Mimoun, H.; Fischer, J.; Weiss, R. J. Am.
Chem. Soc. 1985, 107, 3534.

(5)

Budnik, R. A.; Kochi, J. K. J. Org. Chem. 1976, 41, 1384.

(6)

Tokuyasu, T.; Kunikawa, S.; Masuyama, A.; Nojima, M. Org. Lett. 2002, 4, 3595.

(7)

O'Neill, P. M.; Hindley, S.; Pugh, M. D.; Davies, J.; Bray, P. G.; Park, B. K.;
Kapu, D. S.; Ward, S. A.; Stocks, P. A. Tetrahedron Lett. 2003, 44, 8136.

(8)

Ahmed, A.; Dussault, P. H. Org. Lett. 2004, 6, 3609.

(9)

Oh, C. H.; Kang, J. H. Tetrahedron Lett. 1998, 39, 2771.

(10)

Dussault, P. H.; Trullinger, T. K.; Noor-e-Ain, F. Org. Lett. 2002, 4, 4591.

(11)

Amewu, R.; Stachulski, A. V.; Berry, N. G.; Ward, S. A.; Davies, J.; Labat, G.;
Rossignol, J.-F.; O'Neill, P. M. Bioorg. Med. Chem. Lett. 2006, 16, 6124.

(12)

Singh, C.; Pandey, S.; Saxena, G.; Srivastava, N.; Sharma, M. J. Org. Chem.
2006, 71, 9057.

(13)

Singh, C.; Pandey, S.; Kushwaha, A. K.; Puri, S. K. Bioorg. Med. Chem. Lett.
2008, 18, 5190.

(14)

Dussault, P. H.; Davies, D. R. Tetrahedron Lett. 1996, 37, 463.

(15)

Ushigoe, Y.; Kano, Y.; Nojima, M. J. Chem. Soc., Perkin Trans. 1 1997, 5.

201
(16)

Ushigoe, Y.; Masuyama, A.; Nojima, M.; McCullough, K. J. Tetrahedron Lett.
1997, 38, 8753.

(17)

Ushigoe, Y.; Torao, Y.; Masuyama, A.; Nojima, M. J. Org. Chem. 1997, 62,
4949.

(18)

Wang, X.; Creek, D. J.; Schiaffo, C. E.; Dong, Y.; Chollet, J.; Scheurer, C.;
Wittlin, S.; Charman, S. A.; Dussault, P. H.; Wood, J. K.; Vennerstrom, J. L.
Bioorg. Med. Chem. Lett. 2009, 19, 4542.

(19)

Paquette, L. A. In e-EROS Encycl. Reagents Org. Synth., 2001.

(20)

Dai, P.; Trullinger, T. K.; Liu, X.; Dussault, P. H. J. Org. Chem. 2006, 71, 2283.

(21)

Okuma, K.; Tanaka, Y.; Kaji, S.; Ohta, H. J. Org. Chem. 1983, 48, 5133.

(22)

Jin, H.-X.; Liu, H.-H.; Zhang, Q.; Wu, Y. J. Org. Chem. 2005, 70, 4240.

(23)

Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Antimicrob. Agents
Chemother. 1979, 16, 710.

(24)

Huber, W.; Koella, J. C. Acta Tropica 1993, 55, 257.

(25)

Tang, Y.; Dong, Y.; Wang, X.; Sriraghavan, K.; Wood, J. K.; Vennerstrom, J. L.
J. Org. Chem. 2005, 70, 5103.

(26)

Smith, L. L.; Hill, F. L. J. Chromatogr., A 1972, 66.

(27)

Bourhani, Z.; Malkov, A. V. Chemical Communications 2005, 4592.

(28)

Carr, G.; Whittaker, D. J. Chem. Soc., Perkin Trans. 2 1989, 359.

(29)

Marion, N.; Gealageas, R.; Nolan, S. P. Org. Lett. 2007, 9, 2653.

202
Chapter 4
Re (VII) oxide as a catalyst for the generation of stabilized carbocations

This chapter describes my investigation of Re(VII) as a catalyst for the formation
of stabilized carbocations that are utilized in various displacement of activated alcohols.

Section 1: Previous work
Section 2: Hypothesis
Section 3: Etherification/acetalization of 3-alkoxy-1,2-dioxolanes
Section 4: Etherification of lactols
Section 5: Allylation
Section 6: Stabilized carbocations
Section 7: Conclusions
Section 8: Experimentals
Section 9: References
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Chapter 4 includes a description of my application of Re(VII) to the
transetherification (transacetalisation) of 1,2-dioxolan-3-ols to the corresponding 3alkoxy-1,2-dioxolanes. This chapter will discuss in detail my investigations of the ability
of Re2O7 to catalyze reactions involving in situ generation of carbocations from alcohols.
Several reviews on the chemistry of rhenium have been published.1,2
Section 1
Previous work
Isomerization of allylic alcohols by rhenium
In 1997, Osborn first reported that ReO3(OSiMe3) or ReO3(OSiPh3) was able to
catalyze the isomerization of allyl alcohols.3 Osborn’s proposed mechanism (below)
begins with insertion of rhenium into the C-O bond of 1. This type of insertion is
supported by an analogous insertion reported by Wilkinson.4 Complex 3 rearranges to
the isomerized complex (5) via transition state 4, a pathway supported by the analogous
work of Chabardes.5 Finally, the catalytic cycle in the presence of 1 and produces
isomerized alcohol 6.
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In 2000, Osborn built upon his earlier work by showing that this allylic
rearrangement also works for trimethylsilyl ether of 1.6 Osborn also reported that Re2O7
was able to catalyze this reaction in MeCN, THF, and CH2Cl2. There is a solvent effect
on the reaction with a twenty-fold decrease in turnover observed for MeCN or THF
compared to CH2Cl2. This was attributed to coordination to the ReO3(OSiMe3) catalyst.
The rate of the reaction with Re2O7 could not be determined due to the insolubility in
CH2Cl2.
In 2010, Zakarian developed a method to control the regioselectivity of Re2O7promoted isomerization of enediols,7 providing one solution to the lack of regioselectivity
typically encountered in the reactions of simple allyl alcohols.8-10 Transformation of 7 to
the diol of 8 in the absence of an acetal (9) led to poor conversion (60%) and low
diastereoselectivity. The addition of 9 was found to significantly increase both the yield
of the isomerized product and the diastereoselectivity of the reaction.

The authors

hypothesized that perrhenic acid catalyzed the conversion of the product regioisomer into
the benzylidene acetal, which also provided a bias for formation of the
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thermodynamically preferred 1,3-syn isomer. A variety of solvents were screened and
CH2Cl2 was found to be optimal: Re2O7 was shown to be an effective rhenium source.
This methodology was successfully applied to a variety of substrates. However, it was
noted that acid labile groups such as t-butyldiphenylsilyl ethers (TBDPS) and pmethoxybenzyl ethers (PMB) underwent deprotection upon prolonged exposure (20 hrs)
but deprotection can be circumvented with the use of a different acetal.

Utilization in Prins cyclization
In 2008, Rychnovsky reported using rhenium to catalyze an intramolecular Prins
reaction.11 The reaction of alcohol 10 and benzaldehyde, 11, afforded tetrahydropyran 12
utilizing O3ReOSiPh3 as a catalyst. Rychnovsky postulates that 10 and 11 react to form
hemiacetal 13, which is then able to undergo rearrangement to give 15. Exchange with
Ph3SiOH, formed in the reaction, gives product 12. Rychnovsky found that this reaction
works for a variety of alkenes and benzaldehydes.

The reaction was successfully

performed in several solvent systems but CH2Cl2 was the best. In 2009, Rychnovsky
built upon this work by successfully applying this reaction to a more complicated system
to achieve an intramolecular macrolactonization.12
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Section 2
Hypothesis
The work of Rychnovsky led me to believe that Re (VII) should act as a mild
catalyst for the acetalization/transetherification of 1,2-dioxolan-3-ols and/or the
corresponding trimethylsilyl ethers.
The etherification of 16 under strongly acidic conditions (p-toluene sulfonic acid)
is likely to involve the formation of cationic intermediate 18 that undergoes trapping by
an alcohol. Given the previous work, we anticipated that Re2O7 should be able to insert
in C-OH bond of 16 to afford an intermediate (17) that could fragment to the same
carbocation (18), with the difference being that the ionization might occur under much
milder conditions.

Section 3
Etherification/acetalization of 3-alkoxy-1,2-dioxolanes
To test our hypothesis, I compared the transformation of 20 and 21 in the
presence of Re2O7 vs. sulfonic acid. (below). When Re2O7 (10 mol%) was used it was
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found the yield of 2-phenylethanol was unchanged relative to sulfonic acid (10 mol%).
In contrast, the yield for etherification with 1-adamantanemethanol increased
dramatically with Re2O7. Both of these etherifications proceeded in slightly higher yield
using only 1 mol% of Re2O7. The use of less than 1 mol% Re2O7 was not investigated,
but I believe that the reaction could proceed at even lower catalyst loading. As expected
the etherification of sterically hindered 1-adamantanol was unsuccessful for either
catalyst system.

Alcohol

PTSA

2-phenylethanol
1-adamantanemethanol
1-adamantanol

73% (3h)
28% (>12h)
Failed

Re2O7
10 mol%
75 % (1h)
74 % (1h)
Failed

Re2O7
1 mol%
83% (1h)
78% (2h)
Failed

Table 4.1
I had prepared the dioxolane trimethylsilylether (22) to assist with purification,
and became interested if the 3-trimethyl-1,2-silyloxydioxolane would be a useful
substrate for the transetherification. Gratifyingly the reaction did proceed to afford 21 in
comparable yield relative to the transetherification on the free alcohol. The yield of the
1-adamantylmethyl acetal was slightly depressed compared with the reaction from the
free alcohol. The ability to employ trimethylsilyl ethers represents a useful expansion of
the methodology.
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Alcohol
2-phenylethanol
1-adamantanemethanol
1-adamantanol

Re2O7 (1 mol%)
81% (2h)
65% (>12h)
Failed

Table 4.2
Given the successful application of Re2O7 to catalyze the etherification of
anomerically-activated 1,2-dioxolan-3-ols, I became interested in the potential of this
reagent to catalyze the corresponding etherification (glycosylation) of sugars.

This

approach was unsuccessful with a variety of glucose pentaacetate derivatives, 23. Only
when methanol was employed did any noticeable reaction occur.
Section 4
Etherification of lactols

R
H
OAc
TBS
H

X
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
Me

Yield 24
Failed
Failed
Failed
4%

Table 4.3
The failure to achieve Re2O7-promoted etherification of sugars could result from
the presence of strongly electron-withdrawing C-O linkages on the carbons adjacent to
the hemiacetal. I therefore decided to screen lactols. As was expected from earlier work
with peroxyhemiacetal 20 this reaction proceeded in good yield on the free hemiacetal
(25).

Unexpectedly, transetherification also proceeded in good yield on the t-
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butyldimethylsilyl (TBS) acetal, 26. This result was unexpected as the bulkier TBS
ethers were not expected to undergo insertion of Re(VII) into the C-O bond as had been
observed for the corresponding trimethylsilyl ethers. This result broadens the potential
application of this methodology as the TBS ether is a more widely used protecting group.

Section 5
Allylation
As we postulated that a carbocation intermediate, or something with comparable
reactivity, was formed in the etherification reaction the next logical step was to explore
the possibility of achieving C-C bond formation under these conditions. The allylation of
25 with allyl trimethylsilane appeared to cleanly furnish one major product (TLC) but
resulted in low yield (37%) presumably because of volatility. Therefore, I utilized lactol
27 which was readily synthesized in two steps from 2-adamantanone. As was expected
the allylation of 27 proceeded in excellent yield to afford 28.

These allylation results made me wonder if it was possible to also perform an
allylation of 1.2-dioxolan-3-ol using Re2O7.

Previous reports from our group had

demonstrated successful addition of allylsilane and silyl ketene acetal nucleophiles to 3alkoxy-1,2-dioxolanes, however, these reactions were achieved using very powerful
Lewis acids.

13

I initially investigated the use of allyltrimethylsilane as a nucleophile;
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however, no reaction was observed. I therefore investigated the use of more nucleophilic
allyltributyltin. The use of the tin compound led to no reaction and a change in reaction
color, possibly indicating a reaction with Re2O7.
R
OH
O O
20

Re2O7 (1 mol%)

O
O O
29
R = TMS
Failed
R = SnBu3 Failed

The etherifications of 20 to 21 have shown that a carbocation intermediate is
formed, but does not indicate if it is a fully dissociated carbocation. The failure to
observe allylation led me to conclude that Re2O7 is not able to convert a 1,2-dioxolan-3ol to a carbocation intermediate possessing sufficient reactivity to capture an alkene
nucleophile.
Section 6
Stabilized carbocations
I next conducted a brief investigation of the ability of Re2O7 to catalyze other
reactions involving a stabilized carbocation intermediate. As an initial target, I chose
triphenylmethanol, 31, as a substrate capable of forming a relatively stable trityl cation as
an intermediate. With the first set of conditions the use of excess nucleophile (5 eq). I
found that the reaction was in fact successful, though not in synthetically useful yields
(Entry 1). Interestingly, the amount of Re2O7 catalyst and the reaction time could be
decreased without loss of efficacy (Entry 2). This led to me rethinking how I approached
this investigation. As the trityl group is traditionally used as a protecting group I decided
to use 31 in excess under more standard conditions. This change led to a significant
improvement in the yield (Entry 3). Alternatively, adding activated 3Å molecular sieves
in the reaction allowed me to obtain comparable yields in the presence of two equivalents
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of 31 (Entry 4). A comparison of entries 4 and 5 demonstrate that the use of Re2O7
catalysis provides yields comparable to those obtained with a strong acid catalyst.

Entry
1
2
3
4
5

30
(eq)
5
5
1
1
1

31
(eq)
1
1
5
2
2

Re2O7
(mol%)
10
1
1
1
PTSA (10)

t
(h)
5
3
3
3
3

Sieves
(3Å)
No
No
No
Yes
Yes

Yield 32
(%)
48
59
81
84
87

Table 4.4
These results encouraged me to investigate the Re2O7-mediated activation of
alcohols as a potentially mild method for the synthesis of ethers. The first alcohol that
was chosen was 3,4-dimethoxy benzyl alcohol (3,4-DMB) (Entries 1-4). I found that
under previously known conditions (Entry 1) the reaction with 2-phenylethanol
proceeded in moderate yield, but when MeCN, which is able to solubilize both water and
Re2O7, was used the reaction did not proceed. It is unknown if the Re2O7 forms a
complex with MeCN that renders it inactive.

Under more protecting group like

conditions, an excess of the protecting agent, with the reaction proceeded, but in
depressed yield (Entry 3). I decided to use the OTBS analog of 3,4-DMB as I had
previously demonstrated that Re2O7 was capable of catalyzing the insertion into C-OSiR3
linkages. I found that the reaction proceeded in synthetically useful yield (Entry 4). The
use of less electron rich 4-methoxybenzyl alcohol (PMB) was successful (Entry 5) and
proceeded in similar yield to that of 3,4-DMB (Entry 3). However, when the OTBS
analog of PMB was employed the reaction was unsuccessful (Entry 6). The protection of
cumyl alcohol (cumyl) with 2-phenylethanol also proceeded in moderate yield under the
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reaction conditions (Entry 7). As the alcohol became less electron rich and sterically
hindered formation of the dimer became a serious problem. For example benzhydrol
gave predominantly dimer with a very low yield of the desired product.

R
30
(eq)
(eq)
1
5
3,4-DMB (1)
2a
5
3,4-DMB (1)
3
1
3,4-DMB (2)
4
5
3,4-DMB (1)
5
1
PMB (2)
6
1
PMB (2)
7
1
Cumyl (2)
a
Table 4.5 MeCN used as solvent
Entry

X
H
H
H
TBS
H
TBS
H

Re2O7
mol%
10
10
1
10
1
1
1

t
(h)
5
1
3
1
3
1
3

Sieves
(3Å)
Yes
Yes
Yes
No
Yes
No
Yes

Yield
(%)
58
NR
38
71
40
NR
46

Section 7
Conclusions
Through this work I have shown that Re2O7 is capable of catalyzing a variety of
reactions. The first is the synthesis of 3-alkoxy-1,2-dioxolanes from 1,2-dioxolan-3-ols
in good yield. Re2O7 is also able to catalyze the etherification and allylation of a lactol
and its OTBS analog in excellent yield.
I have also shown that Re2O7 is able to catalyze the formation of stabilized
carbocations, potentially providing a new method for the introduction of several alcohol
protecting groups. This approach is most successful for the introduction of the trityl
group, but also showed promise with the 3,4-DMB group. If this work is to be expanded
to other ether protecting groups further optimization must be done.
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Section 8
Experimentals
All reagents were used as received from commercial vendors, with the exception of
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from
sodium/benzophenone. All reactions were conducted under an atmosphere of N2 except
where noted; “RBF” indicates round-bottom flask. Thin layer chromatography (TLC)
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized
with a hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium
molybdate in 10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-pphenylenediamine solution in 1:20:100 acetic acid/water/methanol (specific for
peroxides);14 1% aq. KMnO4 (for unsaturated compounds); 3% vanillin in 3% H2SO4 in
ethanol (general stain after charring). “Standard drying and purification” refers to drying
of organic extracts over MgSO4, removal of solvent under vacuum, and purification by
flash chromatography using the indicated eluting solvent. 1H /13C NMR spectra were
obtained in CDCl3 unless otherwise indicated; peaks are reported as: chemical shift
(multiplicity, J couplings in Hz, number of protons). Infrared spectra were recorded as
neat ATR films with selected absorbances reported in wavenumbers (cm-1).
OH
O

Tetrahydro-2H-pyran-2-ol (25):
To a RBF containing 3,4-dihydro-2H-pyran (3.4204g, 40.7 mmol) neat cooled to 0oC was
added aq. HCl (8.3 mL, 41.5mmol, 0.2 M). The reaction was stirred overnight and then
diluted with H2O (25 mL) and extracted with CH2Cl2 (25 mL). The combined organic
fractions were washed with sat. aq. NaHCO3 (25 mL) and subjected to standard drying
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and purification with 40% EA/hex to 25 (2.297g, 55%). Rf (50% EA/hex): 0.45. 1H
NMR (600 MHz): 4.60 (m, 1H), 4.02 (m, 1H), 3.54 (m, 1H), 3.45 (d, J = 4.64, 1H), 1.911.76 (2H), 1.57-1.46 (4H). The NMR spectra matched those previously reported.15

tert-Butyldimethyl((tetrahydro-2H-pyran-2-yl)oxy)silane (26):
To a flame-dried RBF containing 25 (501.4 mg, 4.9 mmol) in THF (49 mL) was added
imidazole (0.4g, 5.9 mmol) and TBSCl (0.9g, 5.9 mmol) as a solution in THF (5 mL).
The reaction was stirred for 36 hrs, after which it was treated with H2O (30 mL) and
extracted with Et2O (2 x 30 mL). The combined organic layers were subjected to
standard drying and purification with 10% EA/hex to afford 26 (322.9 mg, 31%). Rf
(10% EA/hex): 0.52.

1

H NMR (300 MHz): 4.93 (m, 1H), 3.97 (m, 1H), 3.49 (m, 1H),

1.94-1.43 (6H), 0.92 (s, 9H), 0.12 (s, 3H), 0.10 (s, 3H).

13

C (75 MHz): 94.3, 63.0, 33.6,

26.0, 25.7, 19.9, 18.3, -4.1, -5.2.

2-Phenethoxytetrahydro-2H-pyran
Via etherification of alcohol
To a flame-dried vial containing 25 (153.1 mg, 1.5 mmol) in CH2Cl2 (15 mL) was added
sequentially 2-phenylethanol (0.9 mL, 7.5 mmol) and Re2O7 (7.26 mg, 0.015 mmol).
After stirring for 1 hr, the reaction was concentrated in vacuo and the residue obtained
was purified via column chromatography with 10% EA/hex to afford 2phenethoxytetrahydro-2H-pyran (275.5 mg, 89%). Rf (10% EA/hex): 0.41.

1

H (400

MHz): 7.36 (m, 5H), 4.63 (t, J = 4.6, 1H), 3.98 (m, 1h), 3.79 (m, 1H), 3.65 (m, 1H), 3.48
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(m, 1H), 2.95 (t, J = 7.2, 2H), 1.90-1.65 (6H).

13

C (100 MHz): 139.3, 129.2, 128.4,

126.3, 98.9, 68.5, 62.4, 36.6, 30.9, 25.6, 19.7. The NMR spectra matched those
previously reported.16
Via etherification of silyl ether
To a flame-dried vial containing a solution of 26 (216 mg, 1 mmol) in CH2Cl2 (10 mL)
was added sequentially 2-phenylethanol (0.6 mL, 5 mmol) and Re2O7 (4.8 mg, 0.01
mmol). After stirring for 1 hr, the reaction was concentrated in vacuo and the residue
obtained was purified via column chromatography with 10% EA/hex to afford 2phenethoxytetrahydro-2H-pyran (168.5 mg, 82%).

4-Oxatricyclo[4.3.1.13,8]undecan-5-ol (27):
To a flame-dried RBF containing a solution of 2-adamantanone (3.0 g, 20 mmol) in
CH2Cl2 (100 mL) was added sequentially m-chloroperoxybenzoic acid (7.15 g, 25 mmol)
and aq. NaHCO3 (40 mL, 20 mmol, 6.5 M in H2O). After stirring for 24 hrs, the reaction
was quenched with Na2SO3 (1g) and washed sequentially with sat. aq. NaHCO3 (20 mL)
and brine (20 mL). The combined organic layers were dried with MgSO4, and the
residue obtained upon concentration in vacuo was purified via column chromatography
with 60% EA/hex to afford 4-oxatricyclo[4.3.1.13,8]undecan-5-one (2.8522g, 86%) as a
white solid. Rf (60% EA/hex):0.48.

1

H (400 MHz): 4.46 (m, 1H), 3.07 (m, 1H), 2.15-

1.68 (12H). The NMR spectra matched those previously reported.17
To

a

flame-dried

RBF

containing

a

-78oC

solution

of

4-

oxatricyclo[4.3.1.13,8]undecan-5-one (2.0 g, 11 mmol) in CH2Cl2 (60 mL) was added
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Dibal-H (8.3 mL, 12.5 mmol, 1.5M in toluene) dropwise. The reaction was stirred at 78oC for 1 hr and quenched with MeOH (0.5 mL). The reaction was warmed to rt and
stirred for 45 min.

Sat. aq. Rochelle’s salt (30 mL) was added and the resulting

suspension was extracted with CH2Cl2 (3 x 40 mL). The combined organic layers were
washed with H2O (40 mL), and subjected to standard drying a purification with 40 %
EA/hex to afford hemiacetal 27 (1.9104g, quant). Rf (40 % EA/hex): 0.43.

1

H NMR

(400 MHz): 5.29 (d, J = 3.0, 1H), 4.27-4.12 (1H), 2.98 (bs, 1H), 2.35-1.28 (13H).

13

C

(100 MHz): 100.2, 72.4, 38.5, 38.3, 37.4, 25.8, 33.0, 29.4, 26.8, 26.7. The NMR spectra
matched those previously reported.18
O

(1R,8S)-5-Allyl-4-oxatricyclo[4.3.1.13,8]undecane (28):
To a flame-dried vial containing a solution of 27 (168.4 mg, 1 mmol) and Re2O7 (4.8mg,
0.01 mmol) in CH2Cl2 (10 mL) was added allyltrimethylsilane (0.8 mL, 5 mmol). The
reaction was stirred for 1 hr and then treated with sat. aq. NaHCO3 (5 mL) and H2O (5
mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were dried
with Na2SO4. The residue obtained upon concentration in vacuo was subjected to column
chromatography with EA/hex (1 x 10% EA/hex, 1 x 5% EA/hex) to afford 28 (166.5 mg,
90%). Rf (10% EA/hex): 0.6. 1H NMR (400 MHz): 5.83 (m, 1H), 5.10-5.00 (2H), 4.18
(m, 1H), 3.81 (t, J = 6.8, 1H), 2.37 (m, 1H), 2.18 (m, 1H), 2.00 – 1.64 (10H), 1.61 -1.49
(3H).

13

C (100 MHz): 136.6, 116.5, 81.9, 71.8, 41.5, 40.9, 40.0, 26.1, 36.0, 34.6, 30.0,

26.9, 26.4.
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Phenylethyl triphenylethyl (trityl) ether (32):
To a flame-dried RBF containing a solution of trityl alcohol (3.9g, 15 mmol) in CH2Cl2
(30 mL) was added sequentially Re2O7 (15 mg, 0.03 mmol) and 2-phenylethanol (0.36
mL, 3 mmol). The reaction was stirred for 3 hrs, and then treated with sat. aq. NaHCO3
(10 mL) and H2O (20 mL). The combined CH2Cl2 (3 x 20) extracts were subjected to
standard drying and purification with 10% EA/hex to afford 112 (879.4 mg, 81%) as a
white solid. Rf (10% EA/hex):0.64.

1

H NMR (400 MHz): 7.46-7.39 (5H), 7.35-7.20

(14H), 3.34 (t, J = 7.0, 2H), 2.93 (t, J = 7.0, 2H).

13

C (100 MHz): 144.4, 139.5, 129.4,

128.8, 128.4, 127.9, 127.0, 126.3, 86.8, 65.2, 36.9.

tert-Butyl-(3,4-dimethoxybenzyloxy)-dimethylsilane:
To a flame-dried RBF containing a solution of imidazole (1.0 g, 15 mmol) and 3,4dimethoxybenzyl alcohol (0.73 mL, 5 mmol) in DMF (50 mL) was added TBSCl (1.1 g,
7.5 mmol). The reaction was stirred for 20 hrs and then treated with H2O (100 mL). The
resulting suspension was extracted with Et2O (3 x 100 mL). The combined organic
layers were subjected to standard drying and purification with (1 x 25% EA/hex and 1 x
10% EA/hex) to afford tert-butyl-(3,4-dimethoxy-benzyloxy)-dimethyl-silane (1.3845 g,
98%). Rf (5% EA/hex):0.46.

1

H NMR (300 MHz): 6.91 (s, 1H), 6.84 (s, 2H), 4.69 (s,

2H), 3.89 (s, 3H), 3.88 (s, 3H), 0.95, 9H), 0.10 (s, 6H).
134.3, 118.4, 111.1, 109.8, 65.0, 56.1, 55.9, 26.1, 18.6, -5.0.

13

C (75 MHz): 149.1, 148.2,
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1,2-dimethoxy-4-(phenethoxymethyl)benzene
To a flame-dried RBF containing a suspension of Re2O7 (48 mg, 0.1 mmol) in CH2Cl2
(10 mL) was added sequentially 3,4-dimethoxybenzyl alcohol (0.15 mL, 1 mmol) and 2phenylethanol (0.6 mL, 5 mmol). The reaction was allowed to stir for 1 hr and then
treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x
20). The combined organic layers were dried with Na2SO4, and the residue obtained
upon concentration in vacuo was purified via column chromatography with 20% EA/hex
to afford 1,2-dimethoxy-4-(phenethoxymethyl)benzene (192 mg, 71%).
Procedure with TBS analog
To a flame-dried RBF containing a suspension of Re2O7 (47.5 mg, 0.1 mmol) in CH2Cl2
(10 mL) was added sequentially tert-butyl-(3,4-dimethoxy-benzyloxy)-dimethyl-silane
(280.4 mg, 0.99 mmol), 2-phenylethanol (0.6 mL, 5 mmol), and 3A sieves. The reaction
was allowed to stir for 5 hrs and was treated with sat. aq. NaHCO3 (5 mL) and extracted
with CH2Cl2 (3 x 10). The combined organic layers were subjected to standard drying
and

purification

with

20%

EA/hex

to

afford

(phenethoxymethyl)benzene (158.9 mg, 58%). Rf (5% EA/hex):0.42.

1,2-dimethoxy-41

H (300 MHz):

7.35-7.19 (5H), 6.90 – 6.81 (3H), 4.5 (s, 2H), 3.89 (s, 3H), 3.87 (s, 3H), 3.72 (t, J = 7.0,
2H), 2.96 (t, J = 7.0, 2H).

13

C (75 MHz): 149.2, 148.7, 139.2, 131.1, 129.1, 128.5, 126.3,

120.2, 111.1, 111.0, 73.0, 71.1, 56.1, 71.1, 56.1, 55.9, 36.5.
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t-Butyl-(4-methoxybenzyloxy)-dimethylsilane
To a flame-dried RBF containing imidazole (2 g, 30 mmol) and 4-methoxybenzyl alcohol
(1.4g, 10 mmol) in DMF (100 mL) was added TBSCl (2.3 g, 15 mmol). After 12 hrs the
reaction was treated with H2O (100 mL) and extracted with Et2O (3 x 75 mL). The
combined organic layers were subjected to standard drying and purification with 5%
EA/hex to afford t-butyl-(4-methoxybenzyloxy)-dimethylsilane (2.4148 g, 96%). Rf (5%
EA/hex):0.67.

1

H (400 MHz): 7.25 (m, 2H), 6.85 (m, 2H), 4.68 (s, 3H), 3.81 (s, 3H),

0.94 (s, 9H), 0.10 (s, 6H). The NMR spectra matched those previously reported.19

4-Methoxybenzyl phenethyl ether
To a flame-dried RBF containing a suspension of Re2O7 (15.2 mg, 0.03 mmol) in CH2Cl2
(30 mL) was added sequentially 4-methoxybenzyl alcohol (824 mg, 6 mmol), 2phenylethanol (0.36 mL, 3 mmol), and 3A sieves. After 3 hrs the reaction was treated
with sat. aq. NaHCO3 (10 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x 20). The
combined organic layers were subjected to standard drying and purification with 10%
EA/hex to afford 4-methoxybenzyl phenethyl ether (291.5 mg, 40%).

Rf (10%

EA/hex):0.56. 1H (300 MHz): 7.39-7.21 (7H), 7.0-6.89 (2H), 4.52 (s, 2H), 3.85 (s, 3H),
3.72 (t, J = 7.1, 2H), 2.98 (t, J = 7.1, 2H). The NMR spectra matched those previously
reported.20
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1-Methyl-1-phenylethyl phenethyl ether
To a flame-dried RBF containing a suspension of Re2O7 (16.6 mg, 0.03 mmol) in CH2Cl2
(30 mL) was added sequentially cumyl alcohol (816 mg, 6 mmol), 2-phenylethanol (0.36
mL, 3 mmol), and 3A sieves. After 3 hrs the reaction was treated with sat. aq. NaHCO3
(10 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x 20). The combined organic
layers were subjected to standard drying and purification with 10% EA/hex to afford 1methyl-1-phenylethyl phenethyl ether (334.4 mg, 46%). Rf (10% EA/hex):0.55. 1H (400
MHz): 7.39-7.16 (10H), 3.41 (t, J = 7.5, 2H), 2.89 (t, J = 7.3, 2H), 1.55 (s, 6H). The
NMR spectra matched those previously reported.20
Section 9
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